{"id":35412,"date":"2015-01-18T18:01:00","date_gmt":"2015-01-18T11:01:00","guid":{"rendered":"https:\/\/luatsubaoho.com\/phapluat\/?p=35412"},"modified":"2024-04-05T17:10:23","modified_gmt":"2024-04-05T10:10:23","slug":"nghi-dinh-so-57-2022-nd-cp-quy-dinh-cac-danh-muc-chat-ma-tuy-va-tien-chat","status":"publish","type":"post","link":"https:\/\/luatsubaoho.com\/phapluat\/nghi-dinh-so-57-2022-nd-cp-quy-dinh-cac-danh-muc-chat-ma-tuy-va-tien-chat\/","title":{"rendered":"Ngh\u1ecb \u0111\u1ecbnh s\u1ed1\u00a057\/2022\/N\u0110-CP\u00a0Quy \u0111\u1ecbnh c\u00e1c danh m\u1ee5c ch\u1ea5t ma t\u00fay v\u00e0 ti\u1ec1n ch\u1ea5t"},"content":{"rendered":"\n

Ngh\u1ecb \u0111\u1ecbnh s\u1ed1 57\/2022\/N\u0110-CP Quy \u0111\u1ecbnh c\u00e1c danh m\u1ee5c ch\u1ea5t ma t\u00fay v\u00e0 ti\u1ec1n ch\u1ea5t.\u00a0<\/p>\n\n\n\n\n
\n

CH\u00cdNH PH\u1ee6
<\/b><\/p>\n<\/td>\n

\n

C\u1ed8NG H\u00d2A X\u00c3 H\u1ed8I CH\u1ee6 NGH\u0128A VI\u1ec6T NAM
\u0110\u1ed9c l\u1eadp \u2013 T\u1ef1 do \u2013 H\u1ea1nh ph\u00fac
<\/b><\/p>\n<\/td>\n<\/tr>\n

\n

S\u1ed1: 57\/2022\/N\u0110-CP<\/p>\n<\/td>\n

\n

H\u00e0 N\u1ed9<\/i>i, ng\u00e0y 25 th\u00e1ng 8 n\u0103m 2022<\/span><\/i><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

NGH\u1eca \u0110\u1ecaNH<\/b><\/p>\n

QUY \u0110\u1ecaNH C\u00c1C DANH M\u1ee4C CH\u1ea4T MA T\u00daY V\u00c0 TI\u1ec0N CH\u1ea4T<\/p>\n

C\u0103n c\u1ee9 Lu\u1eadt T\u1ed5 ch\u1ee9c Ch\u00ednh ph\u1ee7 ng\u00e0y 19 th\u00e1ng 6 n\u0103m 2015; Lu\u1eadt s\u1eeda \u0111\u1ed5i, b\u1ed5 sung m\u1ed9t s\u1ed1 \u0111i\u1ec1u c\u1ee7a Lu\u1eadt T\u1ed5 ch\u1ee9c Ch\u00ednh ph\u1ee7 v\u00e0 Lu\u1eadt T\u1ed5 ch\u1ee9c ch\u00ednh quy\u1ec1n \u0111\u1ecb<\/i>a ph\u01b0\u01a1ng ng\u00e0y 22 th\u00e1ng 11 n\u0103m 2019;<\/span><\/i><\/p>\n

C\u0103n c\u1ee9 Lu\u1eadt Ph\u00f2ng, ch\u1ed1<\/i>ng ma t\u00fay ng\u00e0y 30 th\u00e1ng 3 n\u0103m 2021;<\/span><\/i><\/p>\n

C\u0103n c\u1ee9 B\u1ed9 lu\u1eadt H\u00ecnh s\u1ef1<\/i>\u00a0ng\u00e0y 27 th\u00e1ng 11 n\u0103m 2015 v\u00e0 Lu<\/span>\u1eadt s\u1eeda \u0111\u1ed5i, b\u1ed5 sung m\u1ed9t s\u1ed1 \u0111i\u1ec1u c\u1ee7a B\u1ed9 lu\u1eadt H\u00ecnh s\u1ef1<\/i>\u00a0ng\u00e0y 20 th\u00e1ng 6 n\u0103m 2017;<\/span><\/i><\/p>\n

C\u0103n c\u1ee9 Lu\u1eadt H\u00f3a ch\u1ea5<\/i>t ng\u00e0y 21 th\u00e1ng 11 n\u0103m 2007;<\/span><\/i><\/p>\n

C\u0103n c\u1ee9 Lu\u1ead<\/i>t D\u01b0<\/span>\u1ee3<\/i>c ng\u00e0y 06 th\u00e1ng 4 n\u0103m 2016;<\/span><\/i><\/p>\n

Theo \u0111\u1ec1 ngh\u1ecb c\u1ee7a B\u1ed9<\/i>\u00a0tr\u01b0<\/span>\u1edfng B\u1ed9 C\u00f4ng an;<\/i><\/p>\n

Ch\u00ednh ph\u1ee7 ban h\u00e0nh Ngh\u1ecb \u0111\u1ecbnh quy \u0111\u1ecbnh c\u00e1c danh m\u1ee5c ch\u1ea5t ma t\u00fay v\u00e0 ti\u1ec1n ch\u1ea5t.<\/i><\/p>\n

\u0110i\u1ec1u 1. Danh m\u1ee5c c\u00e1c ch\u1ea5t ma t\u00fay v\u00e0 ti\u1ec1n ch\u1ea5t<\/b><\/p>\n

Ban h\u00e0nh k\u00e8m theo Ngh\u1ecb \u0111\u1ecbnh n\u00e0y Ph\u1ee5 l\u1ee5c c\u00e1c danh m\u1ee5c ch\u1ea5t ma t\u00fay v\u00e0 ti\u1ec1n ch\u1ea5t sau \u0111\u00e2y:<\/p>\n

Danh m\u1ee5c I: C\u00e1c ch\u1ea5t ma t\u00fay tuy\u1ec7t \u0111\u1ed1i c\u1ea5m s\u1eed d\u1ee5ng trong y h\u1ecdc v\u00e0 \u0111<\/span>\u1eddi s\u1ed1ng x\u00e3 h\u1ed9i; vi\u1ec7c s\u1eed d\u1ee5ng c\u00e1c ch\u1ea5t n\u00e0y trong nghi\u00ean c\u1ee9u, ki\u1ec3m nghi\u1ec7m, gi\u00e1m \u0111\u1ecbnh, \u0111i\u1ec1u tra t\u1ed9i ph\u1ea1m theo quy \u0111\u1ecbnh \u0111\u1eb7c bi\u1ec7t c\u1ee7a c\u01a1 quan c\u00f3 th<\/span>\u1ea9m quy\u1ec1n.<\/p>\n

Danh m\u1ee5c II: C\u00e1c ch\u1ea5t ma t\u00fay \u0111\u01b0<\/span>\u1ee3c s\u1eed d\u1ee5ng h\u1ea1n ch\u1ebf trong nghi\u00ean c\u1ee9u, ki\u1ec3m nghi\u1ec7m, gi\u00e1m \u0111\u1ecbnh, \u0111i\u1ec1u tra t\u1ed9i ph\u1ea1m ho\u1eb7c trong l\u0129nh v\u1ef1c y t\u1ebf theo quy \u0111\u1ecbnh c\u1ee7a c\u01a1 quan c\u00f3 th<\/span>\u1ea9m quy\u1ec1n.<\/p>\n

Danh m\u1ee5c III: C\u00e1c ch\u1ea5t ma t\u00fay \u0111\u01b0<\/span>\u1ee3c s\u1eed d\u1ee5ng trong nghi\u00ean c\u1ee9u, ki\u1ec3m nghi\u1ec7m, gi\u00e1m \u0111\u1ecbnh, \u0111i\u1ec1u tra t\u1ed9i ph\u1ea1m ho\u1eb7c trong l\u0129nh v\u1ef1c y t\u1ebf, th\u00fa y theo quy \u0111\u1ecbnh c\u1ee7a c\u01a1 quan c\u00f3 th<\/span>\u1ea9m quy\u1ec1n.<\/p>\n

Danh m\u1ee5c IV: C\u00e1c ti\u1ec1n ch\u1ea5t (IVA: C\u00e1c ti\u1ec1n ch\u1ea5t thi\u1ebft y\u1ebfu, tham gia v\u00e0o c\u1ea5u tr\u00fac ch\u1ea5t ma t\u00fay; IVB: C\u00e1c ti\u1ec1n ch\u1ea5t l\u00e0 h\u00f3a ch\u1ea5t, dung m\u00f4i, ch\u1ea5t x\u00fac t\u00e1c d\u00f9ng trong qu\u00e1 tr\u00ecnh s\u1ea3n xu\u1ea5t ch\u1ea5t ma t\u00fay).<\/p>\n

\u0110i\u1ec1u 2. Tr\u00e1ch nhi\u1ec7m th\u1ef1c hi\u1ec7n<\/b><\/p>\n

1. B\u1ed9\u00a0tr\u01b0<\/span>\u1edfng B\u1ed9 C\u00f4ng an, c\u00e1c B\u1ed9\u00a0tr\u01b0<\/span>\u1edfng, Th\u1ee7\u00a0tr\u01b0<\/span>\u1edfng c\u01a1 quan ngang b<\/span>\u1ed9, Th\u1ee7\u00a0tr\u01b0<\/span>\u1edfng c\u01a1 quan thu<\/span>\u1ed9c Ch\u00ednh ph\u1ee7, Ch\u1ee7 t\u1ecbch \u1ee6y ban nh\u00e2n d\u00e2n c\u00e1c t\u1ec9nh, th\u00e0nh ph\u1ed1 tr\u1ef1c thu\u1ed9c trung \u01b0\u01a1ng v\u00e0 t<\/span>\u1ed5 ch\u1ee9c, c\u00e1 nh\u00e2n c\u00f3 li\u00ean quan ch\u1ecbu tr\u00e1ch nhi\u1ec7m thi h\u00e0nh Ngh\u1ecb \u0111\u1ecbnh n\u00e0y.<\/p>\n

2. B\u1ed9 N\u00f4ng nghi\u1ec7p v\u00e0 Ph\u00e1t tri\u1ec3n n\u00f4ng th\u00f4n c\u00f3 tr\u00e1ch nhi\u1ec7m qu\u1ea3n l\u00fd c\u00e1c thu\u1ed1c th\u00fa y c\u00f3 ch\u1ee9a ch\u1ea5t ma t\u00fay v\u00e0 ti\u1ec1n ch\u1ea5t, ch\u1ea5t ma t\u00fay v\u00e0 ti\u1ec1n ch\u1ea5t d\u00f9ng l\u00e0m nguy\u00ean li\u1ec7u s\u1ea3n xu\u1ea5t thu\u1ed1c th\u00fa y theo quy \u0111\u1ecbnh t\u1ea1i Ngh\u1ecb \u0111\u1ecbnh s\u1ed1\u00a0105\/2021\/N\u0110-CP ng\u00e0y 04 th\u00e1ng 12 n\u0103m 2021 c<\/span>\u1ee7a Ch\u00ednh ph\u1ee7 quy \u0111\u1ecbnh chi ti\u1ebft v\u00e0 h\u01b0<\/span>\u1edbng d\u1eabn thi h\u00e0nh m\u1ed9t s\u1ed1 \u0111i\u1ec1u c\u1ee7a Lu\u1eadt Ph\u00f2ng, ch\u1ed1ng ma t\u00fay.<\/p>\n

3. Khi ph\u00e1t hi\u1ec7n ch\u1ea5t m\u1edbi ch\u01b0a c\u00f3 trong c\u00e1c danh m<\/span>\u1ee5c ch\u1ea5t ma t\u00fay v\u00e0 ti\u1ec1n ch\u1ea5t ban h\u00e0nh k\u00e8m theo Ngh\u1ecb \u0111\u1ecbnh n\u00e0y li\u00ean quan \u0111<\/span>\u1ebfn m\u1ee5c \u0111\u00edch b\u1ea5t h\u1ee3p ph\u00e1p ho\u1eb7c theo quy \u0111\u1ecbnh t\u1ea1i 03 C\u00f4ng \u01b0<\/span>\u1edbc c\u1ee7a Li\u00ean h\u1ee3p qu\u1ed1c v\u1ec1 ph\u00f2ng, ch\u1ed1ng ma t\u00fay th\u00ec B\u1ed9 C\u00f4ng an c\u00f3 tr\u00e1ch nhi\u1ec7m ch\u1ee7 tr\u00ec, ph\u1ed1i h\u1ee3p v\u1edbi B\u1ed9 Y t\u1ebf, B\u1ed9\u00a0C\u00f4ng Th\u01b0\u01a1ng, B<\/span>\u1ed9 Khoa h\u1ecdc v\u00e0 C\u00f4ng ngh\u1ec7, B\u1ed9 N\u00f4ng nghi\u1ec7p v\u00e0 Ph\u00e1t tri\u1ec3n n\u00f4ng th\u00f4n v\u00e0 c\u00e1c c\u01a1 quan c\u00f3 li\u00ean quan xem x\u00e9t, tr<\/span>\u00ecnh Ch\u00ednh ph\u1ee7 s\u1eeda \u0111\u1ed5i, b\u1ed5 sung v\u00e0 c\u00f4ng b\u1ed1 c\u00e1c danh m\u1ee5c \u0111\u00f3.<\/p>\n

\u0110i\u1ec1u 3. Hi\u1ec7u l\u1ef1c thi h\u00e0nh<\/b><\/p>\n

1. Ngh\u1ecb \u0111\u1ecbnh n\u00e0y c\u00f3 hi\u1ec7u l\u1ef1c thi h\u00e0nh t\u1eeb\u00a0ng\u00e0y 25 th\u00e1ng 8 n\u0103m 2022.<\/span><\/p>\n

2. Ngh\u1ecb \u0111\u1ecbnh s\u1ed1\u00a073\/2018\/N\u0110-CP\u00a0ng\u00e0y 15 th\u00e1ng 5 n\u0103m 2018 c<\/span>\u1ee7a Ch\u00ednh ph\u1ee7 quy \u0111\u1ecbnh c\u00e1c danh m\u1ee5c ch\u1ea5t ma t\u00fay v\u00e0 ti\u1ec1n ch\u1ea5t; Ngh\u1ecb \u0111\u1ecbnh s\u1ed1\u00a060\/2020\/N\u0110-CP\u00a0ng\u00e0y 29 th\u00e1ng 5 n\u0103m 2020 c<\/span>\u1ee7a Ch\u00ednh ph\u1ee7 s\u1eeda \u0111\u1ed5i, b\u1ed5 sung danh m\u1ee5c c\u00e1c ch\u1ea5t ma t\u00fay v\u00e0 ti\u1ec1n ch\u1ea5t ban h\u00e0nh k\u00e8m theo Ngh\u1ecb \u0111\u1ecbnh s\u1ed1\u00a073\/2018\/N\u0110-CP\u00a0ng\u00e0y 15 th\u00e1ng 5 n\u0103m 2018 c<\/span>\u1ee7a Ch\u00ednh ph\u1ee7 quy \u0111\u1ecbnh c\u00e1c danh m\u1ee5c ch\u1ea5t ma t\u00fay v\u00e0 ti\u1ec1n ch\u1ea5t h\u1ebft hi\u1ec7u l\u1ef1c k\u1ec3 t\u1eeb ng\u00e0y Ngh\u1ecb \u0111\u1ecbnh n\u00e0y c\u00f3 hi\u1ec7u l\u1ef1c thi h\u00e0nh.<\/p>\n\n\n\n
\n

N\u01a1i nh<\/span>\u1eadn:
<\/i><\/b>\u2013 Ban B\u00ed th\u01b0 Trung \u01b0\u01a1n<\/span>g \u0110\u1ea3ng;
\u2013 Th\u1ee7\u00a0t\u01b0<\/span>\u1edbng, c\u00e1c Ph\u00f3 Th\u1ee7\u00a0t\u01b0<\/span>\u1edbng Ch\u00ednh ph\u1ee7;
\u2013 C\u00e1c b\u1ed9, c\u01a1 quan ngang b<\/span>\u1ed9, c\u01a1 quan thu<\/span>\u1ed9c Ch\u00ednh ph\u1ee7;
\u2013 H\u0110ND, UBND c\u00e1c t\u1ec9nh, th\u00e0nh ph\u1ed1 tr\u1ef1c thu\u1ed9c trung \u01b0\u01a1ng;
\u2013 V\u0103n ph<\/span>\u00f2ng Trung\u00a0\u01b0\u01a1ng v\u00e0 c\u00e1c Ban c<\/span>\u1ee7a \u0110\u1ea3ng;
\u2013 V\u0103n ph\u00f2ng T\u1ed5ng B\u00ed th\u01b0;
\u2013 V\u0103n ph<\/span>\u00f2ng Ch\u1ee7 t\u1ecbch n\u01b0<\/span>\u1edbc;
\u2013 H\u1ed9i \u0111\u1ed3ng D\u00e2n t\u1ed9c v\u00e0 c\u00e1c \u1ee6y ban c\u1ee7a Qu\u1ed1c h\u1ed9i;
\u2013 V\u0103n ph\u00f2ng Qu\u1ed1c h\u1ed9i;
\u2013 T\u00f2a \u00e1n nh\u00e2n d\u00e2n t\u1ed1i cao;
\u2013 Vi\u1ec7n ki\u1ec3m s\u00e1t nh\u00e2n d\u00e2n t\u1ed1i cao;
\u2013 \u1ee6y ban Gi\u00e1m s\u00e1t t\u00e0i ch\u00ednh Qu\u1ed1c gia;
\u2013 Ki\u1ec3m to\u00e1n nh\u00e0 n\u01b0<\/span>\u1edbc;
\u2013 Ng\u00e2n h\u00e0ng Ch\u00ednh s\u00e1ch x\u00e3 h\u1ed9i;
\u2013 Ng\u00e2n h\u00e0ng Ph\u00e1t tri\u1ec3n Vi\u1ec7t Nam;
\u2013 \u1ee6y ban trung \u01b0\u01a1ng M<\/span>\u1eb7t tr\u1eadn T\u1ed5 qu\u1ed1c Vi\u1ec7t Nam;
\u2013 C\u01a1 quan trung \u01b0\u01a1ng c<\/span>\u1ee7a c\u00e1c \u0111o\u00e0n th<\/span>\u1ec3;
\u2013 VPCP: BTCN, c\u00e1c PCN, Tr\u1ee3 l\u00fd TTg, TG\u0110 C\u1ed5ng TT\u0110T,
c\u00e1c V\u1ee5, C\u1ee5c, \u0111\u01a1n v<\/span>\u1ecb tr\u1ef1c thu\u1ed9c, C\u00f4ng b\u00e1o;
\u2013 L\u01b0u: VT, KGVX (2b)<\/span>.<\/p>\n<\/td>\n

\n

TM. CH\u00cdNH PH\u1ee6
KT. TH\u1ee6<\/b>\u00a0T\u01af<\/span>\u1edaNG
PH\u00d3 TH\u1ee6<\/b>\u00a0T\u01af<\/span>\u1edaNG


V\u0169 \u0110\u1ee9c \u0110am<\/b><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

\u00a0<\/p>\n

PH\u1ee4 L\u1ee4C<\/b><\/p>\n

(K\u00e8m theo Ngh\u1ecb \u0111\u1ecbnh s\u1ed1\u00a0<\/i>57\/2022\/N\u0110-CP ng\u00e0y 25 th\u00e1ng 8 n\u0103m 2022 c<\/span>\u1ee7a Ch\u00ednh ph\u1ee7)<\/i><\/p>\n\n\n\n\n\n\n
\n

Danh m\u1ee5c I<\/p>\n<\/td>\n

\n

C\u00e1c ch\u1ea5t ma t\u00fay tuy\u1ec7t \u0111\u1ed1i c\u1ea5m s\u1eed d\u1ee5ng trong y h\u1ecdc v\u00e0 \u0111<\/span>\u1eddi s\u1ed1ng x\u00e3 h\u1ed9i; vi\u1ec7c s\u1eed d\u1ee5ng c\u00e1c ch\u1ea5t n\u00e0y trong nghi\u00ean c\u1ee9u, ki\u1ec3m nghi\u1ec7m, gi\u00e1m \u0111\u1ecbnh, \u0111i\u1ec1u tra t\u1ed9i ph\u1ea1m theo quy \u0111\u1ecbnh \u0111\u1eb7c bi\u1ec7t c\u1ee7a c\u01a1 quan c\u00f3 th<\/span>\u1ea9m quy\u1ec1n<\/p>\n<\/td>\n<\/tr>\n

\n

Danh m\u1ee5c II<\/p>\n<\/td>\n

\n

C\u00e1c ch\u1ea5t ma t\u00fay \u0111\u01b0<\/span>\u1ee3c s\u1eed d\u1ee5ng h\u1ea1n ch\u1ebf trong nghi\u00ean c\u1ee9u, ki\u1ec3m nghi\u1ec7m, gi\u00e1m \u0111\u1ecbnh, \u0111i\u1ec1u tra t\u1ed9i ph\u1ea1m ho\u1eb7c trong l\u0129nh v\u1ef1c y t\u1ebf theo quy \u0111\u1ecbnh c\u1ee7a c\u01a1 quan c\u00f3 th<\/span>\u1ea9m quy\u1ec1n<\/p>\n<\/td>\n<\/tr>\n

\n

Danh m\u1ee5c III<\/p>\n<\/td>\n

\n

C\u00e1c ch\u1ea5t ma t\u00fay \u0111\u01b0<\/span>\u1ee3c s\u1eed d\u1ee5ng trong nghi\u00ean c\u1ee9u, ki\u1ec3m nghi\u1ec7m, gi\u00e1m \u0111\u1ecbnh, \u0111i\u1ec1u tra t\u1ed9i ph\u1ea1m ho\u1eb7c trong l\u0129nh v\u1ef1c y t\u1ebf, th\u00fa y theo quy \u0111\u1ecbnh c\u1ee7a c\u01a1 quan c\u00f3 th<\/span>\u1ea9m quy\u1ec1n<\/p>\n<\/td>\n<\/tr>\n

\n

Danh m\u1ee5c IV<\/p>\n<\/td>\n

\n

C\u00e1c ti\u1ec1n ch\u1ea5t<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

\u00a0<\/p>\n

DANH M\u1ee4C I<\/b><\/p>\n

C\u00c1C CH\u1ea4T MA T\u00daY TUY\u1ec6T \u0110\u1ed0I C\u1ea4M S\u1eec D\u1ee4NG TRONG Y H\u1eccC V\u00c0 \u0110\u1edcI S\u1ed0NG X\u00c3 H\u1ed8I; VI\u1ec6C S\u1eec D\u1ee4NG C\u00c1C CH\u1ea4T N\u00c0Y TRONG NGHI\u00caN C\u1ee8U, KI\u1ec2M NGHI\u1ec6M, GI\u00c1M \u0110\u1ecaNH, \u0110I\u1ec0U TRA T\u1ed8I PH\u1ea0M THEO QUY \u0110\u1ecaNH \u0110\u1eb6C BI\u1ec6T C\u1ee6A C\u01a0 QUAN C\u00d3 TH\u1ea8M QUY\u1ec0N<\/p>\n

IA. C\u00e1c ch\u1ea5t v\u00e0 mu\u1ed1i, \u0111\u1ed3ng ph\u00e2n, ester, ether v\u00e0 mu\u1ed1i c\u1ee7a c\u00e1c \u0111\u1ed3ng ph\u00e2n, ester, ether c\u00f3 th\u1ec3 t\u1ed3n t\u1ea1i c\u1ee7a c\u00e1c ch\u1ea5t n\u00e0y<\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n

STT<\/b><\/p>\n<\/td>\n

\n

T\u00ean ch\u1ea5t<\/b><\/p>\n<\/td>\n

\n

T\u00ean khoa h\u1ecdc<\/b><\/p>\n<\/td>\n

\n

M\u00e3 th\u00f4ng tin CAS<\/b><\/p>\n<\/td>\n<\/tr>\n

\n

1<\/p>\n<\/td>\n

\n

Acetorphine<\/p>\n<\/td>\n

\n

3-O<\/i>-acetyltetrahydro \u2013 7 \u2013\u00a0\u03b1<\/i>\u00a0\u2013\u00a0<\/i>(1 \u2013 hydroxyl \u2013 1 \u2013 methylbutyl) \u2013 6, 14 \u2013\u00a0endo<\/i>etheno \u2013 oripavine<\/p>\n<\/td>\n

\n

25333-77-1<\/p>\n<\/td>\n<\/tr>\n

\n

2<\/p>\n<\/td>\n

\n

Acetyl-alpha<\/i>-methylfenanyl<\/p>\n<\/td>\n

\n

N-<\/i>\u00a0[1 \u2013 (\u03b1<\/i>\u00a0\u2013 methylphenethyl) \u2013 4 \u2013 piperidyl] acetanilide<\/p>\n<\/td>\n

\n

101860-00-8<\/p>\n<\/td>\n<\/tr>\n

\n

3<\/p>\n<\/td>\n

\n

Alphacetylmethadol<\/p>\n<\/td>\n

\n

\u03b1<\/i>\u00a0\u2013 3 \u2013 acetoxy \u2013 6 \u2013 dimethylamino \u2013 4,4 \u2013 diphenylheptane<\/p>\n<\/td>\n

\n

17199-58-5<\/p>\n<\/td>\n<\/tr>\n

\n

4<\/p>\n<\/td>\n

\n

Alpha<\/i>-methylfentanyl<\/p>\n<\/td>\n

\n

N-<\/i>\u00a0[1\u00a0\u2013 (\u03b1 \u2013 me<\/i>thylphenethyl) \u2013 4 \u2013 peperidyl] propionanilide<\/p>\n<\/td>\n

\n

79704-88-4<\/p>\n<\/td>\n<\/tr>\n

\n

5<\/p>\n<\/td>\n

\n

Beta<\/i>-hydroxyfentanyl<\/p>\n<\/td>\n

\n

N-<\/i>\u00a0[1 \u2013 (\u03b2<\/i>\u00a0\u2013 hydroxyphenethyl) \u2013 4 \u2013 peperidyl] propionanilide<\/p>\n<\/td>\n

\n

78995-10-5<\/p>\n<\/td>\n<\/tr>\n

\n

6<\/p>\n<\/td>\n

\n

Beta<\/i>-hydroxymethyl-3-fentanyl<\/p>\n<\/td>\n

\n

N-<\/i>\u00a0[1 \u2013 (\u03b2<\/i>\u00a0\u2013 hydroxyphenethyl) \u2013 3 \u2013 methyl \u2013 4 \u2013 piperidyl] propinonanilide<\/p>\n<\/td>\n

\n

78995-14-9<\/p>\n<\/td>\n<\/tr>\n

\n

7<\/p>\n<\/td>\n

\n

Desomorphine<\/p>\n<\/td>\n

\n

Dihydrodeoxymorphine<\/p>\n<\/td>\n

\n

427-00-9<\/p>\n<\/td>\n<\/tr>\n

\n

8<\/p>\n<\/td>\n

\n

Etorphine<\/p>\n<\/td>\n

\n

Tetrahydro \u2013 7\u03b1<\/i>\u00a0\u2013 (1 \u2013 hydroxy \u2013 1 \u2013 methylbutyl) \u2013 6,14 \u2013\u00a0endo<\/i>etheno \u2013 oripavine<\/p>\n<\/td>\n

\n

14521-96-1<\/p>\n<\/td>\n<\/tr>\n

\n

9<\/p>\n<\/td>\n

\n

Heroin<\/p>\n<\/td>\n

\n

Diacetylmorphine<\/p>\n<\/td>\n

\n

561-27-3<\/p>\n<\/td>\n<\/tr>\n

\n

10<\/p>\n<\/td>\n

\n

Ketobemidone<\/p>\n<\/td>\n

\n

4 \u2013\u00a0meta<\/i>\u00a0\u2013 hydroxyphenyl \u2013 1 \u2013 methyl \u2013 4 \u2013 propionylpiperidine<\/p>\n<\/td>\n

\n

469-79-4<\/p>\n<\/td>\n<\/tr>\n

\n

11<\/p>\n<\/td>\n

\n

3-methylfentanyl<\/p>\n<\/td>\n

\n

N-<\/i>\u00a0(3 \u2013 methyl \u2013 1 \u2013 phenethyl \u2013 4 \u2013 piperidyl) propionanilide<\/p>\n<\/td>\n

\n

42045-86-3<\/p>\n<\/td>\n<\/tr>\n

\n

12<\/p>\n<\/td>\n

\n

3-methylthiofentanyl<\/p>\n<\/td>\n

\n

N-<\/i>\u00a0[3 \u2013 methyl \u2013 1 [2 \u2013 (2 \u2013 thienyl) ethyl] \u2013 4 \u2013 piperidyl] propionanilide<\/p>\n<\/td>\n

\n

86052-04-2<\/p>\n<\/td>\n<\/tr>\n

\n

13<\/p>\n<\/td>\n

\n

Morphine methobromide v\u00e0 c\u00e1c ch\u1ea5t d\u1eabn xu\u1ea5t c\u1ee7a Morphine Nit\u01a1 h\u00f3a tr<\/span>\u1ecb V kh\u00e1c<\/p>\n<\/td>\n

\n

(5\u03b1<\/i>,6\u03b1)<\/i>\u00a0\u2013 17 \u2013 Methyl \u2013 7,8 -didehydro \u2013 4,5 \u2013 epoxymorphinan \u2013 3,6 \u2013 diol \u2013 bromomethane (1:1)<\/p>\n<\/td>\n

\n

125-23-5<\/p>\n<\/td>\n<\/tr>\n

\n

14<\/p>\n<\/td>\n

\n

Para<\/i>-fluorofentanyl<\/p>\n<\/td>\n

\n

4\u2019 \u2013 fluoro \u2013\u00a0N \u2013<\/i>\u00a0(1 \u2013 phenethyl \u2013 4 \u2013 piperidyl) propionanilide<\/p>\n<\/td>\n

\n

90736-23-5<\/p>\n<\/td>\n<\/tr>\n

\n

15<\/p>\n<\/td>\n

\n

PEPAP<\/p>\n<\/td>\n

\n

1 \u2013 phenethyl \u2013 4 \u2013 phenyl \u2013 4 \u2013 piperidinol acetate<\/p>\n<\/td>\n

\n

64-52-8<\/p>\n<\/td>\n<\/tr>\n

\n

16<\/p>\n<\/td>\n

\n

Thiofentanyl<\/p>\n<\/td>\n

\n

N \u2013<\/i>\u00a0(1 [2- (2 \u2013 thienyl) ethyl] \u2013 4 \u2013 piperidyl] \u2013 4 \u2013 propionanilide<\/p>\n<\/td>\n

\n

1165-22-6<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

<\/a>IB. C\u00e1c ch\u1ea5t v\u00e0 mu\u1ed1i, \u0111\u1ed3ng ph\u00e2n c\u00f3 th\u1ec3 t\u1ed3n t\u1ea1i c\u1ee7a c\u00e1c ch\u1ea5t n\u00e0y<\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n

STT<\/b><\/p>\n<\/td>\n

\n

T\u00ean ch\u1ea5t<\/b><\/p>\n<\/td>\n

\n

T\u00ean khoa h\u1ecdc<\/b><\/p>\n<\/td>\n

\n

M\u00e3 th\u00f4ng tin CAS<\/b><\/p>\n<\/td>\n<\/tr>\n

\n

1<\/p>\n<\/td>\n

\n

Brolamphetamine (DOB)<\/p>\n<\/td>\n

\n

2,5 \u2013 dimethoxy \u2013 4 \u2013 bromoamphetamine<\/p>\n<\/td>\n

\n

64638-07-9<\/p>\n<\/td>\n<\/tr>\n

\n

2<\/p>\n<\/td>\n

\n

Cathinone<\/p>\n<\/td>\n

\n

(-) \u2013\u00a0\u03b1<\/i>\u00a0\u2013 aminopropiophenone<\/p>\n<\/td>\n

\n

71031-15-7<\/p>\n<\/td>\n<\/tr>\n

\n

3<\/p>\n<\/td>\n

\n

DET<\/p>\n<\/td>\n

\n

N, N<\/i>\u00a0\u2013 diethyltryptamine<\/p>\n<\/td>\n

\n

7558-72-7<\/p>\n<\/td>\n<\/tr>\n

\n

4<\/p>\n<\/td>\n

\n

Delta-9-tetrahydrocanabinol<\/p>\n<\/td>\n

\n

(6aR<\/i>, 10aR<\/i>) \u2013 6a<\/i>, 7, 8, 10a<\/i>\u00a0\u2013 tetrahydro \u2013 6,6,9 \u2013 trimethyl \u2013 3 \u2013 pentyl \u2013 6H<\/i>\u00a0\u2013 dibenzo [b,d<\/i>] pyran \u2013 1 \u2013 ol<\/p>\n<\/td>\n

\n

1972-08-3<\/p>\n<\/td>\n<\/tr>\n

\n

5<\/p>\n<\/td>\n

\n

DMA<\/p>\n<\/td>\n

\n

(\u00b1) \u2013 2,5 \u2013 dimethoxy \u2013\u00a0\u03b1 \u2013\u00a0<\/i>methylphenylethylamine<\/p>\n<\/td>\n

\n

2801-68-5<\/p>\n<\/td>\n<\/tr>\n

\n

6<\/p>\n<\/td>\n

\n

DMHP<\/p>\n<\/td>\n

\n

3 \u2013 (1,2 \u2013 dimethylheptyl) \u2013 1 \u2013 hydroxy \u2013 7, 8, 9, 10- tetrahydro \u2013 6,6,9 \u2013 trimethyl \u2013 6H\u00a0<\/i>\u2013 dibenzo [b,d<\/i>] pyran<\/p>\n<\/td>\n

\n

32904-22-6<\/p>\n<\/td>\n<\/tr>\n

\n

7<\/p>\n<\/td>\n

\n

DMT<\/p>\n<\/td>\n

\n

N, N \u2013<\/i>\u00a0dimethyltryptamine<\/p>\n<\/td>\n

\n

61-50-7<\/p>\n<\/td>\n<\/tr>\n

\n

8<\/p>\n<\/td>\n

\n

DOET<\/p>\n<\/td>\n

\n

(\u00b1) \u2013 4 \u2013 ethyl \u2013 2,5 \u2013 dimethoxy\u00a0\u2013 \u03b1\u00a0<\/i>\u2013 phenethylamine<\/p>\n<\/td>\n

\n

22004-32-6<\/p>\n<\/td>\n<\/tr>\n

\n

9<\/p>\n<\/td>\n

\n

Eticyclidine<\/p>\n<\/td>\n

\n

N-<\/i>\u00a0ethyl \u2013 1 \u2013 phenylcylohexylamine<\/p>\n<\/td>\n

\n

2201-15-2<\/p>\n<\/td>\n<\/tr>\n

\n

10<\/p>\n<\/td>\n

\n

Etryptamine<\/p>\n<\/td>\n

\n

3 \u2013 (2 \u2013 aminobuty) indole<\/p>\n<\/td>\n

\n

2235-90-7<\/p>\n<\/td>\n<\/tr>\n

\n

11<\/p>\n<\/td>\n

\n

MDMA<\/p>\n<\/td>\n

\n

(\u00b1) \u2013\u00a0N \u2013 \u03b1<\/i>\u00a0\u2013 dimethyl \u2013 3,4 \u2013 (methylenedioxy) phenethylamine<\/p>\n<\/td>\n

\n

42542-10-9<\/p>\n<\/td>\n<\/tr>\n

\n

12<\/p>\n<\/td>\n

\n

Mescalin<\/p>\n<\/td>\n

\n

3,4,5 \u2013 trimethoxyphenethylamine<\/p>\n<\/td>\n

\n

54-04-6<\/p>\n<\/td>\n<\/tr>\n

\n

13<\/p>\n<\/td>\n

\n

Methcathinone<\/p>\n<\/td>\n

\n

2 \u2013 (methylamino)-1- phenylpropan-1- one<\/p>\n<\/td>\n

\n

5650-44-2<\/p>\n<\/td>\n<\/tr>\n

\n

14<\/p>\n<\/td>\n

\n

4-methylaminorex<\/p>\n<\/td>\n

\n

(\u00b1) \u2013\u00a0cis<\/i>\u00a0\u2013 2 \u2013 amino \u2013 4 \u2013 methyl \u2013 5 \u2013 phenyl \u2013 2 \u2013 oxazoline<\/p>\n<\/td>\n

\n

3568-94-3<\/p>\n<\/td>\n<\/tr>\n

\n

15<\/p>\n<\/td>\n

\n

MMDA<\/p>\n<\/td>\n

\n

(\u00b1) \u2013 5 \u2013 methoxy \u2013 3,4 \u2013 methylenedioxy \u2013\u00a0\u03b1 \u2013\u00a0<\/i>methylphenylethylamine<\/p>\n<\/td>\n

\n

13674-05-0<\/p>\n<\/td>\n<\/tr>\n

\n

16<\/p>\n<\/td>\n

\n

(+)-Lysergide (LSD)<\/p>\n<\/td>\n

\n

9,10 \u2013 didehydro \u2013\u00a0N, N \u2013<\/i>\u00a0diethyl \u2013 6 \u2013 methylergoline \u2013 8\u03b2<\/i>\u00a0carboxamide<\/p>\n<\/td>\n

\n

50-37-3<\/p>\n<\/td>\n<\/tr>\n

\n

17<\/p>\n<\/td>\n

\n

N<\/i>-hydroxy MDA (MDOH)<\/p>\n<\/td>\n

\n

(\u00b1) \u2013\u00a0N<\/i>\u00a0\u2013 hydroxy \u2013 [\u03b1<\/i>\u00a0\u2013 methyl \u2013 3,4 \u2013 (methylenedyoxy) phenethyl] hydroxylamine<\/p>\n<\/td>\n

\n

74698-47-8<\/p>\n<\/td>\n<\/tr>\n

\n

18<\/p>\n<\/td>\n

\n

N<\/i>-ethyl MDA<\/p>\n<\/td>\n

\n

(\u00b1)\u00a0N<\/i>\u00a0\u2013 ethyl \u2013 methyl \u2013 3,4 \u2013 (methylenedioxy) phenethylamine<\/p>\n<\/td>\n

\n

82801-81-8<\/p>\n<\/td>\n<\/tr>\n

\n

19<\/p>\n<\/td>\n

\n

Parahexyl<\/p>\n<\/td>\n

\n

3 \u2013 hexyl \u2013 7, 8, 9, 10 \u2013 tetrahydro \u2013 6,6,9 \u2013 trimethyl \u2013 6H<\/i>\u2013 dibenzo [b,d<\/i>] pyran -1- ol<\/p>\n<\/td>\n

\n

117-51-1<\/p>\n<\/td>\n<\/tr>\n

\n

20<\/p>\n<\/td>\n

\n

PMA<\/p>\n<\/td>\n

\n

p<\/i>\u00a0\u2013 methoxy \u2013\u00a0\u03b1\u00a0<\/i>\u2013 methylphenethylamine<\/p>\n<\/td>\n

\n

64-13-1<\/p>\n<\/td>\n<\/tr>\n

\n

21<\/p>\n<\/td>\n

\n

Psilocine, Psilotsin<\/p>\n<\/td>\n

\n

3 \u2013 [2 \u2013 (dimetylamino) ethyl] indol \u2013 4 \u2013 ol<\/p>\n<\/td>\n

\n

520-53-6<\/p>\n<\/td>\n<\/tr>\n

\n

22<\/p>\n<\/td>\n

\n

Psilocybine<\/p>\n<\/td>\n

\n

3 \u2013 [2 \u2013 dimetylaminoethyl] indol -4- yl dihydrogen phosphate<\/p>\n<\/td>\n

\n

520-52-5<\/p>\n<\/td>\n<\/tr>\n

\n

23<\/p>\n<\/td>\n

\n

Rolicyclidine<\/p>\n<\/td>\n

\n

1 \u2013 (1 \u2013 phenylcyclohexy) pyrrolidine<\/p>\n<\/td>\n

\n

2201-39-0<\/p>\n<\/td>\n<\/tr>\n

\n

24<\/p>\n<\/td>\n

\n

STP, DOM<\/p>\n<\/td>\n

\n

2,5- dimethoxy \u2013 4,\u03b1-\u00a0<\/i>dimethylphenethylamine<\/p>\n<\/td>\n

\n

15588-95-1<\/p>\n<\/td>\n<\/tr>\n

\n

25<\/p>\n<\/td>\n

\n

Tenamfetamine (MDA)<\/p>\n<\/td>\n

\n

\u03b1 \u2013\u00a0<\/i>methyl \u2013 3,4 \u2013 (methylendioxy) phenethylamine<\/p>\n<\/td>\n

\n

4764-17-4<\/p>\n<\/td>\n<\/tr>\n

\n

26<\/p>\n<\/td>\n

\n

Tenocyclidine (TCP)<\/p>\n<\/td>\n

\n

1 \u2013 [1 \u2013 (2 \u2013 thienyl) cyclohexyl] piperidine<\/p>\n<\/td>\n

\n

21500-98-1<\/p>\n<\/td>\n<\/tr>\n

\n

27<\/p>\n<\/td>\n

\n

TMA<\/p>\n<\/td>\n

\n

(+) \u2013 3,4,5 \u2013 trimethoxy \u2013\u00a0\u03b1 \u2013\u00a0<\/i>methylphenylethylamine<\/p>\n<\/td>\n

\n

1082-88-8<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

<\/a>IC. C\u00e1c ch\u1ea5t v\u00e0 mu\u1ed1i c\u00f3 th\u1ec3 t\u1ed3n t\u1ea1i c\u1ee7a c\u00e1c ch\u1ea5t n\u00e0y<\/p>\n\n\n\n\n
\n

STT<\/b><\/p>\n<\/td>\n

\n

T\u00ean ch\u1ea5t<\/b><\/p>\n<\/td>\n

\n

T\u00ean khoa h\u1ecdc<\/b><\/p>\n<\/td>\n

\n

M\u00e3 th\u00f4ng tin CAS<\/b><\/p>\n<\/td>\n<\/tr>\n

\n

1<\/p>\n<\/td>\n

\n

MPPP<\/p>\n<\/td>\n

\n

1 \u2013 methyl \u2013 4 \u2013 phenyl \u2013 4 \u2013 piperidinol propionate (ester)<\/p>\n<\/td>\n

\n

13147-09-6<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

<\/a>ID. C\u00e1c ch\u1ea5t sau<\/p>\n\n\n\n\n\n\n
\n

STT<\/b><\/p>\n<\/td>\n

\n

T\u00ean ch\u1ea5t<\/b><\/p>\n<\/td>\n

\n

T\u00ean khoa h\u1ecdc<\/b><\/p>\n<\/td>\n

\n

M\u00e3 th\u00f4ng tin CAS<\/b><\/p>\n<\/td>\n<\/tr>\n

\n

1<\/p>\n<\/td>\n

\n

C\u1ea7n sa v\u00e0 c\u00e1c ch\u1ebf ph\u1ea9m t\u1eeb c\u1ea7n sa<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n

\n

8063-14-7<\/p>\n<\/td>\n<\/tr>\n

\n

2<\/p>\n<\/td>\n

\n

L\u00e1 Khat<\/p>\n<\/td>\n

\n

L\u00e1 c\u00e2y Catha edulis<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

3<\/p>\n<\/td>\n

\n

Thu\u1ed1c phi\u1ec7n v\u00e0 c\u00e1c ch\u1ebf ph\u1ea9m t\u1eeb thu\u1ed1c phi\u1ec7n*<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

* Tr\u1eeb\u00a0tr\u01b0<\/span>\u1eddng h\u1ee3p ethyl este c\u1ee7a acid b\u00e9o iod h\u00f3a trong d\u1ea7u h\u1ea1t thu\u1ed1c phi\u1ec7n m\u00e0 kh\u00f4ng c\u00f2n ch\u1ee9a ch\u1ea5t ma t\u00fay t\u1eeb thu\u1ed1c phi\u1ec7n.<\/p>\n

\u00a0<\/p>\n

DANH M\u1ee4C II<\/b><\/p>\n

C\u00c1C CH\u1ea4T MA T\u00daY \u0110\u01af\u1ee2C S\u1eec D\u1ee4NG H\u1ea0N CH\u1ebe TRONG NGHI\u00caN C\u1ee8U, KI\u1ec2M NGHI\u1ec6M, GI\u00c1M \u0110\u1ecaNH, \u0110I\u1ec0U TRA T\u1ed8I PH\u1ea0M HO\u1eb6C TRONG L\u0128NH V\u1ef0C Y T\u1ebe THEO QUY \u0110\u1ecaNH C\u1ee6A C\u01a0 QUAN C\u00d3 TH\u1ea8M QUY\u1ec0N<\/p>\n

<\/a>IIA. C\u00e1c ch\u1ea5t v\u00e0 mu\u1ed1i, \u0111\u1ed3ng ph\u00e2n, ester, ether v\u00e0 mu\u1ed1i c\u1ee7a c\u00e1c \u0111\u1ed3ng ph\u00e2n, ester, ether c\u00f3 th\u1ec3 t\u1ed3n t\u1ea1i c\u1ee7a c\u00e1c ch\u1ea5t n\u00e0y<\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n

STT<\/b><\/p>\n<\/td>\n

\n

T\u00ean ch\u1ea5t<\/b><\/p>\n<\/td>\n

\n

T\u00ean khoa h\u1ecdc<\/b><\/p>\n<\/td>\n

\n

M\u00e3 th\u00f4ng tin CAS<\/b><\/p>\n<\/td>\n<\/tr>\n

\n

1<\/p>\n<\/td>\n

\n

Acetylmethadol<\/p>\n<\/td>\n

\n

3 \u2013 acetoxy \u2013 6 \u2013 dimethylamino \u2013 4,4 \u2013 diphenylheptane<\/p>\n<\/td>\n

\n

509-74-0<\/p>\n<\/td>\n<\/tr>\n

\n

2<\/p>\n<\/td>\n

\n

AH 7921<\/p>\n<\/td>\n

\n

3, 4- dichloro-\u00a0N-<\/i>\u00a0[[1 \u2013 (dimethylamino) xyclohexyl] methyl] \u2013 benzamit<\/p>\n<\/td>\n

\n

55154-30-8<\/p>\n<\/td>\n<\/tr>\n

\n

3<\/p>\n<\/td>\n

\n

Alfentanil<\/p>\n<\/td>\n

\n

N-<\/i>\u00a0[1 \u2013 [2 \u2013 (4 \u2013 ethyl \u2013 4,5 \u2013 dihydro \u2013 5 \u2013 oxo \u2013 1H<\/i>\u2013 tetrazol \u2013 1 \u2013 yl) ethyl] \u2013 4 \u2013 (methoxymethyl) \u2013 4 \u2013 piperidinyl] \u2013\u00a0N \u2013\u00a0<\/i>phenylpropanamide<\/p>\n<\/td>\n

\n

71195-58-9<\/p>\n<\/td>\n<\/tr>\n

\n

4<\/p>\n<\/td>\n

\n

Allylprodine<\/p>\n<\/td>\n

\n

3 \u2013 allyl \u2013 1 \u2013 methyl \u2013 4 \u2013 phenyl \u2013 4 \u2013 propionoxypiperidine<\/p>\n<\/td>\n

\n

25384-17-2<\/p>\n<\/td>\n<\/tr>\n

\n

5<\/p>\n<\/td>\n

\n

Alphameprodine<\/p>\n<\/td>\n

\n

\u03b1<\/i>\u00a0\u2013 3 \u2013 ethyl \u2013 1 \u2013 methyl \u2013 4 \u2013 phenyl \u2013 4 \u2013 propionoxypiperidine<\/p>\n<\/td>\n

\n

468-51-9<\/p>\n<\/td>\n<\/tr>\n

\n

6<\/p>\n<\/td>\n

\n

Alphamethadol<\/p>\n<\/td>\n

\n

\u03b1<\/i>\u00a0\u2013 6- dimethylamino \u2013 4,4 \u2013 diphenyl \u2013 3 \u2013 heptanol<\/p>\n<\/td>\n

\n

17199-54-1<\/p>\n<\/td>\n<\/tr>\n

\n

7<\/p>\n<\/td>\n

\n

Alphamethylthiofentanyl<\/p>\n<\/td>\n

\n

N \u2013<\/i>\u00a0[1 \u2013 [1 \u2013 methyl \u2013 2 \u2013 (2 \u2013 thienyl) ethyl] \u2013 4 \u2013 piperidyl] propionanilide<\/p>\n<\/td>\n

\n

103963-66-2<\/p>\n<\/td>\n<\/tr>\n

\n

8<\/p>\n<\/td>\n

\n

Alphaprodine<\/p>\n<\/td>\n

\n

(\u03b1<\/i>\u00a0\u2013 1,3- dimethyl \u2013 4 \u2013 phenyl \u2013 4 \u2013 propionoxypiperidine<\/p>\n<\/td>\n

\n

77-20-3<\/p>\n<\/td>\n<\/tr>\n

\n

9<\/p>\n<\/td>\n

\n

Anileridine<\/p>\n<\/td>\n

\n

1 \u2013\u00a0para \u2013<\/i>\u00a0aminophenethyl \u2013 4 \u2013 phenylpiperidine \u2013 4 \u2013 carboxylic acid ethyl ester<\/p>\n<\/td>\n

\n

144-14-9<\/p>\n<\/td>\n<\/tr>\n

\n

10<\/p>\n<\/td>\n

\n

Benzenthidine<\/p>\n<\/td>\n

\n

1 \u2013 (2 \u2013 benzyloxyethyl) \u2013 4 \u2013 phenylpiperidine \u2013 4 \u2013 carboxylic acid ethyl ester<\/p>\n<\/td>\n

\n

3691-78-9<\/p>\n<\/td>\n<\/tr>\n

\n

11<\/p>\n<\/td>\n

\n

Benzylmorphine<\/p>\n<\/td>\n

\n

3 \u2013 benzylmorphine<\/p>\n<\/td>\n

\n

36418-34-5<\/p>\n<\/td>\n<\/tr>\n

\n

12<\/p>\n<\/td>\n

\n

Betacetylmethadol<\/p>\n<\/td>\n

\n

\u03b2-<\/i>\u00a03 \u2013 acetoxy \u2013 6 \u2013 dimethylamino \u2013 4,4 \u2013 diphenylheptane<\/p>\n<\/td>\n

\n

17199-59-6<\/p>\n<\/td>\n<\/tr>\n

\n

13<\/p>\n<\/td>\n

\n

Betameprodine<\/p>\n<\/td>\n

\n

\u03b2-<\/i>\u00a03 \u2013 ethyl \u2013 1 \u2013 methyl \u2013 4 \u2013 phenyl \u2013 propionoxypiperidine<\/p>\n<\/td>\n

\n

468-50-8<\/p>\n<\/td>\n<\/tr>\n

\n

14<\/p>\n<\/td>\n

\n

Betamethadol<\/p>\n<\/td>\n

\n

\u03b2<\/i>\u00a0\u2013 6 \u2013 dimethylamino \u2013 4,4 \u2013 diphenyl \u2013 3 \u2013 hepthanol<\/p>\n<\/td>\n

\n

17199-55-2<\/p>\n<\/td>\n<\/tr>\n

\n

15<\/p>\n<\/td>\n

\n

Betaprodine<\/p>\n<\/td>\n

\n

\u03b2 \u2013<\/i>\u00a01,3 \u2013 dimethyl \u2013 4 \u2013 phenyl \u2013 4 \u2013 propionoxypiperidine<\/p>\n<\/td>\n

\n

468-59-7<\/p>\n<\/td>\n<\/tr>\n

\n

16<\/p>\n<\/td>\n

\n

Bezitramide<\/p>\n<\/td>\n

\n

1 \u2013 (3 \u2013 cyano \u2013 3,3 \u2013 diphenylpropyl) \u2013 4 \u2013 (2 \u2013 oxo \u2013 3 \u2013 propionyl \u2013 1 \u2013 benzimidazolinyl) \u2013 piperidine<\/p>\n<\/td>\n

\n

15301-48-1<\/p>\n<\/td>\n<\/tr>\n

\n

17<\/p>\n<\/td>\n

\n

Clonitrazene<\/p>\n<\/td>\n

\n

(2 \u2013\u00a0para<\/i>\u00a0\u2013 chlobenzyl) \u2013 1 \u2013 diethylaminoethyl \u2013 5 \u2013 nitrobenzimidazole<\/p>\n<\/td>\n

\n

3861-76-5<\/p>\n<\/td>\n<\/tr>\n

\n

18<\/p>\n<\/td>\n

\n

Cocaine<\/p>\n<\/td>\n

\n

Benzoyl \u2013 1 \u2013 ecgoninmethyloxime<\/p>\n<\/td>\n

\n

50-36-2<\/p>\n<\/td>\n<\/tr>\n

\n

19<\/p>\n<\/td>\n

\n

Codoxime<\/p>\n<\/td>\n

\n

Dihydrocodeinone \u2013 6 \u2013 carboxymethyloxime<\/p>\n<\/td>\n

\n

7125-76-0<\/p>\n<\/td>\n<\/tr>\n

\n

20<\/p>\n<\/td>\n

\n

Dextromoramide<\/p>\n<\/td>\n

\n

(+) \u2013 4 [2 \u2013 methyl \u2013 4 \u2013 oxo \u2013 3,3 \u2013 diphenyl \u2013 4 \u2013 (1 \u2013 pyrrolidinyl) butyl] morpholine<\/p>\n<\/td>\n

\n

357-56-2<\/p>\n<\/td>\n<\/tr>\n

\n

21<\/p>\n<\/td>\n

\n

Diampromide<\/p>\n<\/td>\n

\n

N \u2013<\/i>\u00a0[2 \u2013 (methylphenethylamino) \u2013 propyl] propionalinide<\/p>\n<\/td>\n

\n

552-25-0<\/p>\n<\/td>\n<\/tr>\n

\n

22<\/p>\n<\/td>\n

\n

Diethylthiambutene<\/p>\n<\/td>\n

\n

3 \u2013 diethylamino \u2013 1,1 \u2013 di \u2013 (2\u2019 \u2013 thienyl) \u2013 1 \u2013 butene<\/p>\n<\/td>\n

\n

86-14-6<\/p>\n<\/td>\n<\/tr>\n

\n

23<\/p>\n<\/td>\n

\n

Difenoxin<\/p>\n<\/td>\n

\n

1 \u2013 (3 \u2013 cyano \u2013 3,3 \u2013 diphenylpropyl) \u2013 4 \u2013 phenylisonipecotic acid<\/p>\n<\/td>\n

\n

28782-42-5<\/p>\n<\/td>\n<\/tr>\n

\n

24<\/p>\n<\/td>\n

\n

Dihydromorphine<\/p>\n<\/td>\n

\n

7,8 \u2013 dihydromorphine<\/p>\n<\/td>\n

\n

509-60-4<\/p>\n<\/td>\n<\/tr>\n

\n

25<\/p>\n<\/td>\n

\n

Dimenoxadol<\/p>\n<\/td>\n

\n

2 \u2013 dimethylaminoethyl \u2013 1 \u2013 ethoxy \u2013 1,1 \u2013 diphenylacetate<\/p>\n<\/td>\n

\n

509-78-4<\/p>\n<\/td>\n<\/tr>\n

\n

26<\/p>\n<\/td>\n

\n

Dimepheptanol<\/p>\n<\/td>\n

\n

6 \u2013 dimethylamino \u2013 4,4 \u2013 diphenyl \u2013 3 \u2013 hepthanol<\/p>\n<\/td>\n

\n

545-90-4<\/p>\n<\/td>\n<\/tr>\n

\n

27<\/p>\n<\/td>\n

\n

Dimethylthiambutene<\/p>\n<\/td>\n

\n

3 \u2013 dimethylamino \u2013 1,1 \u2013 di \u2013 (2\u2019 \u2013 thienyl) \u2013 1 \u2013 butene<\/p>\n<\/td>\n

\n

524-84-5<\/p>\n<\/td>\n<\/tr>\n

\n

28<\/p>\n<\/td>\n

\n

Dioxaphetyl butyrate<\/p>\n<\/td>\n

\n

Ethyl \u2013 4 \u2013 morpholino \u2013 2,2 \u2013 diphenylbutyrate<\/p>\n<\/td>\n

\n

467-86-7<\/p>\n<\/td>\n<\/tr>\n

\n

29<\/p>\n<\/td>\n

\n

Diphenoxylate<\/p>\n<\/td>\n

\n

1 \u2013 (3 \u2013 cyano \u2013 3,3 \u2013 diphenylpropyl) \u2013 4 \u2013 phenylpiperidine \u2013 4 \u2013 carboxylic acid ethyl ester<\/p>\n<\/td>\n

\n

915-30-0<\/p>\n<\/td>\n<\/tr>\n

\n

30<\/p>\n<\/td>\n

\n

Dipipanone<\/p>\n<\/td>\n

\n

4,4 \u2013 diphenyl \u2013 6 \u2013 piperidine \u2013 3 \u2013 heptanone<\/p>\n<\/td>\n

\n

467-83-4<\/p>\n<\/td>\n<\/tr>\n

\n

31<\/p>\n<\/td>\n

\n

Drotebanol<\/p>\n<\/td>\n

\n

3,4 \u2013 dimethoxy \u2013 17 methylmorphinan -6\u03b2<\/i>, 14 \u2013 diol<\/p>\n<\/td>\n

\n

3176-03-2<\/p>\n<\/td>\n<\/tr>\n

\n

32<\/p>\n<\/td>\n

\n

Ecgonine v\u00e0 c\u00e1c d\u1eabn xu\u1ea5t<\/p>\n<\/td>\n

\n

(-) \u2013 3 \u2013 hydroxytropane \u2013 2 \u2013 carboxylate<\/p>\n<\/td>\n

\n

481-37-8<\/p>\n<\/td>\n<\/tr>\n

\n

33<\/p>\n<\/td>\n

\n

Ethylmethylthiambutene<\/p>\n<\/td>\n

\n

3 \u2013 ethylmethylamino \u2013 1,1 \u2013 di \u2013 (2\u2019 \u2013 thienyl) \u2013 1 \u2013 butene<\/p>\n<\/td>\n

\n

441-61-2<\/p>\n<\/td>\n<\/tr>\n

\n

34<\/p>\n<\/td>\n

\n

Etonitazene<\/p>\n<\/td>\n

\n

1 \u2013 diethylaminoethyl \u2013 2\u00a0para \u2013<\/i>\u00a0ethoxybenzyl \u2013 5 \u2013 nitrobenzimidazole<\/p>\n<\/td>\n

\n

911-65-9<\/p>\n<\/td>\n<\/tr>\n

\n

35<\/p>\n<\/td>\n

\n

Etoxeridine<\/p>\n<\/td>\n

\n

1 \u2013 [2 \u2013 (2 \u2013 hydroxyethoxy) \u2013 ethyl] \u2013 4 \u2013 phenylpiperidine \u2013 4 \u2013 carboxylic acid ethyl ester<\/p>\n<\/td>\n

\n

469-82-9<\/p>\n<\/td>\n<\/tr>\n

\n

36<\/p>\n<\/td>\n

\n

Fentanyl<\/p>\n<\/td>\n

\n

1 \u2013 phenethyl \u2013 4 \u2013\u00a0N \u2013\u00a0<\/i>propionylanilinopiperidine<\/p>\n<\/td>\n

\n

437-38-7<\/p>\n<\/td>\n<\/tr>\n

\n

37<\/p>\n<\/td>\n

\n

Furethidine<\/p>\n<\/td>\n

\n

1 \u2013 (2 \u2013 tetrahydrofurfuryloxyethyl) \u2013 4 \u2013 phenylpiperidine \u2013 4 \u2013 carboxylic acid ethyl ester<\/p>\n<\/td>\n

\n

2385-81-1<\/p>\n<\/td>\n<\/tr>\n

\n

38<\/p>\n<\/td>\n

\n

Hydrocodone<\/p>\n<\/td>\n

\n

Dihydrocodeinone<\/p>\n<\/td>\n

\n

125-29-1<\/p>\n<\/td>\n<\/tr>\n

\n

39<\/p>\n<\/td>\n

\n

Hydromorphinol<\/p>\n<\/td>\n

\n

14 \u2013 hydroxydihydromorphine<\/p>\n<\/td>\n

\n

2183-56-4<\/p>\n<\/td>\n<\/tr>\n

\n

40<\/p>\n<\/td>\n

\n

Hydromorphone<\/p>\n<\/td>\n

\n

Dihydromorphinone<\/p>\n<\/td>\n

\n

466-99-9<\/p>\n<\/td>\n<\/tr>\n

\n

41<\/p>\n<\/td>\n

\n

Hydroxypethidine<\/p>\n<\/td>\n

\n

4 \u2013\u00a0meta \u2013<\/i>\u00a0hydroxyphenyl \u2013 1 \u2013 methylpiperidine \u2013 4 \u2013 carboxylic acid ethyl ester<\/p>\n<\/td>\n

\n

468-56-4<\/p>\n<\/td>\n<\/tr>\n

\n

42<\/p>\n<\/td>\n

\n

Isomethadone<\/p>\n<\/td>\n

\n

6 \u2013 dimethylamino \u2013 5 \u2013 methyl \u2013 4,4 \u2013 diphenyl \u2013 3 \u2013 hexanone<\/p>\n<\/td>\n

\n

466-40-0<\/p>\n<\/td>\n<\/tr>\n

\n

43<\/p>\n<\/td>\n

\n

Levomethorphan<\/p>\n<\/td>\n

\n

(-) \u2013 3 \u2013 methoxy \u2013\u00a0N \u2013<\/i>\u00a0methylmorphinan<\/p>\n<\/td>\n

\n

125-68-8<\/p>\n<\/td>\n<\/tr>\n

\n

44<\/p>\n<\/td>\n

\n

Levomoramide<\/p>\n<\/td>\n

\n

(-) \u2013 4 \u2013 [2 \u2013 methyl \u2013 4 \u2013 oxo \u2013 3,3 \u2013 diphenyl \u2013 4 -(1 \u2013 pyrrolidinyl) butyl] morpholine<\/p>\n<\/td>\n

\n

5666-11-5<\/p>\n<\/td>\n<\/tr>\n

\n

45<\/p>\n<\/td>\n

\n

Levophenacylmorphan<\/p>\n<\/td>\n

\n

(-) \u2013 3 \u2013 hydroxy \u2013\u00a0N<\/i>\u00a0\u2013 phenacylmorphinan<\/p>\n<\/td>\n

\n

10061-32-2<\/p>\n<\/td>\n<\/tr>\n

\n

46<\/p>\n<\/td>\n

\n

Levorphanol<\/p>\n<\/td>\n

\n

(-) \u2013 3 \u2013 hydroxy \u2013\u00a0N<\/i>\u00a0\u2013 methylmorphinan<\/p>\n<\/td>\n

\n

77-07-6<\/p>\n<\/td>\n<\/tr>\n

\n

47<\/p>\n<\/td>\n

\n

Metazocine<\/p>\n<\/td>\n

\n

2\u2019 \u2013 hydroxy \u2013 2,5,9 \u2013 trimethyl \u2013 6,7 \u2013 benzomorphan<\/p>\n<\/td>\n

\n

3734-52-9<\/p>\n<\/td>\n<\/tr>\n

\n

48<\/p>\n<\/td>\n

\n

Methadone<\/p>\n<\/td>\n

\n

6 \u2013 dimethylamino \u2013 4,4 \u2013 diphenyl \u2013 3 \u2013 heptanone<\/p>\n<\/td>\n

\n

76-99-3<\/p>\n<\/td>\n<\/tr>\n

\n

49<\/p>\n<\/td>\n

\n

Methadone intermediate<\/p>\n<\/td>\n

\n

4 \u2013 cyano \u2013 2 dimethylamino \u2013 4,4 \u2013 diphenylbutane<\/p>\n<\/td>\n

\n

125-79-1<\/p>\n<\/td>\n<\/tr>\n

\n

50<\/p>\n<\/td>\n

\n

Methyldesorphine<\/p>\n<\/td>\n

\n

6 \u2013 methyl \u2013\u00a0delta \u2013\u00a0<\/i>6 \u2013 deoxymor phine<\/p>\n<\/td>\n

\n

16008-36-9<\/p>\n<\/td>\n<\/tr>\n

\n

51<\/p>\n<\/td>\n

\n

Methyldihydromorphine<\/p>\n<\/td>\n

\n

6 \u2013 methyldihydromorphine<\/p>\n<\/td>\n

\n

509-56-8<\/p>\n<\/td>\n<\/tr>\n

\n

52<\/p>\n<\/td>\n

\n

Metopon<\/p>\n<\/td>\n

\n

5 \u2013 methyldihydromorphinone<\/p>\n<\/td>\n

\n

143-52-2<\/p>\n<\/td>\n<\/tr>\n

\n

53<\/p>\n<\/td>\n

\n

Moramide<\/p>\n<\/td>\n

\n

2 \u2013 methyl \u2013 3 \u2013 morpholino \u2013 1,1 \u2013 diphenylpropane carboxylic acid<\/p>\n<\/td>\n

\n

545-59-5<\/p>\n<\/td>\n<\/tr>\n

\n

54<\/p>\n<\/td>\n

\n

Morpheridine<\/p>\n<\/td>\n

\n

1 \u2013 (2 \u2013 morpholinoethyl) \u2013 4 \u2013 phenylpiperidine \u2013 4 \u2013 carboxylic acid ethyl ester<\/p>\n<\/td>\n

\n

469-81-8<\/p>\n<\/td>\n<\/tr>\n

\n

55<\/p>\n<\/td>\n

\n

Morphine<\/p>\n<\/td>\n

\n

7,8 \u2013 dehydro \u2013 4,5 \u2013 epoxy \u2013 3,6 \u2013 dihydroxy \u2013\u00a0N \u2013<\/i>\u00a0methylmorphinan<\/p>\n<\/td>\n

\n

57-27-2<\/p>\n<\/td>\n<\/tr>\n

\n

56<\/p>\n<\/td>\n

\n

Morphine \u2013 N \u2013 oxide<\/p>\n<\/td>\n

\n

3,6 \u2013 dihydroxy \u2013\u00a0N \u2013<\/i>\u00a0methyl \u2013 4,5 \u2013 epoxy \u2013 morphinen \u2013 7 \u2013\u00a0N<\/i>\u00a0\u2013 oxide<\/p>\n<\/td>\n

\n

639-46-3<\/p>\n<\/td>\n<\/tr>\n

\n

57<\/p>\n<\/td>\n

\n

Myrophine<\/p>\n<\/td>\n

\n

Myristylbenzylmorphine<\/p>\n<\/td>\n

\n

467-18-5<\/p>\n<\/td>\n<\/tr>\n

\n

58<\/p>\n<\/td>\n

\n

Nicomorphine<\/p>\n<\/td>\n

\n

3,6 \u2013 dinicotinylmorphine<\/p>\n<\/td>\n

\n

639-48-5<\/p>\n<\/td>\n<\/tr>\n

\n

59<\/p>\n<\/td>\n

\n

Noracymethadol<\/p>\n<\/td>\n

\n

(\u00b1) \u2013\u00a0\u03b1<\/i>\u00a0\u2013 3 \u2013 acetoxy \u2013 6 \u2013 methylamino \u2013 4,4 \u2013 diphenyl \u2013 heptane<\/p>\n<\/td>\n

\n

1477-39-0<\/p>\n<\/td>\n<\/tr>\n

\n

60<\/p>\n<\/td>\n

\n

Norlevorphanol<\/p>\n<\/td>\n

\n

(-) \u2013 3 \u2013 hydroxymorphinan<\/p>\n<\/td>\n

\n

1531-12-0<\/p>\n<\/td>\n<\/tr>\n

\n

61<\/p>\n<\/td>\n

\n

Normethadone<\/p>\n<\/td>\n

\n

6 \u2013 dimethylamino \u2013 4,4 diphenyl \u2013 3 \u2013 hexanone<\/p>\n<\/td>\n

\n

467-85-6<\/p>\n<\/td>\n<\/tr>\n

\n

62<\/p>\n<\/td>\n

\n

Normorphine<\/p>\n<\/td>\n

\n

N<\/i>\u00a0\u2013 demethylmorphine<\/p>\n<\/td>\n

\n

466-97-7<\/p>\n<\/td>\n<\/tr>\n

\n

63<\/p>\n<\/td>\n

\n

Norpipanone<\/p>\n<\/td>\n

\n

4,4 \u2013 diphenyl \u2013 6 \u2013 piperidino \u2013 3 \u2013 hexanone<\/p>\n<\/td>\n

\n

561-48-8<\/p>\n<\/td>\n<\/tr>\n

\n

64<\/p>\n<\/td>\n

\n

Oxycodone<\/p>\n<\/td>\n

\n

14 \u2013 hydroxydihydrocodeinone<\/p>\n<\/td>\n

\n

76-42-5<\/p>\n<\/td>\n<\/tr>\n

\n

65<\/p>\n<\/td>\n

\n

Oxymorphone<\/p>\n<\/td>\n

\n

14 \u2013 hydroxydihydromorphinone<\/p>\n<\/td>\n

\n

76-41-5<\/p>\n<\/td>\n<\/tr>\n

\n

66<\/p>\n<\/td>\n

\n

Pethidine<\/p>\n<\/td>\n

\n

1 \u2013 methyl \u2013 4 \u2013 phenylpiperidine \u2013 4 \u2013 carboxylic acid ethyl ester<\/p>\n<\/td>\n

\n

57-42-1<\/p>\n<\/td>\n<\/tr>\n

\n

67<\/p>\n<\/td>\n

\n

Pethidine intermediate A<\/p>\n<\/td>\n

\n

4 \u2013 cyano \u2013 1 \u2013 methyl \u2013 4 \u2013 phenylpiperidine<\/p>\n<\/td>\n

\n

3627-62-1<\/p>\n<\/td>\n<\/tr>\n

\n

68<\/p>\n<\/td>\n

\n

Pethidine intermediate B<\/p>\n<\/td>\n

\n

4 \u2013 Phenylpiperidine \u2013 4 \u2013 carboxylic acid ethyl ester<\/p>\n<\/td>\n

\n

77-17-8<\/p>\n<\/td>\n<\/tr>\n

\n

69<\/p>\n<\/td>\n

\n

Pethidine intermediate C<\/p>\n<\/td>\n

\n

1 \u2013 methyl \u2013 4 \u2013 phenylpiperidine \u2013 4 \u2013 carboxylic acid<\/p>\n<\/td>\n

\n

3627-48-3<\/p>\n<\/td>\n<\/tr>\n

\n

70<\/p>\n<\/td>\n

\n

Phenadoxone<\/p>\n<\/td>\n

\n

6 \u2013 morpholino \u2013 4,4 \u2013 diphenyl \u2013 3 \u2013 heptanone<\/p>\n<\/td>\n

\n

467-84-5<\/p>\n<\/td>\n<\/tr>\n

\n

71<\/p>\n<\/td>\n

\n

Phenampromide<\/p>\n<\/td>\n

\n

N \u2013<\/i>\u00a0(1 \u2013 methyl \u2013 2 \u2013 piperidinoethyl) propionanilide<\/p>\n<\/td>\n

\n

129-83-9<\/p>\n<\/td>\n<\/tr>\n

\n

72<\/p>\n<\/td>\n

\n

Phenazocine<\/p>\n<\/td>\n

\n

2\u2019 \u2013 hydroxy \u2013 5,9 \u2013 dimethyl \u2013 2 \u2013 phenethyl \u2013 6, 7 \u2013 benzomorphan<\/p>\n<\/td>\n

\n

127-35-5<\/p>\n<\/td>\n<\/tr>\n

\n

73<\/p>\n<\/td>\n

\n

Phenomorphan<\/p>\n<\/td>\n

\n

3 \u2013 hydroxy \u2013\u00a0N<\/i>\u00a0\u2013 phenethylmorphinan<\/p>\n<\/td>\n

\n

468-07-5<\/p>\n<\/td>\n<\/tr>\n

\n

74<\/p>\n<\/td>\n

\n

Phenoperidine<\/p>\n<\/td>\n

\n

1 \u2013 (3 \u2013 hydroxy \u2013 3 \u2013 phenylpropyl) \u2013 4 \u2013 phenylpiperidine \u2013 4 \u2013 carboxylic acid ethyl ester<\/p>\n<\/td>\n

\n

562-26-5<\/p>\n<\/td>\n<\/tr>\n

\n

75<\/p>\n<\/td>\n

\n

Piminodine<\/p>\n<\/td>\n

\n

4 \u2013 phenyl \u2013 1 \u2013 (3 \u2013 phenylaminopropyl) \u2013 piperidine \u2013 4 \u2013 carboxylic acid ethyl ester<\/p>\n<\/td>\n

\n

13495-09-5<\/p>\n<\/td>\n<\/tr>\n

\n

76<\/p>\n<\/td>\n

\n

Piritramide<\/p>\n<\/td>\n

\n

1- (3 \u2013 cyano \u2013 3,3 \u2013 diphenylpropyl) \u2013 4 \u2013 (1 \u2013 piperidino) \u2013 piperidine \u2013 4 \u2013 carboxylic acid amide<\/p>\n<\/td>\n

\n

302-41-0<\/p>\n<\/td>\n<\/tr>\n

\n

77<\/p>\n<\/td>\n

\n

Proheptazine<\/p>\n<\/td>\n

\n

1,3 \u2013 dimethyl \u2013 4 \u2013 phenyl \u2013 4 \u2013 propionoxyazacycloheptane<\/p>\n<\/td>\n

\n

77-14-5<\/p>\n<\/td>\n<\/tr>\n

\n

78<\/p>\n<\/td>\n

\n

Properidine<\/p>\n<\/td>\n

\n

1 \u2013 methyl \u2013 4 \u2013 phenylpiperidine \u2013 4 \u2013 carboxylic acid isopropyl ester<\/p>\n<\/td>\n

\n

561-76-2<\/p>\n<\/td>\n<\/tr>\n

\n

79<\/p>\n<\/td>\n

\n

Racemethorphan<\/p>\n<\/td>\n

\n

(\u00b1) \u2013 3 \u2013 methoxy\u00a0\u2013 N \u2013<\/i>\u00a0methylmorphinan<\/p>\n<\/td>\n

\n

510-53-2<\/p>\n<\/td>\n<\/tr>\n

\n

80<\/p>\n<\/td>\n

\n

Racemoramide<\/p>\n<\/td>\n

\n

(\u00b1) \u2013 4 \u2013 [2 \u2013 methyl \u2013 4 \u2013 oxo \u2013 3,3 \u2013 diphenyl \u2013 4 \u2013 (1 \u2013 pyrrolidinyl)butyl] morpholine<\/p>\n<\/td>\n

\n

545-59-5<\/p>\n<\/td>\n<\/tr>\n

\n

81<\/p>\n<\/td>\n

\n

Racemorphan<\/p>\n<\/td>\n

\n

(\u00b1) \u2013 3 \u2013 hydroxy\u00a0\u2013 N \u2013<\/i>\u00a0methylmorphinan<\/p>\n<\/td>\n

\n

297-90-5<\/p>\n<\/td>\n<\/tr>\n

\n

82<\/p>\n<\/td>\n

\n

Remifentanil<\/p>\n<\/td>\n

\n

1 \u2013 (2 \u2013 methoxycarbonylethyl) \u2013 4 \u2013 (phenylpropionylamino)-piperidine \u2013 4carboxylic acid methyl ester<\/p>\n<\/td>\n

\n

132875-61-7<\/p>\n<\/td>\n<\/tr>\n

\n

83<\/p>\n<\/td>\n

\n

Sulfentanil<\/p>\n<\/td>\n

\n

N<\/i>\u00a0\u2013 [4 \u2013 (methoxymethyl) \u2013 1 \u2013 [2 \u2013 (2 \u2013 thienyl) \u2013 ethyl] \u2013 4 \u2013 piperidyl] propionanilide<\/p>\n<\/td>\n

\n

56030-54-7<\/p>\n<\/td>\n<\/tr>\n

\n

84<\/p>\n<\/td>\n

\n

Thebacon<\/p>\n<\/td>\n

\n

Acethyldihydrocodeinone<\/p>\n<\/td>\n

\n

466-90-0<\/p>\n<\/td>\n<\/tr>\n

\n

85<\/p>\n<\/td>\n

\n

Thebaine<\/p>\n<\/td>\n

\n

3,6 \u2013 dimethoxy \u2013\u00a0N-<\/i>\u00a0methyl \u2013 4,5 \u2013 epoxymorphinadien \u2013 6,8<\/p>\n<\/td>\n

\n

115-37-7<\/p>\n<\/td>\n<\/tr>\n

\n

86<\/p>\n<\/td>\n

\n

Tilidine<\/p>\n<\/td>\n

\n

(\u00b1) \u2013 ethyl \u2013 trans \u2013 2 \u2013 (dimethylamino) \u2013 1 \u2013 phenyl \u2013 3 \u2013 cyclohexene \u2013 1 \u2013 carboxylate<\/p>\n<\/td>\n

\n

20380-58-9<\/p>\n<\/td>\n<\/tr>\n

\n

87<\/p>\n<\/td>\n

\n

Trimeperidine<\/p>\n<\/td>\n

\n

1,2,5 \u2013 trimethyl \u2013 4 \u2013 phenyl \u2013 4 \u2013 propionoxypiperidine<\/p>\n<\/td>\n

\n

64-39-1<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

<\/a>IIB. C\u00e1c ch\u1ea5t v\u00e0 mu\u1ed1i, \u0111\u1ed3ng ph\u00e2n c\u00f3 th\u1ec3 t\u1ed3n t\u1ea1i c\u1ee7a c\u00e1c ch\u1ea5t n\u00e0y<\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n

STT<\/b><\/p>\n<\/td>\n

\n

T\u00ean ch\u1ea5t<\/b><\/p>\n<\/td>\n

\n

T\u00ean khoa h\u1ecdc<\/b><\/p>\n<\/td>\n

\n

M\u00e3 th\u00f4ng tin CAS<\/b><\/p>\n<\/td>\n<\/tr>\n

\n

1<\/p>\n<\/td>\n

\n

25B-NBOMe<\/p>\n<\/td>\n

\n

2- (4 \u2013 bromo \u2013 2,5 -dimethoxyphenyl) \u2013\u00a0N<\/i>\u00a0[(2- methoxyphenyl) methyl] ethanamine<\/p>\n<\/td>\n

\n

1026511-90-9<\/p>\n<\/td>\n<\/tr>\n

\n

2<\/p>\n<\/td>\n

\n

25C-NBOMe<\/p>\n<\/td>\n

\n

2- (4-chloro-2,5-dimethoxyphenyl)\u00a0\u2013 N \u2013<\/i>\u00a0[(2- methoxyphenyl) methyl] ethanamine<\/p>\n<\/td>\n

\n

1227608-02-7<\/p>\n<\/td>\n<\/tr>\n

\n

3<\/p>\n<\/td>\n

\n

25I-NBOMe<\/p>\n<\/td>\n

\n

2- (4-iodo-2,5-dimethoxyphenyl)\u00a0-N<\/i>\u00a0\u2013 [(2-methoxyphenyl) methyl] ethanamine<\/p>\n<\/td>\n

\n

919797-19-6<\/p>\n<\/td>\n<\/tr>\n

\n

4<\/p>\n<\/td>\n

\n

Acetyldihydrocodeine<\/p>\n<\/td>\n

\n

(5\u03b1<\/i>, 6\u03b1<\/i>) \u2013 4,5 \u2013 epoxy \u2013 3 \u2013 methoxy \u2013 17 \u2013 methyl \u2013 morphinan \u2013 6 \u2013 ol acetat<\/p>\n<\/td>\n

\n

3861-72-1<\/p>\n<\/td>\n<\/tr>\n

\n

5<\/p>\n<\/td>\n

\n

Amphetamine<\/p>\n<\/td>\n

\n

(\u00b1) \u2013\u00a0\u03b1<\/i>\u00a0\u2013 methylphenethylamine<\/p>\n<\/td>\n

\n

300-62-9<\/p>\n<\/td>\n<\/tr>\n

\n

6<\/p>\n<\/td>\n

\n

Codeine (3 \u2013 methylmorphine)<\/p>\n<\/td>\n

\n

6 \u2013 hydroxy \u2013 3 \u2013 methoxy \u2013\u00a0N<\/i>\u00a0\u2013 methyl \u2013 4,5 \u2013 epoxy \u2013 morphinen \u2013 7<\/p>\n<\/td>\n

\n

76-57-3<\/p>\n<\/td>\n<\/tr>\n

\n

7<\/p>\n<\/td>\n

\n

Dextropropoxyphene<\/p>\n<\/td>\n

\n

\u03b1<\/i>\u00a0\u2013 (+) \u2013 4 \u2013 dimethylamino \u2013 1,2 \u2013 diphenyl \u2013 3 \u2013 methyl \u2013 2 \u2013 butanol propionate<\/p>\n<\/td>\n

\n

469-62-5<\/p>\n<\/td>\n<\/tr>\n

\n

8<\/p>\n<\/td>\n

\n

Dihydrocodeine<\/p>\n<\/td>\n

\n

6 \u2013 hydroxy \u2013 3 \u2013 methoxy \u2013\u00a0N<\/i>\u00a0\u2013 methyl \u2013 4,5 \u2013 epoxy \u2013 morphinan<\/p>\n<\/td>\n

\n

125-28-0<\/p>\n<\/td>\n<\/tr>\n

\n

9<\/p>\n<\/td>\n

\n

Ethylmorphine<\/p>\n<\/td>\n

\n

3 \u2013 Ethylmorphine<\/p>\n<\/td>\n

\n

76-58-4<\/p>\n<\/td>\n<\/tr>\n

\n

10<\/p>\n<\/td>\n

\n

Methylphenidate<\/p>\n<\/td>\n

\n

Methyl\u00a0\u2013 \u03b1 \u2013<\/i>\u00a0phenyl \u2013 2 \u2013 piperidineacetate<\/p>\n<\/td>\n

\n

113-45-1<\/p>\n<\/td>\n<\/tr>\n

\n

11<\/p>\n<\/td>\n

\n

Nicocodine<\/p>\n<\/td>\n

\n

6 \u2013 nicotinylcodeine<\/p>\n<\/td>\n

\n

3688-66-2<\/p>\n<\/td>\n<\/tr>\n

\n

12<\/p>\n<\/td>\n

\n

Nicodicodine<\/p>\n<\/td>\n

\n

6 \u2013 nicotinyldihydrocodeine<\/p>\n<\/td>\n

\n

808-24-2<\/p>\n<\/td>\n<\/tr>\n

\n

13<\/p>\n<\/td>\n

\n

Norcodeine<\/p>\n<\/td>\n

\n

N<\/i>\u00a0\u2013 demethylcodeine<\/p>\n<\/td>\n

\n

467-15-2<\/p>\n<\/td>\n<\/tr>\n

\n

14<\/p>\n<\/td>\n

\n

PMMA<\/p>\n<\/td>\n

\n

Para<\/i>-methoxy methamphetamine<\/p>\n<\/td>\n

\n

3398-68-3<\/p>\n<\/td>\n<\/tr>\n

\n

15<\/p>\n<\/td>\n

\n

Propiram<\/p>\n<\/td>\n

\n

N \u2013<\/i>\u00a0(1 \u2013 methyl \u2013 2 \u2013 piperidinoethyl) \u2013\u00a0N \u2013<\/i>\u00a02 \u2013 pyridylpropionamide<\/p>\n<\/td>\n

\n

15686-91-6<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

IIC. C\u00e1c ch\u1ea5t v\u00e0 mu\u1ed1i c\u00f3 th\u1ec3 t\u1ed3n t\u1ea1i c\u1ee7a c\u00e1c ch\u1ea5t n\u00e0y<\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n

STT<\/b><\/p>\n<\/td>\n

\n

T\u00ean ch\u1ea5t<\/b><\/p>\n<\/td>\n

\n

T\u00ean khoa h\u1ecdc<\/b><\/p>\n<\/td>\n

\n

M\u00e3 th\u00f4ng tin<\/b>\u00a0CAS<\/b><\/p>\n<\/td>\n<\/tr>\n

\n

1<\/p>\n<\/td>\n

\n

(1-(5-fluoropentyl)-3-(2-ethylbenzoyl)indole)<\/p>\n<\/td>\n

\n

(2-ethylphenyl) (1-(5-fluoropentyl)
-1H<\/i>-indol-3-yl) methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

2<\/p>\n<\/td>\n

\n

(1-(5-fluoropentyl)-3-(2-methylbenzoyl)indole)<\/p>\n<\/td>\n

\n

(1-(5-fluoropentyl)-1H<\/i>-indol-3-yl)(o-tolyl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

3<\/p>\n<\/td>\n

\n

(1-Pentyl-1H<\/i>-indazol-3-yl)(2,2,3,3tetramethylcyclopropyl)
methanone<\/p>\n<\/td>\n

\n

(1-Pentyl-1H<\/i>-indazol-3-yl) (2,2,3,3-tetramethylcyclopropyl) methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

4<\/p>\n<\/td>\n

\n

(1-pentyl-1H<\/i>-indazol-3-yl)
piperazin-1-yl)methanone<\/p>\n<\/td>\n

\n

(1-pentyl-1H<\/i>-indazol-3-yl) piperazin-1-yl) methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

5<\/p>\n<\/td>\n

\n

(1-Pentyl-1H<\/i>-indol-3-yl)(pyridin-3-yl)methanone<\/p>\n<\/td>\n

\n

(1-Pentyl-1H<\/i>-indol-3-yl) (pyridin-3-yl) methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

6<\/p>\n<\/td>\n

\n

(1-pentyl-1H<\/i>-indol-3-yl)
piperazin-1-yl)methanone<\/p>\n<\/td>\n

\n

(1-pentyl-1H<\/i>-indol-3-yl)piperazin-1-yl) methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

7<\/p>\n<\/td>\n

\n

1-(Cyclohexylmethyl)-2-[(4-ethoxyphenyl)methyl]
-N,N-<\/i>diethyl-1H<\/i>-benzimidazol-5-carboxamide<\/p>\n<\/td>\n

\n

1-(cyclohexylmethyl)-2-(4-ethoxybenzyl)
\u2013N,N<\/i>-diethyl-1H-<\/i>benzo[d<\/i>]imidazole-5-carboxamide<\/p>\n<\/td>\n

\n

1046140-32-2<\/p>\n<\/td>\n<\/tr>\n

\n

8<\/p>\n<\/td>\n

\n

1-(Phenylmethyl)-1H<\/i>-indole-3-carboxylic acid 8-quinolinyl ester<\/p>\n<\/td>\n

\n

quinolin-8-yl 1-benzyl-1H<\/i>\u2013
indole-3-carboxylate<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

9<\/p>\n<\/td>\n

\n

1-Benzyl-N<\/i>-(quinolin-8-yl)
-1H<\/i>-indazole-3-carboxamide<\/p>\n<\/td>\n

\n

1-benzyl-N<\/i>-(quinolin-8-yl)
-1H<\/i>-indazole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

10<\/p>\n<\/td>\n

\n

1-Benzyl-N<\/i>-(quinolin-8-yl)
-1H<\/i>-indole-3-carboxamide<\/p>\n<\/td>\n

\n

1-benzyl-N<\/i>-(quinolin-8-yl)
-1H<\/i>-indole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

11<\/p>\n<\/td>\n

\n

1-Pentyl-N-(quinolin-8-yl)
-1H-indole-3-carboxamide<\/p>\n<\/td>\n

\n

1-pentyl-N<\/i>-(quinolin-8-yl)-1H<\/i>-indole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

12<\/p>\n<\/td>\n

\n

1Cp-LSD<\/p>\n<\/td>\n

\n

(6aR,9R)-4-(cyclopropanecarbonyl)
-N,N-diethyl-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]
quinoline-9-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

13<\/p>\n<\/td>\n

\n

2C-B<\/p>\n<\/td>\n

\n

4-Bromo-2,5-dimethoxy phenethylamine<\/p>\n<\/td>\n

\n

66142-81-2<\/p>\n<\/td>\n<\/tr>\n

\n

14<\/p>\n<\/td>\n

\n

2C-E<\/p>\n<\/td>\n

\n

4 \u2013 ethyl \u2013 2,5 \u2013 Dimethoxyphenethylamine<\/p>\n<\/td>\n

\n

71539-34-9<\/p>\n<\/td>\n<\/tr>\n

\n

15<\/p>\n<\/td>\n

\n

2C-H<\/p>\n<\/td>\n

\n

2,5-dimethoxy-phenethylamine<\/p>\n<\/td>\n

\n

3600-86-0<\/p>\n<\/td>\n<\/tr>\n

\n

16<\/p>\n<\/td>\n

\n

2-fluorodeschloroketamine (Fluoroketamine)<\/p>\n<\/td>\n

\n

2-(2-fluorophenyl)-2-(methylamino)cyclohexan-1-one<\/p>\n<\/td>\n

\n

111982-50-4<\/p>\n<\/td>\n<\/tr>\n

\n

17<\/p>\n<\/td>\n

\n

2-FMA<\/p>\n<\/td>\n

\n

2-fluoro-N-\u03b1-dimethyl-benzeneethanamine<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

18<\/p>\n<\/td>\n

\n

3-(4-Hydroxymethylbenzoyl)-1-pentylindole<\/p>\n<\/td>\n

\n

(4-(hydroxymethyl)phenyl)(1-pentyl-1H-indol-3-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

19<\/p>\n<\/td>\n

\n

3-(5-Benzyl-1,3,4-oxadiazol-2-yl)
-1-(2-morpholin-4-ylethyl)
-1H-indole<\/p>\n<\/td>\n

\n

4-(2-(3-(5-benzyl-1,3,4-oxadiazol-2-yl)-1H<\/i>-indol-1-yl)ethyl)morpholine<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

20<\/p>\n<\/td>\n

\n

3-(5-Benzyl-1,3,4-oxadiazol-2-yl)
-1-(2-pyrrolidin-1-ylethyl)
-1H-indole<\/p>\n<\/td>\n

\n

2-benzyl-5-(1-(2-(pyrrolidin-1-yl)ethyl)-1H<\/i>-indol-3-yl)-1,3,4-oxadiazole<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

21<\/p>\n<\/td>\n

\n

3-FEA<\/p>\n<\/td>\n

\n

N-ethyl-3-fluoro-\u03b1-methyl-benzeneethanamine, monohydrochloride<\/p>\n<\/td>\n

\n

54982-43-3<\/p>\n<\/td>\n<\/tr>\n

\n

22<\/p>\n<\/td>\n

\n

3-Meo-PCP<\/p>\n<\/td>\n

\n

1-[1-(3-methoxyphenyl)cyclohexy]-piperidine<\/p>\n<\/td>\n

\n

72242-03-6<\/p>\n<\/td>\n<\/tr>\n

\n

23<\/p>\n<\/td>\n

\n

3-MMC<\/p>\n<\/td>\n

\n

2-(methylamino)-1-(3-methylphenyl)-1-propanone<\/p>\n<\/td>\n

\n

1246816-62-5<\/p>\n<\/td>\n<\/tr>\n

\n

24<\/p>\n<\/td>\n

\n

4,4\u2019-DMAR<\/p>\n<\/td>\n

\n

Para<\/i>-methyl-4-methylaminorex<\/p>\n<\/td>\n

\n

364064-08-4<\/p>\n<\/td>\n<\/tr>\n

\n

25<\/p>\n<\/td>\n

\n

4-CEC<\/p>\n<\/td>\n

\n

1-(4-Chlorophenyl)-2-(ethy lamino)-1-propanone<\/p>\n<\/td>\n

\n

14919-85-8<\/p>\n<\/td>\n<\/tr>\n

\n

26<\/p>\n<\/td>\n

\n

4-CMC (Clefedrone, 4-chloromethcathinone)<\/p>\n<\/td>\n

\n

1-(4-chlorophenyl)-2-methylamine)propan-1-one<\/p>\n<\/td>\n

\n

1225843-86-6<\/p>\n<\/td>\n<\/tr>\n

\n

27<\/p>\n<\/td>\n

\n

4-fluoroamphetamine (4-FA)<\/p>\n<\/td>\n

\n

1-(4-Fluorophenyl)-2-propanamine<\/p>\n<\/td>\n

\n

459-02-9<\/p>\n<\/td>\n<\/tr>\n

\n

28<\/p>\n<\/td>\n

\n

4-fluoroisobutyrfentanyl (para Fluoroisobutyrfentanyl,
4-FIBF, pFIBF)<\/p>\n<\/td>\n

\n

N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl) isobutyramide<\/p>\n<\/td>\n

\n

244195-32-2<\/p>\n<\/td>\n<\/tr>\n

\n

29<\/p>\n<\/td>\n

\n

4F-ABUTINACA<\/p>\n<\/td>\n

\n

1-(4-fluorobutyl)-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-indazole-3-carboxamide<\/p>\n<\/td>\n

\n

1445580-39-1<\/p>\n<\/td>\n<\/tr>\n

\n

30<\/p>\n<\/td>\n

\n

4F-MDMB-BICA
(4F-MDMB-BUTICA)<\/p>\n<\/td>\n

\n

methyl 2-({[1-(4-fluorobutyl)-1H-indol-3-yl] carbonyl}amino)-3,3-dimethylbutanoate<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

31<\/p>\n<\/td>\n

\n

4F-MDMB-BINACA (4F-MDMB-BUTINACA)<\/p>\n<\/td>\n

\n

Methyl 2-(1-(4-fluorobutyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

32<\/p>\n<\/td>\n

\n

4-HO-DiPT<\/p>\n<\/td>\n

\n

3-[2-(diisopropylamino) ethyl]-1H-<\/i>indol-4-ol<\/p>\n<\/td>\n

\n

63065-90-7<\/p>\n<\/td>\n<\/tr>\n

\n

33<\/p>\n<\/td>\n

\n

4-Hydroxy-3,3,4-trimethyl-1-
(1-pentyl-1H-indol-3-yl)
pentan-1-one<\/p>\n<\/td>\n

\n

4-hydroxy-3,3,4-trimethyl-1-
(1-pentyl-1H<\/i>-indol-3-yl)pentan-1-one<\/p>\n<\/td>\n

\n

1445751-38-1<\/p>\n<\/td>\n<\/tr>\n

\n

34<\/p>\n<\/td>\n

\n

4-methylcanthinone<\/p>\n<\/td>\n

\n

2-amino-1-(4-metylphenyl) propan-1-one<\/p>\n<\/td>\n

\n

31952-47-3<\/p>\n<\/td>\n<\/tr>\n

\n

35<\/p>\n<\/td>\n

\n

5-APB<\/p>\n<\/td>\n

\n

1-Benzo furan-5-ylpropan-2-amine<\/p>\n<\/td>\n

\n

286834-81-9<\/p>\n<\/td>\n<\/tr>\n

\n

36<\/p>\n<\/td>\n

\n

5C-AKB48<\/p>\n<\/td>\n

\n

N<\/i>-(adamantan-1-yl)-1-(5-chloropentyl)-1H<\/i>-indazole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

37<\/p>\n<\/td>\n

\n

5-Chloro-NNE1<\/p>\n

(5-Cl-MN-24)<\/p>\n<\/td>\n

\n

1-(5-chloropentyl)-N<\/i>-(naphthalen-1-yl)-1H<\/i>-indole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

38<\/p>\n<\/td>\n

\n

5-Cl-AB-PINACA<\/p>\n<\/td>\n

\n

N<\/i>-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-chloropentyl)-1H<\/i>-indazole-3-carboxamide<\/p>\n<\/td>\n

\n

1801552-02-2<\/p>\n<\/td>\n<\/tr>\n

\n

39<\/p>\n<\/td>\n

\n

5F-AB-001<\/p>\n<\/td>\n

\n

adamantan-1-yl(1-(5-fluoropentyl)-1H-<\/i>indol-3-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

40<\/p>\n<\/td>\n

\n

5F-AB-FUPPYCA<\/p>\n<\/td>\n

\n

N-<\/i>(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-5-(4-fluorophenyl)-1H<\/i>-pyrazole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

41<\/p>\n<\/td>\n

\n

5F-AB-PINACA<\/p>\n<\/td>\n

\n

N-<\/i>(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H<\/i>-indazole-3-carboxamide<\/p>\n<\/td>\n

\n

1800101-60-3<\/p>\n<\/td>\n<\/tr>\n

\n

42<\/p>\n<\/td>\n

\n

5F-ADBICA<\/p>\n<\/td>\n

\n

N<\/i>-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H<\/i>-indole-3-carboxamide<\/p>\n<\/td>\n

\n

1863065-82-0<\/p>\n<\/td>\n<\/tr>\n

\n

43<\/p>\n<\/td>\n

\n

5F-ADB-PINACA<\/p>\n<\/td>\n

\n

N<\/i>-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H<\/i>-indazole-3-carboxamide<\/p>\n<\/td>\n

\n

1863065-90-0<\/p>\n<\/td>\n<\/tr>\n

\n

44<\/p>\n<\/td>\n

\n

5F-AEB<\/p>\n<\/td>\n

\n

ethyl (1-(5-fluoropentyl)-1H<\/i>-indazole-3-carbonyl)-L-valinate<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

45<\/p>\n<\/td>\n

\n

5F-AKB48<\/p>\n

(5F-APINACA)<\/p>\n<\/td>\n

\n

N<\/i>-(adamantan-1-yl)-1-(5-fluoropentyl)-1H<\/i>-indazole-3-carboxamide<\/p>\n<\/td>\n

\n

1400742-13-3<\/p>\n<\/td>\n<\/tr>\n

\n

46<\/p>\n<\/td>\n

\n

5F-AMB<\/p>\n<\/td>\n

\n

methyl (1-(5-fluoropentyl)-1H<\/i>-indazole-3-carbonyl)valinate<\/p>\n<\/td>\n

\n

1801552-03-3<\/p>\n<\/td>\n<\/tr>\n

\n

47<\/p>\n<\/td>\n

\n

5F-AMBICA<\/p>\n<\/td>\n

\n

N<\/i>-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H<\/i>-indole-3-carboxamide<\/p>\n<\/td>\n

\n

1801338-26-0<\/p>\n<\/td>\n<\/tr>\n

\n

48<\/p>\n<\/td>\n

\n

5F-APICA<\/p>\n<\/td>\n

\n

N<\/i>-(adamantan-1-yl)-1-(5-fluoropentyl)-1H<\/i>-indole-3-carboxamide<\/p>\n<\/td>\n

\n

1354631-26-7<\/p>\n<\/td>\n<\/tr>\n

\n

49<\/p>\n<\/td>\n

\n

5F-APP-PINACA<\/p>\n<\/td>\n

\n

N<\/i>-(1-amino-1-oxo-3-phenylpropan-2-yl)-1-(5-fluoropentyl)-1H<\/i>-indazole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

50<\/p>\n<\/td>\n

\n

5F-EMB-PINACA<\/p>\n<\/td>\n

\n

Ethyl 2-[[1-(5-fluoropentyl)indazole-3-carbonyl]amino]-3-methyl-butanoate<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

51<\/p>\n<\/td>\n

\n

5F-INPB-22<\/p>\n<\/td>\n

\n

quinolin-8-yl 1-(5-fluoropentyl)-1H-<\/i>indazole-3-carboxylate<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

52<\/p>\n<\/td>\n

\n

5-fluoropentyl-3-pyridinoylindole<\/p>\n<\/td>\n

\n

(1-(5-fluoropentyl)-1H<\/i>-indol-3-yl)(pyridin-3-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

53<\/p>\n<\/td>\n

\n

5F-MDMB-PICA (5F-MDMB-2201, MDMB-2201)<\/p>\n<\/td>\n

\n

(Methyl 2-[[1-(5-fluoropentyl) indole-3-carbonyl]amino]-3,3-dimethyl-butanoate)<\/p>\n<\/td>\n

\n

1971007-88-1<\/p>\n<\/td>\n<\/tr>\n

\n

54<\/p>\n<\/td>\n

\n

5F-MDMB-PINACA<\/p>\n<\/td>\n

\n

methyl 2-(1-(5-fluoropentyl)-1H<\/i>-indazole-3-carboxamido)-3,3-dimethylbutanoate<\/p>\n<\/td>\n

\n

1715016-75-3<\/p>\n<\/td>\n<\/tr>\n

\n

55<\/p>\n<\/td>\n

\n

5F-MMB-PICA<\/p>\n<\/td>\n

\n

methyl (1-(5-fluoropentyl)-1H<\/i>-indole-3-carbonyl)valinate<\/p>\n<\/td>\n

\n

1616253-26-9<\/p>\n<\/td>\n<\/tr>\n

\n

56<\/p>\n<\/td>\n

\n

5F-MN-18<\/p>\n<\/td>\n

\n

1-(5-fluoropentyl)-N<\/i>-(naphthalen-1-yl)-1H<\/i>-indazole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

57<\/p>\n<\/td>\n

\n

5F-MN-24<\/p>\n<\/td>\n

\n

1-(5-fluoropentyl)-N<\/i>-(naphthalen-1-yl)-1H<\/i>-indole-3-carboxamide<\/p>\n<\/td>\n

\n

1445580-60-8<\/p>\n<\/td>\n<\/tr>\n

\n

58<\/p>\n<\/td>\n

\n

5F-PB-22<\/p>\n<\/td>\n

\n

quinolin-8-yl 1-(5-fluoropentyl)-1H<\/i>-indole-3-carboxylate<\/p>\n<\/td>\n

\n

1411742-41-7<\/p>\n<\/td>\n<\/tr>\n

\n

59<\/p>\n<\/td>\n

\n

5F-PCN<\/p>\n<\/td>\n

\n

1-(5-fluoropentyl)-N<\/i>-(naphthalen-1-yl)-1H<\/i>-pyrrolo[3,2-c]pyridine-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

60<\/p>\n<\/td>\n

\n

5F-PY-PICA<\/p>\n<\/td>\n

\n

(1-(5-fluoropentyl)-1H<\/i>-indol-3-yl)(pyrrolidin-1-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

61<\/p>\n<\/td>\n

\n

5F-PY-PINACA<\/p>\n<\/td>\n

\n

(1-(5-fluoropentyl)-1H<\/i>-indazol-3-yl)(pyrrolidin-1-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

62<\/p>\n<\/td>\n

\n

5F-SDB-005<\/p>\n<\/td>\n

\n

naphthalen-1-yl 1-(5-fluoropentyl)-1H-<\/i>indazole-3-carboxylate<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

63<\/p>\n<\/td>\n

\n

5F-SDB-006<\/p>\n<\/td>\n

\n

N<\/i>-benzyl-1-(5-fluoropentyl)-1H<\/i>-indole-3-carboxamide<\/p>\n<\/td>\n

\n

776086-02-2<\/p>\n<\/td>\n<\/tr>\n

\n

64<\/p>\n<\/td>\n

\n

5F-THJ (5F-THJ-018)<\/p>\n<\/td>\n

\n

1-(5-fluoropentyl)-N<\/i>-(quinolin-8-yl)-1H<\/i>-indazole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

65<\/p>\n<\/td>\n

\n

5F-UR-144 indazole<\/p>\n<\/td>\n

\n

(1-(5-fluoropentyl)-1H<\/i>-indazol-3-yl)(2,2,3,3tetramethylcyclopropyl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

66<\/p>\n<\/td>\n

\n

5-Meo-DiPT<\/p>\n<\/td>\n

\n

3- [2- (diisopropylamino) ethyl] -5-methoxyindole<\/p>\n<\/td>\n

\n

4021-34-5<\/p>\n<\/td>\n<\/tr>\n

\n

67<\/p>\n<\/td>\n

\n

5-MeO-MiPT<\/p>\n<\/td>\n

\n

N \u2013<\/i>\u00a0[2- (5-methoxy-1H<\/i>-indol-3-yl) ethyl] \u2013\u00a0N<\/i>\u00a0-methylpropan-2-amin<\/p>\n<\/td>\n

\n

96096-55-8<\/p>\n<\/td>\n<\/tr>\n

\n

68<\/p>\n<\/td>\n

\n

A-796,260<\/p>\n<\/td>\n

\n

(1-(2-morpholinoethyl)-1H<\/i>-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone<\/p>\n<\/td>\n

\n

895155-26-7<\/p>\n<\/td>\n<\/tr>\n

\n

69<\/p>\n<\/td>\n

\n

A-796,260 isomer<\/p>\n<\/td>\n

\n

E)-3,4,4-trimethyl-1-(1-(2-morpholinoethyl)-1H<\/i>-indol-3-yl)pent-2-en-1-one<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

70<\/p>\n<\/td>\n

\n

A-834,735<\/p>\n<\/td>\n

\n

(1-((tetrahydro-2H<\/i>-pyran-4-yl)methyl)-1H<\/i>-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone<\/p>\n<\/td>\n

\n

895155-57-4<\/p>\n<\/td>\n<\/tr>\n

\n

71<\/p>\n<\/td>\n

\n

A-836,339<\/p>\n<\/td>\n

\n

(E)-N<\/i>-(3-(2-methoxyethyl)-4,5-dimethylthiazol-2(3H<\/i>)-ylidene)-2,2,3,3-tetramethylcyclopropane-1-carboxamide<\/p>\n<\/td>\n

\n

959746-77-1<\/p>\n<\/td>\n<\/tr>\n

\n

72<\/p>\n<\/td>\n

\n

AB-005<\/p>\n<\/td>\n

\n

(1-((1-methylpiperidin-2-yl)methyl)-1H<\/i>-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone<\/p>\n<\/td>\n

\n

895155-25-6<\/p>\n<\/td>\n<\/tr>\n

\n

73<\/p>\n<\/td>\n

\n

AB-005 azepane<\/p>\n<\/td>\n

\n

(1-(1-methylazepan-3-yl)-1H<\/i>-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

74<\/p>\n<\/td>\n

\n

AB-CHMFUPPYCA<\/p>\n<\/td>\n

\n

N<\/i>-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-3-(4-fluorophenyl)-1H<\/i>-pyrazole-5-carboxamide<\/p>\n<\/td>\n

\n

1870799-79-3<\/p>\n<\/td>\n<\/tr>\n

\n

75<\/p>\n<\/td>\n

\n

AB-CHMICA<\/p>\n<\/td>\n

\n

(S)-N<\/i>-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H<\/i>-indole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

76<\/p>\n<\/td>\n

\n

AB-CHMINACA<\/p>\n<\/td>\n

\n

(S)-N<\/i>-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-\u00a0<\/i>indazole-3-carboxamide<\/p>\n<\/td>\n

\n

1185887-21-1<\/p>\n<\/td>\n<\/tr>\n

\n

77<\/p>\n<\/td>\n

\n

AB-CHMINACA 2\u2019-indazole<\/p>\n<\/td>\n

\n

(S)-N<\/i>-(1-amino-3-methyl-1-oxobutan-2-yl)-2-(cyclohexylmethyl)-2H<\/i>-indazole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

78<\/p>\n<\/td>\n

\n

AB-FUBINACA<\/p>\n<\/td>\n

\n

(S)-N<\/i>-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H<\/i>-indazole-3-carboxamide<\/p>\n<\/td>\n

\n

1185282-01-2<\/p>\n<\/td>\n<\/tr>\n

\n

79<\/p>\n<\/td>\n

\n

AB-FUBINACA 2- fluorobenzyl<\/p>\n<\/td>\n

\n

(S)-N<\/i>-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(2-fluorobenzyl)-1H<\/i>-indazole-3-carboxamide<\/p>\n<\/td>\n

\n

1185282-16-9<\/p>\n<\/td>\n<\/tr>\n

\n

80<\/p>\n<\/td>\n

\n

AB-PICA<\/p>\n<\/td>\n

\n

N<\/i>-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H<\/i>-indole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

81<\/p>\n<\/td>\n

\n

AB-PINACA<\/p>\n<\/td>\n

\n

(S)-N<\/i>-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H<\/i>-indazole-3- carboxamide<\/p>\n<\/td>\n

\n

1445752-09-9<\/p>\n<\/td>\n<\/tr>\n

\n

82<\/p>\n<\/td>\n

\n

AB-PINACA N-(2-fluoropentyl)<\/p>\n<\/td>\n

\n

N<\/i>-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(2-fluoropentyl)-1H<\/i>-indazole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

83<\/p>\n<\/td>\n

\n

AB-PINACA N-(3-fluoropentyl)<\/p>\n<\/td>\n

\n

N<\/i>-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(3-fluoropentyl)-1H<\/i>-indazole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

84<\/p>\n<\/td>\n

\n

AB-PINACA N-(4-fluoropentyl)<\/p>\n<\/td>\n

\n

N<\/i>-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluoropentyl)-1H<\/i>-indazole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

85<\/p>\n<\/td>\n

\n

AB-PINACA N-(5-fluoropentyl)<\/p>\n<\/td>\n

\n

N<\/i>-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H<\/i>-indazole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

86<\/p>\n<\/td>\n

\n

AB-PINACA-N-FluoroPentyl<\/p>\n<\/td>\n

\n

N-\u00a0<\/i>(1-amino 3 methyl- 1- oxobutan- 2-yl) \u2013 1- fluoropentyl) \u2013 1H-<\/i>\u00a0indazole- 3 cacboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

87<\/p>\n<\/td>\n

\n

Acetyl fentanyl<\/p>\n<\/td>\n

\n

N<\/i>\u00a0\u2013 (1-Phenethylpiperidin-4-yl) \u2013\u00a0N \u2013\u00a0<\/i>phenylacetamide<\/p>\n<\/td>\n

\n

3258-84-2<\/p>\n<\/td>\n<\/tr>\n

\n

88<\/p>\n<\/td>\n

\n

Acetylpsilocine
(Psilacetine, 4-AcO DMT)<\/p>\n<\/td>\n

\n

4-Acetoxy-N,N-dimethyl tryptamine, 3-(2\u2032-dimethylaminoethyl)-4-acetoxy-indole<\/p>\n<\/td>\n

\n

92292-84-7<\/p>\n<\/td>\n<\/tr>\n

\n

89<\/p>\n<\/td>\n

\n

Acryloylfentanyl (Acrylfentanyl)<\/p>\n<\/td>\n

\n

N-(1-phenylethylpiperidin-4-yl)-N-phenylacrylamide<\/p>\n<\/td>\n

\n

82003-75-6<\/p>\n<\/td>\n<\/tr>\n

\n

90<\/p>\n<\/td>\n

\n

Alpha-PHP (PV-7,\u03b1-pyrrolidinohexanophenon)<\/p>\n<\/td>\n

\n

1-phenyl-2-(pyrrolidin-1-yl) hexan-1-one<\/p>\n<\/td>\n

\n

13415-86-6<\/p>\n<\/td>\n<\/tr>\n

\n

91<\/p>\n<\/td>\n

\n

Adamantyl-THPINACA<\/p>\n<\/td>\n

\n

N<\/i>-(adamantan-1-yl)-1-((tetrahydro-2H<\/i>-pyran-4-yl)methyl)-1H<\/i>-indazole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

92<\/p>\n<\/td>\n

\n

ADB-BUTINACA<\/p>\n<\/td>\n

\n

N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-butyl-1H-indazole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

93<\/p>\n<\/td>\n

\n

ADB-CHMICA<\/p>\n<\/td>\n

\n

N<\/i>-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H<\/i>-indole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

94<\/p>\n<\/td>\n

\n

ADB-CHMINACA
(MAB-CHMINACA)<\/p>\n<\/td>\n

\n

N<\/i>-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-\u00a0<\/i>indazole-3-carboxamide<\/p>\n<\/td>\n

\n

1863065-92-2<\/p>\n<\/td>\n<\/tr>\n

\n

95<\/p>\n<\/td>\n

\n

ADB-FUBICA<\/p>\n<\/td>\n

\n

(S)-N<\/i>-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-<\/i>indole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

96<\/p>\n<\/td>\n

\n

ADB-FUBINACA<\/p>\n<\/td>\n

\n

N<\/i>-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H<\/i>-indazole-3-carboxamide<\/p>\n<\/td>\n

\n

1445583-51-6<\/p>\n<\/td>\n<\/tr>\n

\n

97<\/p>\n<\/td>\n

\n

ADBICA<\/p>\n<\/td>\n

\n

N<\/i>-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H<\/i>-indole-3-carboxamide<\/p>\n<\/td>\n

\n

1445583-48-1<\/p>\n<\/td>\n<\/tr>\n

\n

98<\/p>\n<\/td>\n

\n

ADB-PINACA<\/p>\n<\/td>\n

\n

N<\/i>-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H<\/i>-indazole-3-carboxamide<\/p>\n<\/td>\n

\n

1633766-73-0<\/p>\n<\/td>\n<\/tr>\n

\n

99<\/p>\n<\/td>\n

\n

ADSB-FUB-187<\/p>\n<\/td>\n

\n

7-chloro-N<\/i>-(1-((2-(cyclopropanesulfonamido)ethyl)amino)-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H<\/i>-indazole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

100<\/p>\n<\/td>\n

\n

AKB-57<\/p>\n<\/td>\n

\n

adamantan-1-yl 1-pentyl-1H<\/i>-indazole-3-carboxylate<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

101<\/p>\n<\/td>\n

\n

Alpha
\u2013\u00a0<\/i>Pyrrolidinopentiophenone<\/p>\n<\/td>\n

\n

(RS<\/i>)-1-Phenyl-2-(1-pyrrolidinyl)-1-pentanone<\/p>\n<\/td>\n

\n

14530-33-7<\/p>\n<\/td>\n<\/tr>\n

\n

102<\/p>\n<\/td>\n

\n

AM-1220<\/p>\n<\/td>\n

\n

(1-((1-methylpiperidin-2-yl)methyl)-1H<\/i>-indol-3-yl)(naphthalen-1-yl)methanone<\/p>\n<\/td>\n

\n

134959-64-1<\/p>\n<\/td>\n<\/tr>\n

\n

103<\/p>\n<\/td>\n

\n

AM-1220 azepane<\/p>\n<\/td>\n

\n

(1-((1-methylazepan-3-yl)methyl)-1H-<\/i>indol-3-yl)(naphthalen-1-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

104<\/p>\n<\/td>\n

\n

AM-1241<\/p>\n<\/td>\n

\n

(2-iodo-5-nitrophenyl)(1-((1-methylpiperidin-2-yl)methyl)-1H<\/i>-indol-3-yl)methanone<\/p>\n<\/td>\n

\n

444912-48-5<\/p>\n<\/td>\n<\/tr>\n

\n

105<\/p>\n<\/td>\n

\n

AM-1248<\/p>\n<\/td>\n

\n

adamantan-1-yl(1-((1-methylpiperidin-2-yl)methyl)-1H<\/i>-indol-3-yl)methanone<\/p>\n<\/td>\n

\n

335160-66-2<\/p>\n<\/td>\n<\/tr>\n

\n

106<\/p>\n<\/td>\n

\n

AM-1248 azepane<\/p>\n<\/td>\n

\n

adamantan-1-yl(1-(1-methylazepan-3-yl)-1H<\/i>-indol-3-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

107<\/p>\n<\/td>\n

\n

AM-2201<\/p>\n<\/td>\n

\n

1 \u2013 [(5-fluoropentyl) -1H\u00a0<\/i>-indole-3-yl] \u2013 (naphthalen-1-yl) methanone<\/p>\n<\/td>\n

\n

335161-24-5<\/p>\n<\/td>\n<\/tr>\n

\n

108<\/p>\n<\/td>\n

\n

AM-2201 4-methoxynaphtyl<\/p>\n<\/td>\n

\n

(1-(5-fluoropentyl)-1H<\/i>-indol-3-yl)(4-methoxynaphthalen-1-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

109<\/p>\n<\/td>\n

\n

AM-2201 N-(4-fluoropentyl)<\/p>\n<\/td>\n

\n

(1-(4-fluoropentyl)-1H<\/i>-indol-3-yl)(naphthalen-1-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

110<\/p>\n<\/td>\n

\n

AM-2232<\/p>\n<\/td>\n

\n

5-(3-(1-naphthoyl)-1H<\/i>-indol-1-yl)pentanenitrile<\/p>\n<\/td>\n

\n

335161-19-8<\/p>\n<\/td>\n<\/tr>\n

\n

111<\/p>\n<\/td>\n

\n

AM-2233<\/p>\n<\/td>\n

\n

(2-iodophenyl)(1-((1-methylpiperidin-2-yl)methyl)-1H<\/i>-indol-3-yl)methanone<\/p>\n<\/td>\n

\n

444912-75-8<\/p>\n<\/td>\n<\/tr>\n

\n

112<\/p>\n<\/td>\n

\n

AM-356<\/p>\n<\/td>\n

\n

(5Z,8Z,11Z,14Z)-N<\/i>-((R)-1-hydroxypropan-2-yl)icosa-5,8,11,14-tetraenamide<\/p>\n<\/td>\n

\n

157182-49-5<\/p>\n<\/td>\n<\/tr>\n

\n

113<\/p>\n<\/td>\n

\n

AM-6527 N-(5-fluoropentyl)<\/p>\n<\/td>\n

\n

1-(5-fluoropentyl)-N<\/i>-(naphthalen-2-yl)-1H<\/i>-indole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

114<\/p>\n<\/td>\n

\n

AM-679<\/p>\n<\/td>\n

\n

(2-iodophenyl)(1-pentyl-1H<\/i>-indol-3-yl)methanone<\/p>\n<\/td>\n

\n

335160-91-3<\/p>\n<\/td>\n<\/tr>\n

\n

115<\/p>\n<\/td>\n

\n

AM-694<\/p>\n<\/td>\n

\n

(1-(5-fluoropentyl)-1H<\/i>-indol-3-yl)(2-iodophenyl)methanone<\/p>\n<\/td>\n

\n

335161-03-0<\/p>\n<\/td>\n<\/tr>\n

\n

116<\/p>\n<\/td>\n

\n

AM-694 (Chloro)<\/p>\n<\/td>\n

\n

(1-(5-chloropentyl)-1H<\/i>-indol-3-yl)(2-iodophenyl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

117<\/p>\n<\/td>\n

\n

AMB (MMB-PINACA,AMB-PINACA)<\/p>\n<\/td>\n

\n

methyl (1-pentvl-1H<\/i>-indazole-3-carbonyl)-L-valinate<\/p>\n<\/td>\n

\n

1890250-13-1<\/p>\n<\/td>\n<\/tr>\n

\n

118<\/p>\n<\/td>\n

\n

AMB-CHMICA (MMB-CHMICA)<\/p>\n<\/td>\n

\n

methyl (1-(cyclohexylmethyl)-1H<\/i>-indole-3-carbonyl) valinate<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

119<\/p>\n<\/td>\n

\n

AMB-CHMINACA<\/p>\n<\/td>\n

\n

methyl (1-(cyclohexylmethyl)-1H<\/i>-indazole-3-carbonyl)-valinate<\/p>\n<\/td>\n

\n

1863066-03-8<\/p>\n<\/td>\n<\/tr>\n

\n

120<\/p>\n<\/td>\n

\n

APICA<\/p>\n<\/td>\n

\n

N<\/i>-(adamantan-1-yl)-1-pentyl-1H<\/i>-indole-3-carboxamide<\/p>\n<\/td>\n

\n

1345973-50-3<\/p>\n<\/td>\n<\/tr>\n

\n

121<\/p>\n<\/td>\n

\n

APINACA (AKB48)<\/p>\n<\/td>\n

\n

N<\/i>-(adamantan-1-yl)-1-pentyl-1H<\/i>-indazole-3-carboxamide<\/p>\n<\/td>\n

\n

1345973-53-6<\/p>\n<\/td>\n<\/tr>\n

\n

122<\/p>\n<\/td>\n

\n

APP-CHMINACA<\/p>\n<\/td>\n

\n

N<\/i>-(1-amino-1-oxo-3-phenylpropan-2-yl)-1-(cyclohexylmethyl)-1H<\/i>-indazole-3-carboxamide<\/p>\n<\/td>\n

\n

1185887-14-2<\/p>\n<\/td>\n<\/tr>\n

\n

123<\/p>\n<\/td>\n

\n

Benzylone (BMDP)<\/p>\n<\/td>\n

\n

1-(1,3-benzodioxol-5-yl)-2-(benzylamino)propan-1-one<\/p>\n<\/td>\n

\n

1823274-68-5<\/p>\n<\/td>\n<\/tr>\n

\n

124<\/p>\n<\/td>\n

\n

Brorphine<\/p>\n<\/td>\n

\n

1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-1,3-dihydro-2H-benzo[d]imidazol-2-one<\/p>\n<\/td>\n

\n

2244737-98-0<\/p>\n<\/td>\n<\/tr>\n

\n

125<\/p>\n<\/td>\n

\n

Butyrfentanyl<\/p>\n<\/td>\n

\n

N<\/i>-(1-phenethylpiperidin-4-yl)-N<\/i>-phenylbutyramide<\/p>\n<\/td>\n

\n

1169-70-6<\/p>\n<\/td>\n<\/tr>\n

\n

126<\/p>\n<\/td>\n

\n

BZP<\/p>\n<\/td>\n

\n

1-Benzylpiperazine<\/p>\n<\/td>\n

\n

2759-28-6<\/p>\n<\/td>\n<\/tr>\n

\n

127<\/p>\n<\/td>\n

\n

Cannabipiperidiethanone<\/p>\n<\/td>\n

\n

2-(2-methoxyphenyl)-1-(1-((1-methylpiperidin-2-yl)methyl)-1H<\/i>-indol-3-yl)ethan-1-one<\/p>\n<\/td>\n

\n

1345970-43-5<\/p>\n<\/td>\n<\/tr>\n

\n

128<\/p>\n<\/td>\n

\n

Carfentanil<\/p>\n<\/td>\n

\n

Methyl 4-(N-propionyl-N-phenylamino)-1 -(2- phenylethyl)-4- piperidinecarboxylate<\/p>\n<\/td>\n

\n

59708-52-0<\/p>\n<\/td>\n<\/tr>\n

\n

129<\/p>\n<\/td>\n

\n

Crotonylfentanyl<\/p>\n<\/td>\n

\n

(E)-N-(1-phenethylpiperidin-4-yl)-N-phenylbut-2-enamide<\/p>\n<\/td>\n

\n

760930-59-0<\/p>\n<\/td>\n<\/tr>\n

\n

130<\/p>\n<\/td>\n

\n

Cyclopropylfentanyl<\/p>\n<\/td>\n

\n

N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopropane carboxamide<\/p>\n<\/td>\n

\n

1169-68-2<\/p>\n<\/td>\n<\/tr>\n

\n

131<\/p>\n<\/td>\n

\n

CBL-018<\/p>\n<\/td>\n

\n

naphthalen-1-yl 1-pentyl-1H<\/i>-indole-3-carboxylate<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

132<\/p>\n<\/td>\n

\n

CL-2201<\/p>\n<\/td>\n

\n

(4-chloronaphthalen-1-yl)(1-(5-fluoropentyl)-1H<\/i>-indol-3-yl)methanone<\/p>\n<\/td>\n

\n

1391486-12-6<\/p>\n<\/td>\n<\/tr>\n

\n

133<\/p>\n<\/td>\n

\n

CP-47,497<\/p>\n<\/td>\n

\n

rel-2-((1R,3S)-3-hydroxycyclohexyl)-5-(2-methyloctan-2-yl)phenol<\/p>\n<\/td>\n

\n

70434-82-1<\/p>\n<\/td>\n<\/tr>\n

\n

134<\/p>\n<\/td>\n

\n

CP-47,497 (C8 + C2)<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

135<\/p>\n<\/td>\n

\n

CP-47,497-C6<\/p>\n<\/td>\n

\n

rel-2-((1R,3S)-3-hydroxycyclohexyl)-5-(2-methylheptan-2-yl)phenol<\/p>\n<\/td>\n

\n

132296-20-9<\/p>\n<\/td>\n<\/tr>\n

\n

136<\/p>\n<\/td>\n

\n

CP-47,497-
C8 Cannabicyclohexanol<\/p>\n<\/td>\n

\n

rel-2-((1R,3S)-3-hydroxycyclohexyl)-5-(2-methylnonan-2-yl)phenol<\/p>\n<\/td>\n

\n

70434-92-3<\/p>\n<\/td>\n<\/tr>\n

\n

137<\/p>\n<\/td>\n

\n

CP-47,497-C9<\/p>\n<\/td>\n

\n

rel-2-((1R,3S)-3-hydroxycyclohexyl)-5-(2-methyldecan-2-yl)phenol<\/p>\n<\/td>\n

\n

132296-12-9<\/p>\n<\/td>\n<\/tr>\n

\n

138<\/p>\n<\/td>\n

\n

CP-55,244<\/p>\n<\/td>\n

\n

(2S,4S,4aS,6R,8aR)-4-(2-hydroxy-4-(2-methyloctan-2-yl)phenyl)-6- (hydroxymethyl)decahydronaphthalen-2-ol<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

139<\/p>\n<\/td>\n

\n

CP-55,940<\/p>\n<\/td>\n

\n

rel-2-((1R,2R,5R)-5-hydroxy-2-(3-hydroxypropyl)cyclohexyl)-5-(2- methyloctan-2-yl)phenol<\/p>\n<\/td>\n

\n

83003-12-7<\/p>\n<\/td>\n<\/tr>\n

\n

140<\/p>\n<\/td>\n

\n

CRA-13<\/p>\n<\/td>\n

\n

naphthalen-1-yl(4-(pentyloxy)naphthalen-1-yl)methanone<\/p>\n<\/td>\n

\n

432047-72-8<\/p>\n<\/td>\n<\/tr>\n

\n

141<\/p>\n<\/td>\n

\n

CUMYL-4CNBINACA<\/p>\n<\/td>\n

\n

1-(4-cyanobutyl)-N<\/i>-(1-methyl-1-phenyl-ethyl)indazole-3-carboxamide<\/p>\n<\/td>\n

\n

1631074-54-8<\/p>\n<\/td>\n<\/tr>\n

\n

142<\/p>\n<\/td>\n

\n

CUMYL-5F-P7AICA<\/p>\n<\/td>\n

\n

1-(5-fluoropentyl)-N<\/i>-(2-phenylpropan-2-yl)-1H<\/i>-pyrrole[2,3-b]pyridine-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

143<\/p>\n<\/td>\n

\n

CUMYL-5F-PICA<\/p>\n<\/td>\n

\n

1-(5-fluoropentyl)-N<\/i>-(2-phenylpropan-2-yl)-1H<\/i>-indole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

144<\/p>\n<\/td>\n

\n

CUMYL-5F-PINACA<\/p>\n<\/td>\n

\n

1-(5-fluoropentyl)-N<\/i>-(2-phenylpropan-2-yl)-1H<\/i>-indazole-3-carboxamide<\/p>\n<\/td>\n

\n

1400742-16-6<\/p>\n<\/td>\n<\/tr>\n

\n

145<\/p>\n<\/td>\n

\n

CUMYL-BICA<\/p>\n<\/td>\n

\n

1-butyl-N<\/i>-(2-phenylpropan-2-yl)-1H-<\/i>indole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

146<\/p>\n<\/td>\n

\n

CUMYL PEGACLONE<\/p>\n<\/td>\n

\n

5-pentyl-2-(2-phenylpropan-2-yl)-2,5-dihydro-1H-pyrido[4,3-b]indol-1-one<\/p>\n<\/td>\n

\n

2160555-55-3<\/p>\n<\/td>\n<\/tr>\n

\n

147<\/p>\n<\/td>\n

\n

CUMYL-PICA<\/p>\n<\/td>\n

\n

1-pentyl-N<\/i>-(2-phenylpropan-2-yl)-1H-<\/i>indole-3-carboxamide<\/p>\n<\/td>\n

\n

1400742-32-6<\/p>\n<\/td>\n<\/tr>\n

\n

148<\/p>\n<\/td>\n

\n

CUMYL-PINACA<\/p>\n<\/td>\n

\n

1-pentyl-N<\/i>-(2-phenylpropan-2-yl)-1H-<\/i>indazole-3-carboxamide<\/p>\n<\/td>\n

\n

1400742-15-5<\/p>\n<\/td>\n<\/tr>\n

\n

149<\/p>\n<\/td>\n

\n

CUMYL-THPINACA<\/p>\n<\/td>\n

\n

N<\/i>-(2-phenylpropan-2-yl)-1-((tetrahydro-2H<\/i>-pyran-4-yl)methyl)-1H<\/i>-indazole-3-carboxamide<\/p>\n<\/td>\n

\n

1400742-50-8<\/p>\n<\/td>\n<\/tr>\n

\n

150<\/p>\n<\/td>\n

\n

Dexamphetamine<\/p>\n<\/td>\n

\n

(+) \u2013 2 \u2013 amino \u2013 1 \u2013 phenylpropane<\/p>\n<\/td>\n

\n

51-64-9<\/p>\n<\/td>\n<\/tr>\n

\n

151<\/p>\n<\/td>\n

\n

Diethylpropion<\/p>\n<\/td>\n

\n

2-(Diethylamino) propiophenone<\/p>\n<\/td>\n

\n

90-84-6<\/p>\n<\/td>\n<\/tr>\n

\n

152<\/p>\n<\/td>\n

\n

Dimethyl CP-47,497-C8<\/p>\n<\/td>\n

\n

rel-2-((1R,5S)-5-hydroxy-3,3-dimethylcyclohexyl)-5-(2-methylnonan-2-yl)phenol<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

153<\/p>\n<\/td>\n

\n

Diphenidine<\/p>\n<\/td>\n

\n

1-(1,2-diphenylethyl)piperidine<\/p>\n<\/td>\n

\n

28383-15-5<\/p>\n<\/td>\n<\/tr>\n

\n

154<\/p>\n<\/td>\n

\n

DOC (2,5-Dimethoxy-4-chloroamphetamine)<\/p>\n<\/td>\n

\n

1-(4-chloro-2,5-dimethoxy phenyl) propan-2-amine<\/p>\n<\/td>\n

\n

42203-77-0<\/p>\n<\/td>\n<\/tr>\n

\n

155<\/p>\n<\/td>\n

\n

EAM-2201 (5F-JWH-210)<\/p>\n<\/td>\n

\n

(4-ethylnaphthalen-1-yl)(1-(5-fluoropentyl)-1H<\/i>-indol-3-yl)methanone<\/p>\n<\/td>\n

\n

1364933-60-7<\/p>\n<\/td>\n<\/tr>\n

\n

156<\/p>\n<\/td>\n

\n

EG-018<\/p>\n<\/td>\n

\n

naphthalen-1-yl(9-pentyl-9H<\/i>-carbazol-3-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

157<\/p>\n<\/td>\n

\n

EG-2201<\/p>\n<\/td>\n

\n

(9-(5-fluoropentyl)-9H<\/i>-carbazol-3-yl)(naphthalen-1-yl)methanone<\/p>\n<\/td>\n

\n

3652-90-2<\/p>\n<\/td>\n<\/tr>\n

\n

158<\/p>\n<\/td>\n

\n

EMB-FUBINACA<\/p>\n<\/td>\n

\n

ethyl (1-(4-fluorobenzyl)-1H<\/i>-indazole-3-carbonyl)valinate<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

159<\/p>\n<\/td>\n

\n

Ethylone<\/p>\n<\/td>\n

\n

( RS ) -1- (1,3-benzodioxol-5-yl) -2- (ethylamino) propane-1-one<\/p>\n<\/td>\n

\n

1112937-64-0<\/p>\n<\/td>\n<\/tr>\n

\n

160<\/p>\n<\/td>\n

\n

Ethylphenidate<\/p>\n<\/td>\n

\n

( RS )-ethyl 2-phenyl-2-piperidin-2-yl acetate<\/p>\n<\/td>\n

\n

57413-43-1<\/p>\n<\/td>\n<\/tr>\n

\n

161<\/p>\n<\/td>\n

\n

Eutylone
(bk-EBDB, N-Ethylbutylone)<\/p>\n<\/td>\n

\n

1-(1,3-benzodioxol-5-yl)-2-(ethylamino) butan-1-one<\/p>\n<\/td>\n

\n

802855-66-9<\/p>\n<\/td>\n<\/tr>\n

\n

162<\/p>\n<\/td>\n

\n

FDU-NNEI<\/p>\n<\/td>\n

\n

1-(4-fluorobenzyl)-N<\/i>-(naphthalen-1-yl)-1H<\/i>-indole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

163<\/p>\n<\/td>\n

\n

FDU-PB-22<\/p>\n<\/td>\n

\n

naphthalen-1-yl 1-(4-fluorobenzyl)-1H-<\/i>indole-3-carboxylate<\/p>\n<\/td>\n

\n

1883282-94-3<\/p>\n<\/td>\n<\/tr>\n

\n

164<\/p>\n<\/td>\n

\n

Fenethylline<\/p>\n<\/td>\n

\n

7 \u2013 [2 \u2013 (\u03b1<\/i>\u00a0\u2013 methylphenethyl \u2013 amino) ethyl] theophylline<\/p>\n<\/td>\n

\n

3736-08-1<\/p>\n<\/td>\n<\/tr>\n

\n

165<\/p>\n<\/td>\n

\n

FUB-144 (FUB-UR-144)<\/p>\n<\/td>\n

\n

[1-(4-fluorobenzyl)-1H<\/i>-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

166<\/p>\n<\/td>\n

\n

FUB-AKB-48<\/p>\n<\/td>\n

\n

N<\/i>-((3s,5s,7s)-adamantan-1-yl)-1-(4-fluorobenzyl)-1H<\/i>-indazole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

167<\/p>\n<\/td>\n

\n

FUB-AMB (AMB-FUBINACA, MMB-FUBINACA)<\/p>\n<\/td>\n

\n

methyl (1 -(4-fluoroben\/yl)- 1H- inda\/ole-3 -carbonyl)valinate<\/p>\n<\/td>\n

\n

1715016-76-4<\/p>\n<\/td>\n<\/tr>\n

\n

168<\/p>\n<\/td>\n

\n

FUBIMINA<\/p>\n<\/td>\n

\n

(1-(5-fluoropentyl)-1H-\u00a0<\/i>benzo [d]imidazol-2-yl)(naphthalen-1-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

169<\/p>\n<\/td>\n

\n

FUB-JWH-018<\/p>\n<\/td>\n

\n

(1-(4-fluorobenzyl)-1H<\/i>-indol-3-yl)(naphthalen-1-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

170<\/p>\n<\/td>\n

\n

FUB-PB-22<\/p>\n<\/td>\n

\n

quinolin-8-yl 1-(4-fluorobenzyl)-1H-<\/i>indole-3-carboxylate<\/p>\n<\/td>\n

\n

1800098-36-5<\/p>\n<\/td>\n<\/tr>\n

\n

171<\/p>\n<\/td>\n

\n

Furanylfentanyl<\/p>\n<\/td>\n

\n

N<\/i>-Phenyl-N<\/i>-[1-(2-phenylethyl)piperidin- 4-yl]furan-2-carboxamide<\/p>\n<\/td>\n

\n

101345-66-8<\/p>\n<\/td>\n<\/tr>\n

\n

172<\/p>\n<\/td>\n

\n

GHB<\/p>\n<\/td>\n

\n

\u03b3<\/i>-Hydroxybutyric acid<\/p>\n<\/td>\n

\n

591-81-1<\/p>\n<\/td>\n<\/tr>\n

\n

173<\/p>\n<\/td>\n

\n

HU-210<\/p>\n<\/td>\n

\n

(6aR, 10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydro-6H<\/i>-benzo[c]chromen-1-ol<\/p>\n<\/td>\n

\n

112830-95-2<\/p>\n<\/td>\n<\/tr>\n

\n

174<\/p>\n<\/td>\n

\n

HU-211<\/p>\n<\/td>\n

\n

(6a,10a)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydro-6H<\/i>-benzo[c]chromen-1-ol<\/p>\n<\/td>\n

\n

112924-45-5<\/p>\n<\/td>\n<\/tr>\n

\n

175<\/p>\n<\/td>\n

\n

HU-308<\/p>\n<\/td>\n

\n

(4-(2,6-dimethoxy-4-(2-methyloctan-2-yl)phenyl)-6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl) methanol<\/p>\n<\/td>\n

\n

256934-39-1<\/p>\n<\/td>\n<\/tr>\n

\n

176<\/p>\n<\/td>\n

\n

HU-331<\/p>\n<\/td>\n

\n

(1\u2019R)-6-hydroxy-3\u2032-methyl-4-pentyl-6\u2032-(prop-1-en-2-yl)-[1,1\u2032-bi(cyclohexane)]-2\u2032,3,6-triene-2,5-dione<\/p>\n<\/td>\n

\n

137252-25-6<\/p>\n<\/td>\n<\/tr>\n

\n

177<\/p>\n<\/td>\n

\n

inzpb-22<\/p>\n<\/td>\n

\n

quinolin-8-yl 1-pentyl-1H<\/i>-indazole-3-carboxylate<\/p>\n<\/td>\n

\n

1445579-61-2<\/p>\n<\/td>\n<\/tr>\n

\n

178<\/p>\n<\/td>\n

\n

Isotonitazene<\/p>\n<\/td>\n

\n

N,N-diethyl-2-(2-(4-isopropoxybenzyl)-5-nitro-1H-benzo[d]imidazol-1-yl)ethan-1-amine<\/p>\n<\/td>\n

\n

14188-81-9<\/p>\n<\/td>\n<\/tr>\n

\n

179<\/p>\n<\/td>\n

\n

JTE-907<\/p>\n<\/td>\n

\n

N<\/i>-(benzo[d][1,3]dioxol-5-ylmethyl)-7-methoxy-2-oxo-8-(pentyloxy)-1,2-dihydroquinoline-3-carboxamide<\/p>\n<\/td>\n

\n

282089-49-0<\/p>\n<\/td>\n<\/tr>\n

\n

180<\/p>\n<\/td>\n

\n

JWH-007<\/p>\n<\/td>\n

\n

(2-methyl-1-pentyl-1H<\/i>-indol-3-yl)(naphthalen-1-yl)methanone<\/p>\n<\/td>\n

\n

155471-10-6<\/p>\n<\/td>\n<\/tr>\n

\n

181<\/p>\n<\/td>\n

\n

JWH-015<\/p>\n<\/td>\n

\n

(2-methyl-1-propyl-1H<\/i>-indol-3-yl)(naphthalen-1-yl)methanone<\/p>\n<\/td>\n

\n

155471-08-2<\/p>\n<\/td>\n<\/tr>\n

\n

182<\/p>\n<\/td>\n

\n

JWH-018<\/p>\n<\/td>\n

\n

1-pentyl-3-(1-naphthoyl) indole<\/p>\n<\/td>\n

\n

209414-07-3<\/p>\n<\/td>\n<\/tr>\n

\n

183<\/p>\n<\/td>\n

\n

JWH-018 adamantyl (AB-001)<\/p>\n<\/td>\n

\n

adamantan-1-yl(1-pentyl-1H<\/i>-indol-3-yl)methanone<\/p>\n<\/td>\n

\n

1345973-49-0<\/p>\n<\/td>\n<\/tr>\n

\n

184<\/p>\n<\/td>\n

\n

JWH-018 cyclohexylmethyl<\/p>\n<\/td>\n

\n

(1-(cyclohexylmethyl)-1H<\/i>-indol-3-yl)(naphthalen-1-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

185<\/p>\n<\/td>\n

\n

JWH-018 isopentyl<\/p>\n<\/td>\n

\n

(1-isopentyl-1H<\/i>-indol-3-yl)(naphthalen-1-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

186<\/p>\n<\/td>\n

\n

JWH-018 N-(5-bromopentyl)<\/p>\n<\/td>\n

\n

(1-(5-bromopentyl)-1H<\/i>-indol-3-yl)(naphthalen-1-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

187<\/p>\n<\/td>\n

\n

JWH-018 N-(5-chloropentyl)<\/p>\n<\/td>\n

\n

(1-(5-chloropentyl)-1H<\/i>-indol-3-yl)(naphthalen-1-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

188<\/p>\n<\/td>\n

\n

JWH-018 N-(5-hydroxypentyl)<\/p>\n<\/td>\n

\n

(1-(5-hydroxypentyl)-1H<\/i>-indol-3-yl)(naphthalen-1-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

189<\/p>\n<\/td>\n

\n

JWH-019<\/p>\n<\/td>\n

\n

(1-hexyl-1H<\/i>-indol-3-yl)(naphthalen-1-yl)methanone<\/p>\n<\/td>\n

\n

209414-08-4<\/p>\n<\/td>\n<\/tr>\n

\n

190<\/p>\n<\/td>\n

\n

JWH-022<\/p>\n<\/td>\n

\n

naphthalen-1-yl(1-(pent-4-en-1-yl)-1H-<\/i>indol-3-yl)methanone<\/p>\n<\/td>\n

\n

209414-16-4<\/p>\n<\/td>\n<\/tr>\n

\n

191<\/p>\n<\/td>\n

\n

JWH-030<\/p>\n<\/td>\n

\n

naphthalen-1-yl(1-pentyl-1H<\/i>-pyrrol-3-yl)methanone<\/p>\n<\/td>\n

\n

162934-73-8<\/p>\n<\/td>\n<\/tr>\n

\n

192<\/p>\n<\/td>\n

\n

JWH-071<\/p>\n<\/td>\n

\n

(1-ethyl-1H<\/i>-indol-3-yl)(naphthalen-1-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

193<\/p>\n<\/td>\n

\n

JWH-073<\/p>\n<\/td>\n

\n

1-butyl-3-(1-naphthoyl) indole<\/p>\n<\/td>\n

\n

208987-48-8<\/p>\n<\/td>\n<\/tr>\n

\n

194<\/p>\n<\/td>\n

\n

JWH-073 (4-methylnaphthyl)<\/p>\n<\/td>\n

\n

(1-butyl-1H<\/i>-indol-3-yl)(4-methylnaphthalen-1-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

195<\/p>\n<\/td>\n

\n

JWH-081<\/p>\n<\/td>\n

\n

(4-methoxynaphthalen-1-yl)(1-pentyl-1H<\/i>-indol-3-yl)methanone<\/p>\n<\/td>\n

\n

210179-46-7<\/p>\n<\/td>\n<\/tr>\n

\n

196<\/p>\n<\/td>\n

\n

JWH-122<\/p>\n<\/td>\n

\n

(4-methylnaphthalen-1-yl)(1-pentyl-1H<\/i>-indol-3-yl)methanone<\/p>\n<\/td>\n

\n

619294-47-2<\/p>\n<\/td>\n<\/tr>\n

\n

197<\/p>\n<\/td>\n

\n

JWH-122 5-Methyl-naphty<\/p>\n<\/td>\n

\n

(5-methylnaphthalen-1-yl)(1-pentyl-1H<\/i>-indol-3-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

198<\/p>\n<\/td>\n

\n

JWH-122 N-(4-pentenyl)<\/p>\n<\/td>\n

\n

(4-methylnaphthalen-1-yl)(1-(pent-4-en-1-yl)-1H<\/i>-indol-3-yl)methanone<\/p>\n<\/td>\n

\n

1445577-68-3<\/p>\n<\/td>\n<\/tr>\n

\n

199<\/p>\n<\/td>\n

\n

JWH-122 N-(4-pentenyl)-2-methylindole<\/p>\n<\/td>\n

\n

(4-methylnaphthalen-1-yl)(1-(4-pentenyl) -2-methylindole)-1H<\/i>-indol-3-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

200<\/p>\n<\/td>\n

\n

JWH-122 N-(5-chloropentyl)<\/p>\n<\/td>\n

\n

(1-(5-chloropentyl)-1H<\/i>-indol-3 -yl)(4-methylnaphthalen-1-yl)methanone<\/p>\n<\/td>\n

\n

1445578-25-5<\/p>\n<\/td>\n<\/tr>\n

\n

201<\/p>\n<\/td>\n

\n

JWH-122 N-(5-hydroxypentyl)<\/p>\n<\/td>\n

\n

(1-(5-hydroxypentyl)-1H<\/i>-indol-3-yl)(4-methylnaphthalen-1-yl)methanone<\/p>\n<\/td>\n

\n

1379604-68-8<\/p>\n<\/td>\n<\/tr>\n

\n

202<\/p>\n<\/td>\n

\n

JWH-145<\/p>\n<\/td>\n

\n

naphthalen-1-yl(1-pentyl-5-phenyl-1H-<\/i>pyrrol-3-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

203<\/p>\n<\/td>\n

\n

JWH-175<\/p>\n<\/td>\n

\n

(1-pentylindol-3-yl)naphthalen-1-ylmethane<\/p>\n<\/td>\n

\n

619294-35-8<\/p>\n<\/td>\n<\/tr>\n

\n

204<\/p>\n<\/td>\n

\n

JWH-182<\/p>\n<\/td>\n

\n

(1-pentyl-1H<\/i>-indol-3-yl)(4-propylnaphthalen-1-yl)methanone<\/p>\n<\/td>\n

\n

824960-02-3<\/p>\n<\/td>\n<\/tr>\n

\n

205<\/p>\n<\/td>\n

\n

JWH-200<\/p>\n<\/td>\n

\n

(1-(2-morpholinoethyl)-1H<\/i>-indol-3-yl)(naphthalen-1-yl)methanone<\/p>\n<\/td>\n

\n

103610-04-4<\/p>\n<\/td>\n<\/tr>\n

\n

206<\/p>\n<\/td>\n

\n

JWH-201<\/p>\n<\/td>\n

\n

2-(4-methoxyphenyl)-1-(1-pentyl-1H-<\/i>indol-3-yl)ethan-1-one<\/p>\n<\/td>\n

\n

864445-47-6<\/p>\n<\/td>\n<\/tr>\n

\n

207<\/p>\n<\/td>\n

\n

JWH-203<\/p>\n<\/td>\n

\n

2-(2-chlorophenyl)-1-(1-pentyl-1H-<\/i>indol-3-yl)ethan-1-one<\/p>\n<\/td>\n

\n

864445-54-5<\/p>\n<\/td>\n<\/tr>\n

\n

208<\/p>\n<\/td>\n

\n

JWH-206<\/p>\n<\/td>\n

\n

2-(4-chlorophenyl)-1-(1-pentyl-1H-<\/i>indol-3-yl)ethan-1-one<\/p>\n<\/td>\n

\n

864445-58-9<\/p>\n<\/td>\n<\/tr>\n

\n

209<\/p>\n<\/td>\n

\n

JWH-210<\/p>\n<\/td>\n

\n

(4-ethylnaphthalen-1-yl)(1-pentyl-1H-<\/i>indol-3-yl)methanone<\/p>\n<\/td>\n

\n

824959-81-1<\/p>\n<\/td>\n<\/tr>\n

\n

210<\/p>\n<\/td>\n

\n

JWH-213<\/p>\n<\/td>\n

\n

(4-ethylnaphthalen-1-yl)(2-methyl-1-pentyl-1H<\/i>-indol-3-yl)methanone<\/p>\n<\/td>\n

\n

824959-83-3<\/p>\n<\/td>\n<\/tr>\n

\n

211<\/p>\n<\/td>\n

\n

JWH-250<\/p>\n<\/td>\n

\n

1-pentyl-3-(2-methoxyphenylacetyl) indole<\/p>\n<\/td>\n

\n

864445-43-2<\/p>\n<\/td>\n<\/tr>\n

\n

212<\/p>\n<\/td>\n

\n

JWH-251<\/p>\n<\/td>\n

\n

1-(1-pentyl-1H<\/i>-indol-3-yl)-2-(o-tolyl)ethan-1-one<\/p>\n<\/td>\n

\n

864445-39-6<\/p>\n<\/td>\n<\/tr>\n

\n

213<\/p>\n<\/td>\n

\n

JWH-267<\/p>\n<\/td>\n

\n

(2-methoxynaphthalen-1-yl)(1-pentyl-1H-indol-3-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

214<\/p>\n<\/td>\n

\n

JWH-302<\/p>\n<\/td>\n

\n

2-(3-methoxyphenyl)-1-(1-pentyl-1H-<\/i>indol-3-yl)ethan-1-one<\/p>\n<\/td>\n

\n

864445-45-4<\/p>\n<\/td>\n<\/tr>\n

\n

215<\/p>\n<\/td>\n

\n

JWH-307<\/p>\n<\/td>\n

\n

(5-(2-fluorophenyl)-1-pentyl-1H-<\/i>pyrrol-3-yl)(naphthalen-1-yl)methanone<\/p>\n<\/td>\n

\n

914458-26-7<\/p>\n<\/td>\n<\/tr>\n

\n

216<\/p>\n<\/td>\n

\n

JWH-368<\/p>\n<\/td>\n

\n

(5-(3-fluorophenyl)-1-pentyl-1H-<\/i>pyrrol-3-yl)(naphthalen-1-yl)methanone<\/p>\n<\/td>\n

\n

914458-31-4<\/p>\n<\/td>\n<\/tr>\n

\n

217<\/p>\n<\/td>\n

\n

JWH-370<\/p>\n<\/td>\n

\n

naphthalen-1-yl(1-pentyl-5-(o-tolyl)-1H<\/i>-pyrrol-3-yl)methanone<\/p>\n<\/td>\n

\n

914458-22-3<\/p>\n<\/td>\n<\/tr>\n

\n

218<\/p>\n<\/td>\n

\n

JWH-387<\/p>\n<\/td>\n

\n

(4-bromonaphthalen-1-yl)(1-pentyl-1H-<\/i>indol-3-yl)methanone<\/p>\n<\/td>\n

\n

207227-49-4<\/p>\n<\/td>\n<\/tr>\n

\n

219<\/p>\n<\/td>\n

\n

JWH-398<\/p>\n<\/td>\n

\n

(4-chloronaphthalen-1-yl)(1-pentyl-1H-<\/i>indol-3-yl)methanone<\/p>\n<\/td>\n

\n

1292765-18-4<\/p>\n<\/td>\n<\/tr>\n

\n

220<\/p>\n<\/td>\n

\n

JWH-412<\/p>\n<\/td>\n

\n

(4-fluoronaphthalen-1-yl)(1-pentyl-1H-<\/i>indol-3-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

221<\/p>\n<\/td>\n

\n

JWH-412 N-(-5-fluoropentyl)<\/p>\n<\/td>\n

\n

(4-fluoronaphthalen-1-yl)(1-(5-fluoropentyl)-1H<\/i>-indol-3-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

222<\/p>\n<\/td>\n

\n

Levamphetamine<\/p>\n<\/td>\n

\n

1 \u2013\u00a0\u03b1 \u2013\u00a0<\/i>methylphenethylamine<\/p>\n<\/td>\n

\n

156-34-3<\/p>\n<\/td>\n<\/tr>\n

\n

223<\/p>\n<\/td>\n

\n

Levomethamphetamine<\/p>\n<\/td>\n

\n

(-) \u2013\u00a0N,\u03b1<\/i>\u00a0\u2013 dimethylphenethylamine<\/p>\n<\/td>\n

\n

537-46-2<\/p>\n<\/td>\n<\/tr>\n

\n

224<\/p>\n<\/td>\n

\n

LS-91297<\/p>\n<\/td>\n

\n

(4-methoxyphenyl)(1-methyl-1H<\/i>-indol-3-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

225<\/p>\n<\/td>\n

\n

LTI-701<\/p>\n<\/td>\n

\n

1-(5-fluoropentyl)-N<\/i>-phenyl-1H<\/i>-indole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

226<\/p>\n<\/td>\n

\n

LY-2183240<\/p>\n<\/td>\n

\n

5-([1,1\u2032-biphenyl]-4-ylmethyl)-N,N-<\/i>dimethyl-1H<\/i>-tetrazole-1-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

227<\/p>\n<\/td>\n

\n

LY2183240-2\u2032-isomer<\/p>\n<\/td>\n

\n

5-([1,1\u2019-biphenyl]-4-ylmethyl)-N,N<\/i>-dimethyl-2H<\/i>-tetrazole-2-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

228<\/p>\n<\/td>\n

\n

M5FPIC<\/p>\n<\/td>\n

\n

methyl 1-(5-fluoropentyl)-1H<\/i>-indole-3-carboxylate<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

229<\/p>\n<\/td>\n

\n

MAM-2201<\/p>\n<\/td>\n

\n

(1-(5-fluoropentyl)-1H<\/i>-indol-3-yl)(4-methylnaphthalen-1-yl)methanone<\/p>\n<\/td>\n

\n

1354631-24-5<\/p>\n<\/td>\n<\/tr>\n

\n

230<\/p>\n<\/td>\n

\n

MAM-2201 N-(2-Fluoropentyl)<\/p>\n<\/td>\n

\n

(1-(2-fluoropentyl)-1H<\/i>-indol-3-yl)(4-methylnaphthalen-1-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

231<\/p>\n<\/td>\n

\n

MAM-2201 N-(3-Fluoropentyl)<\/p>\n<\/td>\n

\n

(1-(3-fluoropentyl)-1H<\/i>-indol-3-yl)(4-methylnaphthalen-1-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

232<\/p>\n<\/td>\n

\n

MAM-2201 N-(4-Fluoropentyl)<\/p>\n<\/td>\n

\n

(1-(4-fluoropentyl)-1H<\/i>-indol-3-yl)(4-methylnaphthalen-1-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

233<\/p>\n<\/td>\n

\n

MAM-2201 N-(4-hydroxypentyl)<\/p>\n<\/td>\n

\n

(1-(4-hydroxypentyl)-1H<\/i>-indol-3-yl)(4-methylnaphthalen-1-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

234<\/p>\n<\/td>\n

\n

M-CHMIC<\/p>\n<\/td>\n

\n

methyl 1-(cyclohexylmethyl)-1H-<\/i>indole-3-carboxylate<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

235<\/p>\n<\/td>\n

\n

MCPP (m<\/i>CPP)<\/p>\n<\/td>\n

\n

Meta<\/i>\u00a0\u2013 Chlorophenyl piperazine<\/p>\n<\/td>\n

\n

6640-24-0<\/p>\n<\/td>\n<\/tr>\n

\n

236<\/p>\n<\/td>\n

\n

MDMB-CHMCZCA<\/p>\n<\/td>\n

\n

methyl 2-(9-(cyclohexylmethyl)-9H<\/i>-carbazole-3-carboxamido)-3,3- dimethylbutanoate<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

237<\/p>\n<\/td>\n

\n

MDMB-CHMICA<\/p>\n<\/td>\n

\n

methyl (S)-2-(1-(cyclohexylmethyl)-1H<\/i>-indole-3-carboxamido)-3,3- dimethylbutanoate<\/p>\n<\/td>\n

\n

1971007-95-0<\/p>\n<\/td>\n<\/tr>\n

\n

238<\/p>\n<\/td>\n

\n

MDMB-CHMINACA<\/p>\n<\/td>\n

\n

methyl 2-(1-(cyclohexylmethyl)-1H-<\/i>indazole-3-carboxamido)-3,3-dimethylbutanoate<\/p>\n<\/td>\n

\n

1185888-32-7<\/p>\n<\/td>\n<\/tr>\n

\n

239<\/p>\n<\/td>\n

\n

MDMB-FUBICA<\/p>\n<\/td>\n

\n

Methyl 2-(1-(4-fluorobenzyl)-1H<\/i>-indol-3-carboxamido)-3,3-dimethylbutanoate<\/p>\n<\/td>\n

\n

1971007-91-6<\/p>\n<\/td>\n<\/tr>\n

\n

240<\/p>\n<\/td>\n

\n

MDMB-FUBINACA<\/p>\n<\/td>\n

\n

methyl 2-(1-(4-fluorobenzyl)-1H-<\/i>indazole-3-carboxamido)-3,3-dimethylbutanoate<\/p>\n<\/td>\n

\n

1715016-77-5<\/p>\n<\/td>\n<\/tr>\n

\n

241<\/p>\n<\/td>\n

\n

MDMB-4en-PINACA<\/p>\n<\/td>\n

\n

3-methyl-N-[[1-(4-penten-1-yl)-1H-indazol-3-yl]carbonyl]-L-valine, methyl ester<\/p>\n<\/td>\n

\n

2504100-70-1<\/p>\n<\/td>\n<\/tr>\n

\n

242<\/p>\n<\/td>\n

\n

MDPBP<\/p>\n<\/td>\n

\n

(RS)<\/i>-1-(3,4-methylenedioxyphenyl)-2-(1-pyrrolidinyl)-1-butanone<\/p>\n<\/td>\n

\n

784985-33-7<\/p>\n<\/td>\n<\/tr>\n

\n

243<\/p>\n<\/td>\n

\n

MDPV<\/p>\n<\/td>\n

\n

(RS<\/i>)-1-(benzo[d][1,3]dioxol-5-yl)-2-(pyrrolidin-1-yl)pentan-1-one<\/p>\n<\/td>\n

\n

687603-66-3<\/p>\n<\/td>\n<\/tr>\n

\n

244<\/p>\n<\/td>\n

\n

Mecloqualone<\/p>\n<\/td>\n

\n

3 \u2013 (o<\/i>\u00a0\u2013 chlorophenyl) \u2013 2 \u2013 methyl \u2013 4 \u2013 (3H<\/i>) \u2013 quinazolinone<\/p>\n<\/td>\n

\n

340-57-8<\/p>\n<\/td>\n<\/tr>\n

\n

245<\/p>\n<\/td>\n

\n

Mephedrone<\/p>\n<\/td>\n

\n

4- methyl methcathinone<\/p>\n<\/td>\n

\n

1189805-46-6<\/p>\n<\/td>\n<\/tr>\n

\n

246<\/p>\n<\/td>\n

\n

Mepirapim<\/p>\n<\/td>\n

\n

(4-methylpiperazin-1-yl)(1-pentyl-1H-<\/i>indol-3-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

247<\/p>\n<\/td>\n

\n

Methamphetamine<\/p>\n<\/td>\n

\n

(+) \u2013 (S<\/b>) \u2013\u00a0N \u2013 \u03b1<\/i>\u00a0\u2013 dimethylphenethylamine<\/p>\n<\/td>\n

\n

537-46-2<\/p>\n<\/td>\n<\/tr>\n

\n

248<\/p>\n<\/td>\n

\n

Methamphetamine racemate<\/p>\n<\/td>\n

\n

(\u00b1) \u2013\u00a0N, \u03b1<\/i>\u2013 dimethylphenethylamine<\/p>\n<\/td>\n

\n

7632-10-2<\/p>\n<\/td>\n<\/tr>\n

\n

249<\/p>\n<\/td>\n

\n

Methaqualone<\/p>\n<\/td>\n

\n

2 \u2013 methyl \u2013 3 \u2013\u00a0o<\/i>\u00a0\u2013 tolyl \u2013 4 \u2013 (3H<\/i>) \u2013 quinazolinone<\/p>\n<\/td>\n

\n

72-44-6<\/p>\n<\/td>\n<\/tr>\n

\n

250<\/p>\n<\/td>\n

\n

Methoxetamine (MXE)<\/p>\n<\/td>\n

\n

2-(3-methoxyphenyl)-2-(ethylamino)-cyclohexanone<\/p>\n<\/td>\n

\n

1239943-76-0<\/p>\n<\/td>\n<\/tr>\n

\n

251<\/p>\n<\/td>\n

\n

Methoxyacetylfentanyl<\/p>\n<\/td>\n

\n

2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide<\/p>\n<\/td>\n

\n

101345-67-9<\/p>\n<\/td>\n<\/tr>\n

\n

252<\/p>\n<\/td>\n

\n

Methylone<\/p>\n<\/td>\n

\n

3,4 \u2013 methylenedioxy \u2013\u00a0N \u2013\u00a0<\/i>methylcathinone<\/p>\n<\/td>\n

\n

186028-79-5<\/p>\n<\/td>\n<\/tr>\n

\n

253<\/p>\n<\/td>\n

\n

Metonitazene<\/p>\n<\/td>\n

\n

N,N-diethyl-2-(2-(4-methoxybenzyl)-5-nitro-1H-benzo[d]imidazol-1-yl)ethan-1-amine<\/p>\n<\/td>\n

\n

14680-51-4<\/p>\n<\/td>\n<\/tr>\n

\n

254<\/p>\n<\/td>\n

\n

MMB-018 (MMB-PICA,AMB-PICA)<\/p>\n<\/td>\n

\n

methyl (1-pentyl-1H-indole-3-carbonyl) valinate<\/p>\n<\/td>\n

\n

1971007-97-2<\/p>\n<\/td>\n<\/tr>\n

\n

255<\/p>\n<\/td>\n

\n

MMB-022 (MMB-4en- PICA)<\/p>\n<\/td>\n

\n

Methyl 3 -methyl-2-{[1-(pent-4-en-1-yl)-1H-indol-3-yl] formamido} butanoate<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

256<\/p>\n<\/td>\n

\n

MMB-FUBICA (AMB-FUBICA)<\/p>\n<\/td>\n

\n

methyl 2-(1-(4-fluorobenzyl)-1H-indole-3-carboxamido)-3-methylbutanoate<\/p>\n<\/td>\n

\n

1971007-90-5<\/p>\n<\/td>\n<\/tr>\n

\n

257<\/p>\n<\/td>\n

\n

MN-18<\/p>\n<\/td>\n

\n

N<\/i>-(naphthalen-1-yl)-1-pentyl-1H-<\/i>indazole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

258<\/p>\n<\/td>\n

\n

MN-24<\/p>\n

(AM-6527; NNE1)<\/p>\n<\/td>\n

\n

N<\/i>-(naphthalen-1-yl)-1-pentyl-1H<\/i>-indole-3-carboxamide<\/p>\n<\/td>\n

\n

1338925-11-3<\/p>\n<\/td>\n<\/tr>\n

\n

259<\/p>\n<\/td>\n

\n

MO-CHMINACA<\/p>\n<\/td>\n

\n

1-methoxy-3,3-dimethyl-1-oxobutan-2-yl 1-(cyclohexylmethyl)-1H<\/i>-indazole-3-carboxylate<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

260<\/p>\n<\/td>\n

\n

MPA<\/p>\n

(Methiopropamine)<\/p>\n<\/td>\n

\n

1- (thiophen-2-yl) -2- methylaminopropane<\/p>\n<\/td>\n

\n

801156-47-8<\/p>\n<\/td>\n<\/tr>\n

\n

261<\/p>\n<\/td>\n

\n

MT-45<\/p>\n<\/td>\n

\n

1-xyclohexyl-4 (1,2-diphenylethyl) piperazine<\/p>\n<\/td>\n

\n

52694-55-0<\/p>\n<\/td>\n<\/tr>\n

\n

262<\/p>\n<\/td>\n

\n

N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(phenylmethyl)-1H-indazole-3-carboxamide<\/p>\n<\/td>\n

\n

N<\/i>-(1-amino-3-methyl-1-oxobutan-2-yl)-1-benzyl-1H<\/i>-indazole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

N-(1-Amino-3-methyl-1oxobutan-2-yl)-1-(phenylmethyl)-1H-indole-3-carboxamide<\/p>\n<\/td>\n

\n

N<\/i>-(1-amino-3-methyl-1-oxobutan-2-yl)-1-benzyl-1H<\/i>-indole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

N-(2-Methoxyethyl)-N-(1-methylethyl)-2-(1-pentyl-1H-indol-3-yl)-4-thiazol-methanamine<\/p>\n<\/td>\n

\n

N-(2-methoxyethyl)-N<\/i>-((2-(1-pentyl-1H<\/i>-indol-3-yl)thiazol-4-yl)methyl)propan-2-amine<\/p>\n<\/td>\n

\n

1400742-45-1<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

265<\/p>\n<\/td>\n

\n

N-(6-Quinolinyl)-1-pentyl-1H-indazole-3-carboxamide<\/p>\n<\/td>\n

\n

1-pentyl-N<\/i>-(quinolin-6-yl)-1H-<\/i>indazole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

266<\/p>\n<\/td>\n

\n

N-(Naphthalen-1-yl)-1H-indazole-3-carboxamide<\/p>\n<\/td>\n

\n

N<\/i>-(naphthalen-1-yl)-1H<\/i>-indazole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

267<\/p>\n<\/td>\n

\n

N-(naphthalen-1-yl)-1-pentyl-1H-pyrrolo[2,3-b]pyridine-3-carboxamide<\/p>\n<\/td>\n

\n

N<\/i>-(naphthalen-1-yl)-1-pentyl-1H-<\/i>pyrrolo[2,3-b]pyridine-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

268<\/p>\n<\/td>\n

\n

N,N-Diethyl-2-(1-pentyl-1H-indol-3-yl)-4-thiazol- methanamine<\/p>\n<\/td>\n

\n

N<\/i>-ethyl-N<\/i>-((2-(1-pentyl-1H<\/i>-indol-3-yl)thiazol-4-yl)methyl)ethanamine<\/p>\n<\/td>\n

\n

1400742-46-2<\/p>\n<\/td>\n<\/tr>\n

\n

269<\/p>\n<\/td>\n

\n

Naphthalen-1-yl(1-(pent-4-enyl)-1H-pyrrolo[2,3- b]pyridin-3-yl)methanone<\/p>\n<\/td>\n

\n

naphthalen-1-yl(1-(pent-4-en-1-yl)-1H-<\/i>pyrrolo[2,3-b]pyridin-3-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

270<\/p>\n<\/td>\n

\n

Naphthalen-1-yl(1-(pentyl-1H-benzo[d]imidazol-2-yl)methanone<\/p>\n<\/td>\n

\n

naphthalen-1-yl(1-pentyl-1H-<\/i>benzo[d]imidazol-2-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

271<\/p>\n<\/td>\n

\n

Naphthalen-1-yl-(1-pentyl-1H-7-azaindol-3-yl)methanone<\/p>\n<\/td>\n

\n

Naphthalen-1-yl-(1-pentyl-1H<\/i>-7-azaindol-3-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

272<\/p>\n<\/td>\n

\n

Naphthalen-1-yl-1-benzyl-1H-indole-3-carboxylate<\/p>\n<\/td>\n

\n

naphthalen-1-yl 1-benzyl-1H<\/i>-indole-3-carboxylate<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

273<\/p>\n<\/td>\n

\n

N-Ethylnorpentylone (Ephylone)<\/p>\n<\/td>\n

\n

1-(2H-1,3-Benzodioxol-5-yl)-2-(ethylamino) pentan-1-one<\/p>\n<\/td>\n

\n

17763-02-9<\/p>\n<\/td>\n<\/tr>\n

\n

274<\/p>\n<\/td>\n

\n

N-Ethylhexedrone<\/p>\n

(NEH, Hexen, Ethyl-Hex)<\/p>\n<\/td>\n

\n

2-(Ethylamino)-1-phenyl-1-hexanone<\/p>\n<\/td>\n

\n

802857-66-5<\/p>\n<\/td>\n<\/tr>\n

\n

275<\/p>\n<\/td>\n

\n

N-methyl ethylone<\/p>\n<\/td>\n

\n

1-(benzo[d][1,3]dioxol-5-yl)-2-(ethyl(methyl)amino)propan-1-one<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

276<\/p>\n<\/td>\n

\n

NM-2201<\/p>\n<\/td>\n

\n

naphthalen-1-yl 1-(5-fluoropentyl)-1H-<\/i>indole-3-carboxylate<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

277<\/p>\n<\/td>\n

\n

NNEI 2\u2019-indazole isomer<\/p>\n<\/td>\n

\n

N<\/i>-(naphthalen-1-yl)-2-pentyl-2H<\/i>-indazole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

278<\/p>\n<\/td>\n

\n

Ocfentanil<\/p>\n<\/td>\n

\n

N<\/i>-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl) acetamide<\/p>\n<\/td>\n

\n

101343-69-5<\/p>\n<\/td>\n<\/tr>\n

\n

279<\/p>\n<\/td>\n

\n

ORG 27569<\/p>\n<\/td>\n

\n

5-chloro-3-ethyl-N<\/i>-(4-(piperidin-1-yl)phenethyl)-1H<\/i>-indole-2-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

280<\/p>\n<\/td>\n

\n

ORG 27759<\/p>\n<\/td>\n

\n

N<\/i>-(4-(dimethylamino)phenethyl)-3-ethyl-5-fluoro-1H<\/i>-indole-2-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

281<\/p>\n<\/td>\n

\n

ORG 29647<\/p>\n<\/td>\n

\n

N<\/i>-(1-benzylpyrrolidin-3-yl)-5-chloro-3-ethyl-1H<\/i>-indole-2-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

282<\/p>\n<\/td>\n

\n

Orthofluorofentanyl (2-Fluorofentanyl)<\/p>\n<\/td>\n

\n

N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl) propionamide<\/p>\n<\/td>\n

\n

910616-29-4<\/p>\n<\/td>\n<\/tr>\n

\n

283<\/p>\n<\/td>\n

\n

PB-22 (QUPIC)<\/p>\n<\/td>\n

\n

quinolin-8-yl 1-pentyl-1H<\/i>-indole-3-carboxylate<\/p>\n<\/td>\n

\n

1400742-17-7<\/p>\n<\/td>\n<\/tr>\n

\n

284<\/p>\n<\/td>\n

\n

PB-22 N-(2-fluoropentyl)<\/p>\n<\/td>\n

\n

quinolin-8-yl 1-(2-fluoropentyl)-1H-<\/i>indazole-3-carboxylate<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

285<\/p>\n<\/td>\n

\n

PB-22 N-(4-fluoropentyl)<\/p>\n<\/td>\n

\n

quinolin-8-yl 1-(4-fluoropentyl)-1H-<\/i>indazole-3-carboxylate<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

286<\/p>\n<\/td>\n

\n

Parafluorobutyrylfentanyl (4-Fluorobutyrfentanyl)<\/p>\n<\/td>\n

\n

N-(4-fluorophenyl)-N-(1-phenethyl piperidin-4-yl) butyramide<\/p>\n<\/td>\n

\n

244195-31-1<\/p>\n<\/td>\n<\/tr>\n

\n

287<\/p>\n<\/td>\n

\n

Pentedrone<\/p>\n<\/td>\n

\n

(\u00b1) -1-phenyl-2- (metylamino) pentan-1-one<\/p>\n<\/td>\n

\n

879722-57-3<\/p>\n<\/td>\n<\/tr>\n

\n

288<\/p>\n<\/td>\n

\n

Phencyclidine<\/p>\n<\/td>\n

\n

1 \u2013 (1 \u2013 phenylcyclohexyl) piperidine<\/p>\n<\/td>\n

\n

77-10-1<\/p>\n<\/td>\n<\/tr>\n

\n

289<\/p>\n<\/td>\n

\n

Phenazepam<\/p>\n<\/td>\n

\n

7-Bromo-5- (2-clophenyl) -1,3-dihydro-2\u00a0H \u2013<\/i>1,4-benzodiazepine-2-one<\/p>\n<\/td>\n

\n

51753-57-2<\/p>\n<\/td>\n<\/tr>\n

\n

290<\/p>\n<\/td>\n

\n

Phenmetrazine<\/p>\n<\/td>\n

\n

3 \u2013 methyl \u2013 2 \u2013 phenylmorpholine<\/p>\n<\/td>\n

\n

134-49-6<\/p>\n<\/td>\n<\/tr>\n

\n

291<\/p>\n<\/td>\n

\n

Pholcodine<\/p>\n<\/td>\n

\n

3 \u2013 morpholinylethylmorphine<\/p>\n<\/td>\n

\n

509-67-1<\/p>\n<\/td>\n<\/tr>\n

\n

292<\/p>\n<\/td>\n

\n

Pravadoline (WIN 48,098)<\/p>\n<\/td>\n

\n

(4-methoxyphenyl)(2-methyl-1-(2-morpholinoethyl)-1H<\/i>-indol-3-yl) methanone<\/p>\n<\/td>\n

\n

92623-83-1<\/p>\n<\/td>\n<\/tr>\n

\n

293<\/p>\n<\/td>\n

\n

Propylphenidate (PPH)<\/p>\n<\/td>\n

\n

Propyl 2-phenyl-2-(piperidin-2-yl) acetate<\/p>\n<\/td>\n

\n

1071564-47-0<\/p>\n<\/td>\n<\/tr>\n

\n

294<\/p>\n<\/td>\n

\n

PX-1<\/p>\n<\/td>\n

\n

N<\/i>-(1-amino-1-oxo-3-phenylpropan-2-yl)-1-(5-fluoropentyl)-1H<\/i>-indole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

295<\/p>\n<\/td>\n

\n

QUCHIC (BB-22)<\/p>\n<\/td>\n

\n

quinolin-8-yl 1-(cyclohexylmethyl)-1H-<\/i>indole-3-carboxylate<\/p>\n<\/td>\n

\n

1400742-42-8<\/p>\n<\/td>\n<\/tr>\n

\n

296<\/p>\n<\/td>\n

\n

Quinolin-8-yl-1-benzyl-1H-<\/i>indazole-3-carboxylate<\/p>\n<\/td>\n

\n

quinolin-8-yl 1-benzyl-1H<\/i>-indazole-3-carboxylate<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

297<\/p>\n<\/td>\n

\n

RCS-2 butyl<\/p>\n<\/td>\n

\n

1-butyl-2-(2-methoxyphenyl)-1H-<\/i>indole-3-carbaldehyde<\/p>\n<\/td>\n

\n

1345966-63-3<\/p>\n<\/td>\n<\/tr>\n

\n

298<\/p>\n<\/td>\n

\n

RCS-3<\/p>\n<\/td>\n

\n

2-(3-methoxyphenyl)-1-(1-pentyl-indol-3-yl) methanone<\/p>\n<\/td>\n

\n

1379922-51-6<\/p>\n<\/td>\n<\/tr>\n

\n

299<\/p>\n<\/td>\n

\n

RCS-4<\/p>\n<\/td>\n

\n

(4-methoxyphenyl)(1-pentyl-1H<\/i>-indol-3-yl) methanone<\/p>\n<\/td>\n

\n

1345966-78-0<\/p>\n<\/td>\n<\/tr>\n

\n

300<\/p>\n<\/td>\n

\n

RCS-4 butyl<\/p>\n<\/td>\n

\n

(4-methoxyphenyl)(1-butyl-1H<\/i>-indol-3-yl) methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

301<\/p>\n<\/td>\n

\n

RCS-4 ortho isomer<\/p>\n<\/td>\n

\n

(2-methoxyphenyl)(1-pentyl-1H<\/i>-indol-3-yl) methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

302<\/p>\n<\/td>\n

\n

RCS-8<\/p>\n

(SR-18; BTM-8)<\/p>\n<\/td>\n

\n

1-(1-(2-cyclohexylethyl)-1H<\/i>-indol-3-yl)-2-(2-methoxyphenyl)ethan-1-one<\/p>\n<\/td>\n

\n

1345970-42-4<\/p>\n<\/td>\n<\/tr>\n

\n

303<\/p>\n<\/td>\n

\n

Rimonabant<\/p>\n<\/td>\n

\n

5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-(piperidin-1-yl)-1H<\/i>-pyrazole-3-carboxamide<\/p>\n<\/td>\n

\n

168273-06-1<\/p>\n<\/td>\n<\/tr>\n

\n

304<\/p>\n<\/td>\n

\n

SDB-005<\/p>\n<\/td>\n

\n

naphthalen-1-yl 1-pentyl-1H<\/i>-indazole-3-carboxylate<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

305<\/p>\n<\/td>\n

\n

SDB-006<\/p>\n<\/td>\n

\n

N<\/i>-benzy 1-1-pentyl-1H<\/i>-indole-3-carboxamide<\/p>\n<\/td>\n

\n

695213-59-3<\/p>\n<\/td>\n<\/tr>\n

\n

306<\/p>\n<\/td>\n

\n

Secobarbital<\/p>\n<\/td>\n

\n

5 \u2013 ally \u2013 5 \u2013 (1 \u2013 methylbutyl) barbituric acid<\/p>\n<\/td>\n

\n

76-73-3<\/p>\n<\/td>\n<\/tr>\n

\n

307<\/p>\n<\/td>\n

\n

Tetrahydrofuranylfentanyl (THF-F)<\/p>\n<\/td>\n

\n

N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide<\/p>\n<\/td>\n

\n

2142571-01-3<\/p>\n<\/td>\n<\/tr>\n

\n

308<\/p>\n<\/td>\n

\n

TFMPP<\/p>\n<\/td>\n

\n

1[3-(trifluoromethyl) phenyl] piperazine<\/p>\n<\/td>\n

\n

15532-75-9<\/p>\n<\/td>\n<\/tr>\n

\n

309<\/p>\n<\/td>\n

\n

THJ-018<\/p>\n<\/td>\n

\n

naphthalen-1-yl(1-pentyl-1H<\/i>-indazol-3-yl) methanone<\/p>\n<\/td>\n

\n

1364933-55-0<\/p>\n<\/td>\n<\/tr>\n

\n

310<\/p>\n<\/td>\n

\n

THJ-2201<\/p>\n<\/td>\n

\n

(1-(5-fluoropentyl)-1H<\/i>-indazol-3-yl)(naphthalen-1-yl) methanone<\/p>\n<\/td>\n

\n

1801552-01-1<\/p>\n<\/td>\n<\/tr>\n

\n

311<\/p>\n<\/td>\n

\n

Tramadol<\/p>\n<\/td>\n

\n

(\u00b1)-Trans-2-Dimethylaminomethyl-1-(3-methoxyphenyl) cyclohexan-1-ol<\/p>\n<\/td>\n

\n

27203-92-5<\/p>\n<\/td>\n<\/tr>\n

\n

312<\/p>\n<\/td>\n

\n

Trans-CP 47,497-C8<\/p>\n<\/td>\n

\n

2-[(1S,3S)-3-hydroxycyclohexyl]-5-(2-methylnonan-2-yl)phenol<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

313<\/p>\n<\/td>\n

\n

U-47700<\/p>\n<\/td>\n

\n

3,4-dichloro-N<\/i>-[(1R,2R)-2-(dimetylamino)cyclohexyl]-N<\/i>\u2013 methyl benzamide<\/p>\n<\/td>\n

\n

82657-23-6<\/p>\n<\/td>\n<\/tr>\n

\n

314<\/p>\n<\/td>\n

\n

UR-144 (KM-X1)<\/p>\n<\/td>\n

\n

(1-pentyl-1H<\/i>-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl) methanone<\/p>\n<\/td>\n

\n

1199943-44-6<\/p>\n<\/td>\n<\/tr>\n

\n

315<\/p>\n<\/td>\n

\n

UR-144 N-(3-chloropentyl)<\/p>\n<\/td>\n

\n

(1-(3-chloropentyl)-1H<\/i>-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl) methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

316<\/p>\n<\/td>\n

\n

UR-144 N-(4-pentenyl)<\/p>\n<\/td>\n

\n

(1-(pent-4-en-1-yl)-1H<\/i>-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl) methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

317<\/p>\n<\/td>\n

\n

UR-144 N-(5-bromopentyl)<\/p>\n<\/td>\n

\n

(1-(5-bromopentyl)-1H<\/i>-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl) methanone<\/p>\n<\/td>\n

\n

1628690-26-5<\/p>\n<\/td>\n<\/tr>\n

\n

318<\/p>\n<\/td>\n

\n

UR-144 N-(5-chlorophentyl)<\/p>\n<\/td>\n

\n

(1-(5-chloropentyl)-1H<\/i>-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl) methanone<\/p>\n<\/td>\n

\n

1445577-42-3<\/p>\n<\/td>\n<\/tr>\n

\n

319<\/p>\n<\/td>\n

\n

UR-144 N-heptyl<\/p>\n<\/td>\n

\n

(1-heptyl-1H<\/i>-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone<\/p>\n<\/td>\n

\n

1616469-06-7<\/p>\n<\/td>\n<\/tr>\n

\n

320<\/p>\n<\/td>\n

\n

URB447<\/p>\n<\/td>\n

\n

(4-amino-1-(4-chlorobenzyl)-2-methyl-5-phenyl-1H<\/i>-pyrrol-3-yl) (phenyl) methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

321<\/p>\n<\/td>\n

\n

URB597<\/p>\n<\/td>\n

\n

(3\u2032-carbamoyl-[1,1\u2032-biphenyl]-3-yl)(cyclohexyl)carbamate<\/p>\n<\/td>\n

\n

546141-08-6<\/p>\n<\/td>\n<\/tr>\n

\n

322<\/p>\n<\/td>\n

\n

URB-602<\/p>\n<\/td>\n

\n

cyclohexyl [1,1\u2032-biphenyl]-3-yl carbamate<\/p>\n<\/td>\n

\n

565460-15-3<\/p>\n<\/td>\n<\/tr>\n

\n

323<\/p>\n<\/td>\n

\n

URB754<\/p>\n<\/td>\n

\n

6-methyl-2-(p-tolylamino)-4H<\/i>-benzo[d][1,3]oxazin-4-one<\/p>\n<\/td>\n

\n

86672-58-4<\/p>\n<\/td>\n<\/tr>\n

\n

324<\/p>\n<\/td>\n

\n

Valerylfentanyl<\/p>\n<\/td>\n

\n

N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide<\/p>\n<\/td>\n

\n

122882-90-0<\/p>\n<\/td>\n<\/tr>\n

\n

325<\/p>\n<\/td>\n

\n

WIN 55, 212-2<\/p>\n<\/td>\n

\n

(R)-(5-methyl-3-(morpholinomethyl)-2,3-dihydro-[1,4]oxazino[2,3,4- hi]indol-6-yl)(naphthalen-1-yl)methanone<\/p>\n<\/td>\n

\n

131543-23-2<\/p>\n<\/td>\n<\/tr>\n

\n

326<\/p>\n<\/td>\n

\n

XLR-11<\/p>\n<\/td>\n

\n

(1-(5-Fluoro-pentyl)-1H<\/i>-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl) methanone<\/p>\n<\/td>\n

\n

1364933-54-9<\/p>\n<\/td>\n<\/tr>\n

\n

327<\/p>\n<\/td>\n

\n

XLR-11 N-(2-fluoropentyl)<\/p>\n<\/td>\n

\n

(1-(2-fluoropentyl)-1H<\/i>-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl) methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

328<\/p>\n<\/td>\n

\n

XLR-11 N-(3-fluoropentyl)<\/p>\n<\/td>\n

\n

(1-(3-fluoropentyl)-1H<\/i>-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl) methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

329<\/p>\n<\/td>\n

\n

XLR-11 N-(4-fluoropentyl)<\/p>\n<\/td>\n

\n

(1-(4-fluoropentyl)-1H<\/i>-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl) methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

330<\/p>\n<\/td>\n

\n

XLR-12<\/p>\n<\/td>\n

\n

(2,2,3,3-tetramethylcyclopropyl)(1-(4,4,4-trifluorobutyl)-1H<\/i>-indol-3- yl) methanone<\/p>\n<\/td>\n

\n

895155-78-9<\/p>\n<\/td>\n<\/tr>\n

\n

331<\/p>\n<\/td>\n

\n

Zipeprol<\/p>\n<\/td>\n

\n

\u03b1<\/i>\u00a0\u2013 (\u03b1<\/i>\u00a0\u2013 methoxybenzyl) \u2013 4 \u2013 (\u03b2<\/i>\u00a0\u2013 methoxyphenethyl)-1-piperazineethanol<\/p>\n<\/td>\n

\n

34758-83-3<\/p>\n<\/td>\n<\/tr>\n

\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

<\/a>IID. C\u00e1c ch\u1ea5t sau<\/p>\n\n\n\n\n
\n

STT<\/b><\/p>\n<\/td>\n

\n

T\u00ean ch\u1ea5t<\/b><\/p>\n<\/td>\n

\n

T\u00ean khoa h\u1ecdc<\/b><\/p>\n<\/td>\n

\n

M\u00e3 th\u00f4ng tin<\/b>\u00a0CAS<\/b><\/p>\n<\/td>\n<\/tr>\n

\n

1<\/p>\n<\/td>\n

\n

L\u00e1 Coca<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

\u00a0<\/p>\n

<\/a>DANH M\u1ee4C III<\/b><\/p>\n

<\/a>C\u00c1C CH\u1ea4T MA T\u00daY \u0110\u01af\u1ee2C S\u1eec D\u1ee4NG TRONG NGHI\u00caN C\u1ee8U, KI\u1ec2M NGHI\u1ec6M, GI\u00c1M \u0110\u1ecaNH, \u0110I\u1ec0U TRA T\u1ed8I PH\u1ea0M HO\u1eb6C TRONG L\u0128NH V\u1ef0C Y T\u1ebe, TH\u00da Y THEO QUY \u0110\u1ecaNH C\u1ee6A C\u01a0 QUAN C\u00d3 TH\u1ea8M QUY\u1ec0N<\/p>\n

Danh M\u1ee5c n\u00e0y bao g\u1ed3m c\u1ea3 c\u00e1c mu\u1ed1i c\u00f3 th\u1ec3 t\u1ed3n t\u1ea1i c\u1ee7a c\u00e1c ch\u1ea5t d\u01b0<\/span>\u1edbi \u0111\u00e2y:<\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n

STT<\/b><\/p>\n<\/td>\n

\n

T\u00ean ch\u1ea5t<\/b><\/p>\n<\/td>\n

\n

T\u00ean khoa h\u1ecdc<\/b><\/p>\n<\/td>\n

\n

M\u00e3 th\u00f4ng tin CAS<\/b><\/p>\n<\/td>\n<\/tr>\n

\n

1<\/p>\n<\/td>\n

\n

Allobarbital<\/p>\n<\/td>\n

\n

5,5 \u2013 diallylbarbituric acid<\/p>\n<\/td>\n

\n

52-43-7<\/p>\n<\/td>\n<\/tr>\n

\n

2<\/p>\n<\/td>\n

\n

Alprazolam<\/p>\n<\/td>\n

\n

8 \u2013 chloro -1 \u2013 methyl \u2013 6 \u2013 phenyl \u2013 4H \u2013 s \u2013\u00a0<\/i>triazolo [4,3 \u2013\u00a0a]<\/i>\u00a0[1,4] \u2013 benzodiazepine<\/p>\n<\/td>\n

\n

289981-97-7<\/p>\n<\/td>\n<\/tr>\n

\n

3<\/p>\n<\/td>\n

\n

Aminorex<\/p>\n<\/td>\n

\n

2 \u2013 amino \u2013 5 \u2013 phenyl \u2013 2 \u2013 oxazoline<\/p>\n<\/td>\n

\n

2207-50-3<\/p>\n<\/td>\n<\/tr>\n

\n

4<\/p>\n<\/td>\n

\n

Amobarbital<\/p>\n<\/td>\n

\n

5 \u2013 ethyl \u2013 5 \u2013 isopentylbarbituric acid<\/p>\n<\/td>\n

\n

57-43-2<\/p>\n<\/td>\n<\/tr>\n

\n

5<\/p>\n<\/td>\n

\n

Barbital<\/p>\n<\/td>\n

\n

5,5 \u2013 diethylbarbituric acid<\/p>\n<\/td>\n

\n

57-44-3<\/p>\n<\/td>\n<\/tr>\n

\n

6<\/p>\n<\/td>\n

\n

Benzfetamine<\/p>\n<\/td>\n

\n

N<\/i>\u00a0\u2013 benzyl\u00a0\u2013 N \u2013 \u03b1 \u2013<\/i>\u00a0dimethylphenethylamine<\/p>\n<\/td>\n

\n

156-08-1<\/p>\n<\/td>\n<\/tr>\n

\n

7<\/p>\n<\/td>\n

\n

Bromazepam<\/p>\n<\/td>\n

\n

7 \u2013 bromo -1,3 \u2013 dihydro \u2013 5 \u2013 (2 \u2013 pyridyl) \u2013 2H\u00a0<\/i>\u2013 1,4 \u2013 benzodiazepin \u2013 2 -one<\/p>\n<\/td>\n

\n

1812-30-2<\/p>\n<\/td>\n<\/tr>\n

\n

8<\/p>\n<\/td>\n

\n

Buprenorphine<\/p>\n<\/td>\n

\n

21 \u2013 cyclopropyl 7 \u2013\u00a0\u03b1<\/i>\u00a0\u2013 [(S<\/i>) \u2013 1- hydroxy -1,2,2 trimethylpropyl] \u2013 6,14 \u2013\u00a0endo<\/i>\u00a0-ethano -6,7,8,14 \u2013 tetrahydrooripavine<\/p>\n<\/td>\n

\n

52485-79-7<\/p>\n<\/td>\n<\/tr>\n

\n

9<\/p>\n<\/td>\n

\n

Butalbital<\/p>\n<\/td>\n

\n

5 \u2013 allyl \u2013 5 \u2013 isobutylbarbituric acid<\/p>\n<\/td>\n

\n

77-26-9<\/p>\n<\/td>\n<\/tr>\n

\n

10<\/p>\n<\/td>\n

\n

Butobarbital<\/p>\n<\/td>\n

\n

5 \u2013 butyl \u2013 5 \u2013 ethylbarbituric acid<\/p>\n<\/td>\n

\n

77-28-1<\/p>\n<\/td>\n<\/tr>\n

\n

11<\/p>\n<\/td>\n

\n

Camazepam<\/p>\n<\/td>\n

\n

7 \u2013 chloro \u2013 1,3 \u2013 dihydro \u2013 3 \u2013 hydroxy \u2013 1 \u2013 methyl \u2013 5 \u2013 phenyl \u2013 2H<\/i>\u00a0\u2013 1,4 benzodiazepin \u2013 2 \u2013 one dimethylcarbamate (ester)<\/p>\n<\/td>\n

\n

36104-80-0<\/p>\n<\/td>\n<\/tr>\n

\n

12<\/p>\n<\/td>\n

\n

Cathine ((+)norpseudoephedrine)<\/p>\n<\/td>\n

\n

(+) \u2013 (R<\/i>)-\u00a0\u03b1<\/i>\u00a0\u2013 [(R<\/i>) \u2013 1 \u2013 aminoethyl] benzylalcohol<\/p>\n<\/td>\n

\n

492-39-7<\/p>\n<\/td>\n<\/tr>\n

\n

13<\/p>\n<\/td>\n

\n

Chlordiazepoxide<\/p>\n<\/td>\n

\n

7 \u2013 chloro \u2013 2 \u2013 (methylamino) \u2013 5 \u2013 phenyl \u2013 3H<\/i>\u00a0\u2013 1,4 \u2013 benzodiazepine \u2013 4 \u2013 oxide<\/p>\n<\/td>\n

\n

58-25-3<\/p>\n<\/td>\n<\/tr>\n

\n

14<\/p>\n<\/td>\n

\n

Clobazam<\/p>\n<\/td>\n

\n

7 \u2013 chloro -1 \u2013 methyl \u2013 5 \u2013 phenyl \u2013 1H\u00a0<\/i>\u2013 1,5 \u2013 benzodiazepine \u2013 2,4 (3H<\/i>, 5H)<\/i>\u00a0\u2013 dione<\/p>\n<\/td>\n

\n

22316-47-8<\/p>\n<\/td>\n<\/tr>\n

\n

15<\/p>\n<\/td>\n

\n

Clonazepam<\/p>\n<\/td>\n

\n

5 \u2013 (o<\/i>\u2013 chlorophenyl) \u2013 1,3 \u2013 nitro \u2013 2H<\/i>\u00a0\u2013 1,4 \u2013 benzodiazepine \u2013 2 \u2013 one<\/p>\n<\/td>\n

\n

1622-61-3<\/p>\n<\/td>\n<\/tr>\n

\n

16<\/p>\n<\/td>\n

\n

Clonazolam<\/p>\n<\/td>\n

\n

6-(2-chlorophenyl)-1-methyl-8-nitro-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine<\/p>\n<\/td>\n

\n

33887-02-4<\/p>\n<\/td>\n<\/tr>\n

\n

17<\/p>\n<\/td>\n

\n

Clorazepate<\/p>\n<\/td>\n

\n

7 \u2013 chloro \u2013 2,3 \u2013 dihydro \u2013 2 \u2013 oxo \u2013 5 \u2013 phenyl \u2013 1H<\/i>\u00a0\u2013 1,4 \u2013 benzodiazepine \u2013 3 \u2013 carboxylic acid<\/p>\n<\/td>\n

\n

23887-31-2<\/p>\n<\/td>\n<\/tr>\n

\n

18<\/p>\n<\/td>\n

\n

Clotiazepam<\/p>\n<\/td>\n

\n

5-(2-chlorophenyl) -7-ethyl-1,3-dihydro-1-methyl -2H -thieno[2,3,e] \u2013 1-4 -diazepin \u2013 2 \u2013 one<\/p>\n<\/td>\n

\n

33671-46-4<\/p>\n<\/td>\n<\/tr>\n

\n

19<\/p>\n<\/td>\n

\n

Cloxazolam<\/p>\n<\/td>\n

\n

10 \u2013 chloro \u2013 11b \u2013 (o<\/i>\u00a0\u2013 chlorophenyl) \u2013 2,3,7,11b<\/i>\u00a0\u2013 tetrahydrooxazolon \u2013 [3,2-d<\/i>][1,4] benzodiazepin \u2013 6(5H<\/i>) \u2013 one<\/p>\n<\/td>\n

\n

24166-13-0<\/p>\n<\/td>\n<\/tr>\n

\n

20<\/p>\n<\/td>\n

\n

Cyclobarbital<\/p>\n<\/td>\n

\n

5 \u2013 (1-cyclohexen-1-yl) -5-ethylbarbituric acid<\/p>\n<\/td>\n

\n

52-31-3<\/p>\n<\/td>\n<\/tr>\n

\n

21<\/p>\n<\/td>\n

\n

Delorazepam<\/p>\n<\/td>\n

\n

7 \u2013 chloro \u2013 5 \u2013 (o<\/i>-chlorophenyl) -1,3 \u2013 dihydro \u2013 2H<\/i>\u00a0\u2013 1,4 \u2013 benzodiazepin \u2013 2 \u2013 one<\/p>\n<\/td>\n

\n

2894-67-9<\/p>\n<\/td>\n<\/tr>\n

\n

22<\/p>\n<\/td>\n

\n

Diazepam<\/p>\n<\/td>\n

\n

7 \u2013 chloro -1,3- dihydro \u2013 1 \u2013 methyl \u2013 5 \u2013 phenyl \u2013 2H<\/i>\u00a0\u2013 1,4 \u2013 benzodiazepin -2 \u2013 one<\/p>\n<\/td>\n

\n

439-14-5<\/p>\n<\/td>\n<\/tr>\n

\n

23<\/p>\n<\/td>\n

\n

Diclazepam<\/p>\n<\/td>\n

\n

7-chloro-5-(2-chlorophenyl)-1-methyl-1,3-dihydro-2H-benzo[e][1,4]diazepin-2-one<\/p>\n<\/td>\n

\n

2894-68-0<\/p>\n<\/td>\n<\/tr>\n

\n

24<\/p>\n<\/td>\n

\n

Estazolam<\/p>\n<\/td>\n

\n

8-chloro \u2013 6 \u2013 phenyl \u2013 4H<\/i>\u00a0\u2013\u00a0s<\/i>\u00a0\u2013 triazolo \u2013 [4,3 \u2013\u00a0a]<\/i>\u00a0[1,4 \u2013 benzodiazepin<\/p>\n<\/td>\n

\n

29975-16-4<\/p>\n<\/td>\n<\/tr>\n

\n

25<\/p>\n<\/td>\n

\n

Ethchlorvynol<\/p>\n<\/td>\n

\n

1 \u2013 choloro-3 \u2013 ethyl \u2013 1 \u2013 penten \u2013 4yn \u2013 3 \u2013 ol<\/p>\n<\/td>\n

\n

113-18-8<\/p>\n<\/td>\n<\/tr>\n

\n

26<\/p>\n<\/td>\n

\n

Ethinamate<\/p>\n<\/td>\n

\n

1 \u2013 ethynylcyclohexanolcarbamate<\/p>\n<\/td>\n

\n

126-52-3<\/p>\n<\/td>\n<\/tr>\n

\n

27<\/p>\n<\/td>\n

\n

Ethylloflazepate<\/p>\n<\/td>\n

\n

Ethyl -7-chloro-5-(o<\/i>\u00a0\u2013 fluorophenyl)-2-3-dihydro -2-oxo-1H<\/i>-1,4- benzodiazepin-3-carboxylate<\/p>\n<\/td>\n

\n

29177-84-2<\/p>\n<\/td>\n<\/tr>\n

\n

28<\/p>\n<\/td>\n

\n

Etilamfetamine<\/p>\n<\/td>\n

\n

N<\/i>-ethyl\u00a0\u2013 \u03b1 \u2013<\/i>\u00a0methylphenylethylamine<\/p>\n<\/td>\n

\n

457-87-4<\/p>\n<\/td>\n<\/tr>\n

\n

29<\/p>\n<\/td>\n

\n

Etizolam<\/p>\n<\/td>\n

\n

4-(2-chlorophenyl)-2-ethyl-9-methyl-6H-thieno [3,2-f] [1,2,4]triazolo[4,3-a][1,4] diazepine<\/p>\n<\/td>\n

\n

40054-69-1<\/p>\n<\/td>\n<\/tr>\n

\n

30<\/p>\n<\/td>\n

\n

Fencamfamine<\/p>\n<\/td>\n

\n

N<\/i>-ethyl \u2013 3 \u2013 phenyl \u2013 2 \u2013 norbomanamine<\/p>\n<\/td>\n

\n

1209-98-9<\/p>\n<\/td>\n<\/tr>\n

\n

31<\/p>\n<\/td>\n

\n

Fenproporex<\/p>\n<\/td>\n

\n

(\u00b1) \u2013 3 \u2013 [(\u03b1 \u2013 methylphenylethyl) aminol propionitrile<\/p>\n<\/td>\n

\n

16397-28-7<\/p>\n<\/td>\n<\/tr>\n

\n

32<\/p>\n<\/td>\n

\n

Flualprazolam<\/p>\n<\/td>\n

\n

8-chloro-6-(2-fluorophenyl)-1-methyl-4H-[1,2,4] triazolo[4,3-a][1,4] benzodiazepine<\/p>\n<\/td>\n

\n

28910-91-0<\/p>\n<\/td>\n<\/tr>\n

\n

33<\/p>\n<\/td>\n

\n

Flubromazolam<\/p>\n<\/td>\n

\n

8-bromo-6-(2-fluorophenyl)-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine<\/p>\n<\/td>\n

\n

612526-40-6<\/p>\n<\/td>\n<\/tr>\n

\n

34<\/p>\n<\/td>\n

\n

Fludiazepam<\/p>\n<\/td>\n

\n

7 \u2013 chloro \u2013 5 \u2013 (o<\/i>\u00a0\u2013 fluorofenyl) -1,3 \u2013 dihydro \u2013 2H<\/i>\u00a0\u2013 1,4 \u2013 benzodiazepin \u2013 2 \u2013 one<\/p>\n<\/td>\n

\n

3900-31-0<\/p>\n<\/td>\n<\/tr>\n

\n

35<\/p>\n<\/td>\n

\n

Flunitrazepam<\/p>\n<\/td>\n

\n

5 \u2013\u00a0(o \u2013<\/i>\u00a0fluorophenyl) \u2013 1,3 \u2013 dihydro -1 \u2013 methyl \u2013 7 \u2013 nitro \u2013 2H<\/i>\u00a0\u2013 1,4 \u2013 benzodiazepin \u2013 2 \u2013 one<\/p>\n<\/td>\n

\n

1622-62-4<\/p>\n<\/td>\n<\/tr>\n

\n

36<\/p>\n<\/td>\n

\n

Flurazepam<\/p>\n<\/td>\n

\n

7-chloro-1-[2-(diethylamino) ethyl] -5 -(o<\/i>-fluorophenyl) -1,3 -dihydro -2H -1,4 \u2013 benzodiazepin -2 -one<\/p>\n<\/td>\n

\n

17617-23-1<\/p>\n<\/td>\n<\/tr>\n

\n

37<\/p>\n<\/td>\n

\n

Glutethimide<\/p>\n<\/td>\n

\n

2 \u2013 ethyl \u2013 2 \u2013 phenylglutarimide<\/p>\n<\/td>\n

\n

77-21-4<\/p>\n<\/td>\n<\/tr>\n

\n

38<\/p>\n<\/td>\n

\n

Halazepam<\/p>\n<\/td>\n

\n

7 \u2013 chloro \u2013 1,3 \u2013 dihydro \u2013 5 \u2013 phenyl \u2013 1 \u2013 (2,2,2 \u2013 trifluoroethyl) \u2013 2H<\/i>\u00a0\u2013 1,4 \u2013 benzodiazepin \u2013 2 \u2013 one<\/p>\n<\/td>\n

\n

23092-17-3<\/p>\n<\/td>\n<\/tr>\n

\n

39<\/p>\n<\/td>\n

\n

Haloxazolam<\/p>\n<\/td>\n

\n

10 \u2013 bromo \u2013 11b<\/i>\u00a0\u2013 (o<\/i>\u00a0\u2013 fluorophenyl) \u2013 2,3,7,11b<\/i>\u00a0\u2013 tetrahydrooxazolo [3,2 \u2013\u00a0d<\/i>] [1,4] benzodiazepin \u2013 6 \u2013 (5H) \u2013 one<\/p>\n<\/td>\n

\n

59128-97-1<\/p>\n<\/td>\n<\/tr>\n

\n

40<\/p>\n<\/td>\n

\n

Ketamine<\/p>\n<\/td>\n

\n

(\u00b1)-2-(2-Chlorophenyl)-2-methylaminocyclohexanone<\/p>\n<\/td>\n

\n

6740-88-1<\/p>\n<\/td>\n<\/tr>\n

\n

41<\/p>\n<\/td>\n

\n

Ketazolam<\/p>\n<\/td>\n

\n

11 \u2013 chloro \u2013 8 \u2013 12b<\/i>\u00a0\u2013 dihydro \u2013 2,8 \u2013 dimethyl \u2013 12b<\/i>\u00a0\u2013 phenyl \u2013 4H<\/i>\u00a0\u2013 [1,3] \u2013 oxazino [3,2 \u2013\u00a0d]\u00a0<\/i>[1,4] benzodiazepin \u2013 4,7 (6H<\/i>)\u00a0\u2013<\/i>\u00a0dione<\/p>\n<\/td>\n

\n

27223-35-4<\/p>\n<\/td>\n<\/tr>\n

\n

42<\/p>\n<\/td>\n

\n

Lefetamine (SPA)<\/p>\n<\/td>\n

\n

(-) \u2013\u00a0N,N<\/i>\u00a0\u2013 dimethyl \u2013 1,2 \u2013 diphenylethylamine<\/p>\n<\/td>\n

\n

7262-75-1<\/p>\n<\/td>\n<\/tr>\n

\n

43<\/p>\n<\/td>\n

\n

Loprazolam<\/p>\n<\/td>\n

\n

6 \u2013 (o- chlorophenyl) -2,4 -dihydro \u2013 2-[(4-methyl -1 -[piperazinyl) methylene] \u2013 8 \u2013 nitro \u2013 1 \u2013H<\/i>\u2013 imidazo -[1,2 \u2013\u00a0a<\/i>] [1,4] benzodiazepin- 1 -one<\/p>\n<\/td>\n

\n

61197-73-7<\/p>\n<\/td>\n<\/tr>\n

\n

44<\/p>\n<\/td>\n

\n

Lorazepam<\/p>\n<\/td>\n

\n

7 \u2013 chloro \u2013 5 \u2013\u00a0(o \u2013<\/i>\u00a0chlorofenyl) \u2013 1,3 \u2013 dihydro \u2013 3 \u2013 hydroxy \u2013 2H<\/i>\u00a0\u2013 1,4 \u2013 benzodiazepin \u2013 2 \u2013 one<\/p>\n<\/td>\n

\n

846-49-1<\/p>\n<\/td>\n<\/tr>\n

\n

45<\/p>\n<\/td>\n

\n

Lormetazepam<\/p>\n<\/td>\n

\n

7-chloro-5 -(o<\/i>\u00a0-chlorofenyl) -1,3-dihydro -3 hydroxy-1-methyl-2H<\/i>\u00a0-1,4-benzodiazepin-2 \u2013 one<\/p>\n<\/td>\n

\n

848-75-9<\/p>\n<\/td>\n<\/tr>\n

\n

46<\/p>\n<\/td>\n

\n

Mazindol<\/p>\n<\/td>\n

\n

5 \u2013 (p<\/i>-chlorophenyl) \u2013 2,5 dihydro \u2013 3H<\/i>\u2013 imidazo \u2013 (2,1 \u2013\u00a0a)<\/i>\u00a0isoindol \u2013 5 \u2013 ol<\/p>\n<\/td>\n

\n

22232-71-9<\/p>\n<\/td>\n<\/tr>\n

\n

47<\/p>\n<\/td>\n

\n

Medazepam<\/p>\n<\/td>\n

\n

7 \u2013 chloro \u2013 2,3 \u2013 dihydro \u2013 1 \u2013 methyl \u2013 5 \u2013 phenyl \u2013 1H \u2013<\/i>\u00a01,4 \u2013 benzodiazepine<\/p>\n<\/td>\n

\n

2898-12-6<\/p>\n<\/td>\n<\/tr>\n

\n

48<\/p>\n<\/td>\n

\n

Mefenorex<\/p>\n<\/td>\n

\n

N<\/i>-(3\u00a0\u2013<\/i>\u00a0chloropropyl) \u2013\u00a0\u03b1 \u2013 me<\/i>thylphenethylamine<\/p>\n<\/td>\n

\n

17243-57-1<\/p>\n<\/td>\n<\/tr>\n

\n

49<\/p>\n<\/td>\n

\n

Meprobamate<\/p>\n<\/td>\n

\n

2-methyl -2-propyl -1,3 -propanediol dicarbamate<\/p>\n<\/td>\n

\n

57-53-4<\/p>\n<\/td>\n<\/tr>\n

\n

50<\/p>\n<\/td>\n

\n

Mesocarb<\/p>\n<\/td>\n

\n

3 \u2013\u00a0(\u03b1 \u2013 me<\/i>thylphenethyl) \u2013\u00a0N \u2013\u00a0<\/i>(phenylcarbamoyl) syndnoneimine<\/p>\n<\/td>\n

\n

34262-84-5<\/p>\n<\/td>\n<\/tr>\n

\n

51<\/p>\n<\/td>\n

\n

Methylphenobarbital<\/p>\n<\/td>\n

\n

5 \u2013 ethyl \u2013 1 \u2013 methyl \u2013 5 \u2013 phenylbarbituric acid<\/p>\n<\/td>\n

\n

115-38-8<\/p>\n<\/td>\n<\/tr>\n

\n

52<\/p>\n<\/td>\n

\n

Methyprylon<\/p>\n<\/td>\n

\n

3,3 \u2013 diethyl \u2013 5 \u2013 methyl \u2013 2,4 \u2013 piperidine \u2013 dione<\/p>\n<\/td>\n

\n

125-64-4<\/p>\n<\/td>\n<\/tr>\n

\n

53<\/p>\n<\/td>\n

\n

Midazolam<\/p>\n<\/td>\n

\n

8 \u2013 chloro \u2013 6 \u2013\u00a0(o \u2013<\/i>\u00a0fluorophenyl) \u2013 1 \u2013 methyl \u2013 4H-<\/i>\u00a0imidazo \u2013 [1,5 \u2013\u00a0a]<\/i>\u00a0[1,4] \u2013 benzodiazepin<\/p>\n<\/td>\n

\n

59467-70-8<\/p>\n<\/td>\n<\/tr>\n

\n

54<\/p>\n<\/td>\n

\n

Nimetazepam<\/p>\n<\/td>\n

\n

1,3 \u2013 dihydro -1 \u2013 methyl \u2013 7 \u2013 nitro \u2013 5 \u2013 phenyl\u00a0\u2013\u00a0<\/i>2H<\/i>\u00a0\u2013 1,4- benzodiazepin \u2013 2 \u2013 one<\/p>\n<\/td>\n

\n

2011-67-8<\/p>\n<\/td>\n<\/tr>\n

\n

55<\/p>\n<\/td>\n

\n

Nitrazepam<\/p>\n<\/td>\n

\n

1,3- dihydro \u2013 7 \u2013 nitro \u2013 5 phenyl \u2013 2H<\/i>\u00a0\u2013 1,4 \u2013 benzodiazepin \u2013 2 \u2013 one<\/p>\n<\/td>\n

\n

146-22-5<\/p>\n<\/td>\n<\/tr>\n

\n

56<\/p>\n<\/td>\n

\n

Nordazepam<\/p>\n<\/td>\n

\n

7 \u2013 chloro \u2013 1,3 \u2013 dihydro \u2013 5 \u2013 phenyl \u2013 2H<\/i>\u00a0\u2013 1,4 \u2013 benzodiazepin \u2013 2 \u2013 one<\/p>\n<\/td>\n

\n

1088-11-5<\/p>\n<\/td>\n<\/tr>\n

\n

57<\/p>\n<\/td>\n

\n

Oxazepam<\/p>\n<\/td>\n

\n

7 \u2013 chloro \u2013 1,3 \u2013 dihydro \u2013 3 \u2013 hydroxy \u2013 5 \u2013 phenyl \u2013 2H<\/i>\u00a0\u2013 1,4 \u2013 benzodiazepin \u2013 2 \u2013 one<\/p>\n<\/td>\n

\n

604-75-1<\/p>\n<\/td>\n<\/tr>\n

\n

58<\/p>\n<\/td>\n

\n

Oxazolam<\/p>\n<\/td>\n

\n

10 \u2013 chloro \u2013 2,3,7,11b<\/i>\u00a0\u2013 tetrahydro \u2013 2 \u2013 methyl \u2013 11b<\/i>\u00a0\u2013 phenyloxazolo [3,2 \u2013\u00a0d<\/i>][1,4] benzodiazepin \u2013 6(5H<\/i>) \u2013 one<\/p>\n<\/td>\n

\n

24143-17-7<\/p>\n<\/td>\n<\/tr>\n

\n

59<\/p>\n<\/td>\n

\n

Pemoline<\/p>\n<\/td>\n

\n

2 \u2013 amino \u2013 5 \u2013 phenyl \u2013 2 \u2013 oxazolin \u2013 4 \u2013 one<\/p>\n<\/td>\n

\n

2152-34-3<\/p>\n<\/td>\n<\/tr>\n

\n

60<\/p>\n<\/td>\n

\n

Pentazocine<\/p>\n<\/td>\n

\n

(2R*,6R*, 11R*) \u2013 1,2,3,4,5,6 \u2013 hexahydro \u2013 6,11 \u2013 dimethyl \u2013 3 \u2013 (3 \u2013 methyl \u2013 2 \u2013 butenyl) \u2013 2,6 \u2013 methano \u2013 3 \u2013 benzazocin \u2013 8 \u2013 ol<\/p>\n<\/td>\n

\n

55643-30-6<\/p>\n<\/td>\n<\/tr>\n

\n

61<\/p>\n<\/td>\n

\n

Pentobarbital<\/p>\n<\/td>\n

\n

5 \u2013 ethyl \u2013 5 \u2013 (1 \u2013 methylbutyl) barbituric acid<\/p>\n<\/td>\n

\n

76-74-4<\/p>\n<\/td>\n<\/tr>\n

\n

62<\/p>\n<\/td>\n

\n

Phendimetrazine<\/p>\n<\/td>\n

\n

(+) \u2013 3,4 \u2013 dimethyl \u2013 2 \u2013 phenylmorpholine<\/p>\n<\/td>\n

\n

634-03-7<\/p>\n<\/td>\n<\/tr>\n

\n

63<\/p>\n<\/td>\n

\n

Phenobarbital<\/p>\n<\/td>\n

\n

5 \u2013 ethyl \u2013 5 \u2013 phenylbarbituric acid<\/p>\n<\/td>\n

\n

50-06-6<\/p>\n<\/td>\n<\/tr>\n

\n

64<\/p>\n<\/td>\n

\n

Phentermine<\/p>\n<\/td>\n

\n

\u03b1, \u03b1<\/i>\u00a0\u2013 dimethylphenethylamine<\/p>\n<\/td>\n

\n

122-09-8<\/p>\n<\/td>\n<\/tr>\n

\n

65<\/p>\n<\/td>\n

\n

Pinazepam<\/p>\n<\/td>\n

\n

7 \u2013 chloro \u2013 1,3 \u2013 dihydro \u2013 5 \u2013 phenyl \u2013 1 \u2013 (2 \u2013 propynyl) \u2013 2H<\/i>\u00a0\u2013 1,4 \u2013 benzodiazepin \u2013 2 \u2013 one<\/p>\n<\/td>\n

\n

52463-83-9<\/p>\n<\/td>\n<\/tr>\n

\n

66<\/p>\n<\/td>\n

\n

Pipradrol<\/p>\n<\/td>\n

\n

1 \u2013 1 \u2013 diphenyl \u2013 1 \u2013 (2 \u2013 piperidyl) \u2013 methanol<\/p>\n<\/td>\n

\n

467-60-7<\/p>\n<\/td>\n<\/tr>\n

\n

67<\/p>\n<\/td>\n

\n

Prazepam<\/p>\n<\/td>\n

\n

7 -chloro -1 -(cyclopropylmethyl) -1,3 -dihydro -5 -phenyl -2H\u00a0<\/i>-1,4 -benzodiazepin -2 -one<\/p>\n<\/td>\n

\n

2955-38-6<\/p>\n<\/td>\n<\/tr>\n

\n

68<\/p>\n<\/td>\n

\n

Pyrovalerone<\/p>\n<\/td>\n

\n

4\u2019 \u2013 methyl \u2013 2 \u2013 (1 \u2013 pyrrolidinyl) valerophenone<\/p>\n<\/td>\n

\n

3563-49-3<\/p>\n<\/td>\n<\/tr>\n

\n

69<\/p>\n<\/td>\n

\n

Secbutabarbital<\/p>\n<\/td>\n

\n

5 \u2013\u00a0sec<\/i>\u00a0\u2013 butyl \u2013 5 \u2013 ethylbarbituric acid<\/p>\n<\/td>\n

\n

125-40-6<\/p>\n<\/td>\n<\/tr>\n

\n

70<\/p>\n<\/td>\n

\n

Temazepam<\/p>\n<\/td>\n

\n

7 \u2013 chloro -1,3 \u2013 dihydro \u2013 3 \u2013 hydroxy -1 \u2013 methyl \u2013 5 \u2013 phenyl \u2013 2H<\/i>\u00a0\u2013 1,4 \u2013 benzodiazepin \u2013 2 \u2013 one<\/p>\n<\/td>\n

\n

846-50-4<\/p>\n<\/td>\n<\/tr>\n

\n

71<\/p>\n<\/td>\n

\n

Tetrazepam<\/p>\n<\/td>\n

\n

7 -chloro -5 -(1 -cyclohexen- 1-yl) -1,3 \u2013 dihydro -1 methyl \u2013 2H<\/i>\u00a0-1,4 \u2013 benzodiazepin-2 \u2013 one<\/p>\n<\/td>\n

\n

10379-14-3<\/p>\n<\/td>\n<\/tr>\n

\n

72<\/p>\n<\/td>\n

\n

Tiletamine<\/p>\n<\/td>\n

\n

2-(ethylamino)-2-thiophen-2-yl cyclohexan -1- one<\/p>\n<\/td>\n

\n

14176-49-9<\/p>\n<\/td>\n<\/tr>\n

\n

73<\/p>\n<\/td>\n

\n

Triazolam<\/p>\n<\/td>\n

\n

8 \u2013 chloro \u2013 6 \u2013 (o<\/i>\u00a0\u2013 chlorophenyl) \u2013 1 \u2013 methyl \u2013 4H<\/i>\u00a0\u2013\u00a0s<\/i>\u00a0\u2013 triazolo [4,3 \u2013\u00a0a]<\/i>\u00a0[1,4] benzodiazepine<\/p>\n<\/td>\n

\n

28911-01-5<\/p>\n<\/td>\n<\/tr>\n

\n

74<\/p>\n<\/td>\n

\n

Vinylbital<\/p>\n<\/td>\n

\n

5 \u2013 (1 \u2013 methylbutyl) \u2013 5 \u2013 vinylbarbituric acid<\/p>\n<\/td>\n

\n

2430-49-1<\/p>\n<\/td>\n<\/tr>\n

\n

75<\/p>\n<\/td>\n

\n

Zolazepam<\/p>\n<\/td>\n

\n

4 \u2013 (2 \u2013 fluorophenyl) \u2013 1,3,8 \u2013 trimethyl\u00a0\u2013<\/i>6H \u2013\u00a0<\/i>pyrazolo [3,4-e] [1,4] diazepin \u2013 7 -one<\/p>\n<\/td>\n

\n

31352-82-6<\/p>\n<\/td>\n<\/tr>\n

\n

76<\/p>\n<\/td>\n

\n

Zolpidem<\/p>\n<\/td>\n

\n

N, N,\u00a0<\/i>6 \u2013 trimethyl \u2013 2 \u2013\u00a0p \u2013<\/i>\u00a0tolylimidazol [1,2 \u2013\u00a0a]<\/i>\u00a0pyridine \u2013 3 \u2013 acetamide<\/p>\n<\/td>\n

\n

82626-48-0<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

\u00a0<\/p>\n

DANH M\u1ee4C IV<\/b><\/p>\n

C\u00c1C TI\u1ec0N CH\u1ea4T<\/p>\n

IVA: C\u00e1c ti\u1ec1n ch\u1ea5t thi\u1ebft y\u1ebfu, tham gia v\u00e0o c\u1ea5u tr\u00fac ch\u1ea5t ma t\u00fay.<\/p>\n

Danh m\u1ee5c n\u00e0y bao g\u1ed3m c\u1ea3 c\u00e1c mu\u1ed1i c\u00f3 th\u1ec3 t\u1ed3n t\u1ea1i c\u1ee7a c\u00e1c ch\u1ea5t c\u00f3 \u0111\u00e1nh d\u1ea5u *.<\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n

STT<\/b><\/p>\n<\/td>\n

\n

T\u00ean ch\u1ea5t<\/b><\/p>\n<\/td>\n

\n

T\u00ean khoa h\u1ecdc<\/b><\/p>\n<\/td>\n

\n

M\u00e3 th\u00f4ng tin<\/b>\u00a0CAS<\/b><\/p>\n<\/td>\n

\n

M\u00e3 s\u1ed1 h\u00e0ng h\u00f3a<\/b><\/p>\n<\/td>\n

\n

C\u01a1 quan qu<\/span>\u1ea3n l\u00fd<\/b><\/p>\n<\/td>\n<\/tr>\n

\n

1<\/p>\n<\/td>\n

\n

1 -boc-4-AP<\/p>\n<\/td>\n

\n

tert-Butyl 4-(phenylamino) piperidine-1-carboxylate<\/p>\n<\/td>\n

\n

125541-22-2<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n

\n

B\u1ed9 C\u00f4ng an<\/p>\n<\/td>\n<\/tr>\n

\n

2<\/p>\n<\/td>\n

\n

1-phenyl-2-propanone (P2P)<\/p>\n<\/td>\n

\n

1-phenyl-2-propanone<\/p>\n<\/td>\n

\n

103-79-7<\/p>\n<\/td>\n

\n

2914.31.00<\/p>\n<\/td>\n

\n

B\u1ed9\u00a0C\u00f4ng Th\u01b0\u01a1ng<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

3<\/p>\n<\/td>\n

\n

3,4-MDP-2P-methyl glycidate (PMK glycidate)<\/p>\n<\/td>\n

\n

2-oxiranecarboxylic acid,3-(1,3-benzodioxol-5-yl)-2-methyl-, methyl ester<\/p>\n<\/td>\n

\n

13605-48-6<\/p>\n<\/td>\n

\n

2932.99.90<\/p>\n<\/td>\n

\n

B\u1ed9 C\u00f4ng an<\/p>\n<\/td>\n<\/tr>\n

\n

4<\/p>\n<\/td>\n

\n

3,4-MDP-2P-methyl glycidic acid (PMK glycidic acid)<\/p>\n<\/td>\n

\n

2-oxiranecarboxylic acid, 3-(1,3-benzo dioxol-5-yl)-2-methyl-<\/p>\n<\/td>\n

\n

2167189-50-4<\/p>\n<\/td>\n

\n

2932.99.90<\/p>\n<\/td>\n

\n

B\u1ed9 C\u00f4ng an<\/p>\n<\/td>\n<\/tr>\n

\n

5<\/p>\n<\/td>\n

\n

4-ANPP *<\/p>\n<\/td>\n

\n

4-aminophenyl-1-phenethylpiperidine<\/p>\n<\/td>\n

\n

21409-26-7<\/p>\n<\/td>\n

\n

2933.39.90<\/p>\n<\/td>\n

\n

B\u1ed9 C\u00f4ng an<\/p>\n<\/td>\n<\/tr>\n

\n

6<\/p>\n<\/td>\n

\n

4-AP<\/p>\n<\/td>\n

\n

N-Phenyl-4-piperidinamine<\/p>\n<\/td>\n

\n

23056-29-3<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n

\n

B\u1ed9 C\u00f4ng an<\/p>\n<\/td>\n<\/tr>\n

\n

7<\/p>\n<\/td>\n

\n

Acetic anhydride<\/p>\n<\/td>\n

\n

Acetic oxide<\/p>\n<\/td>\n

\n

108-24-7<\/p>\n<\/td>\n

\n

2915.24.00<\/p>\n<\/td>\n

\n

B\u1ed9\u00a0C\u00f4ng Th\u01b0\u01a1ng<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

8<\/p>\n<\/td>\n

\n

Alpha<\/i>-phenyl acetoacetonitrile (APAAN)<\/p>\n<\/td>\n

\n

3-oxo-2-phenylbutanenitrile<\/p>\n<\/td>\n

\n

4468-48-8<\/p>\n<\/td>\n

\n

2926.40.00<\/p>\n<\/td>\n

\n

B\u1ed9\u00a0C\u00f4ng Th\u01b0\u01a1ng<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

9<\/p>\n<\/td>\n

\n

Alpha-phenylaceto acetamide (APAA)<\/p>\n<\/td>\n

\n

3-oxo-2-phenylbutanamide<\/p>\n<\/td>\n

\n

4433-77-6<\/p>\n<\/td>\n

\n

2924.29.90<\/p>\n<\/td>\n

\n

B\u1ed9 C\u00f4ng an<\/p>\n<\/td>\n<\/tr>\n

\n

10<\/p>\n<\/td>\n

\n

Alpha-bromo-(o-chlorophenyl)-cyclopentyl ketone<\/p>\n<\/td>\n

\n

Alpha-bromo-(o-chlorophenyl)-cyclopentyl ketone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n

\n

B\u1ed9 C\u00f4ng an<\/p>\n<\/td>\n<\/tr>\n

\n

11<\/p>\n<\/td>\n

\n

Anthranilic acid*<\/p>\n<\/td>\n

\n

2 \u2013 Aminobenzoic acid<\/p>\n<\/td>\n

\n

118-92-3<\/p>\n<\/td>\n

\n

2922.43.00<\/p>\n<\/td>\n

\n

B\u1ed9\u00a0C\u00f4ng Th\u01b0\u01a1ng<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

12<\/p>\n<\/td>\n

\n

Benzaldehyde<\/p>\n<\/td>\n

\n

Benzaldehyde<\/p>\n<\/td>\n

\n

100-52-7<\/p>\n<\/td>\n

\n

2912.21.00<\/p>\n<\/td>\n

\n

B\u1ed9\u00a0C\u00f4ng Th\u01b0\u01a1ng<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

13<\/p>\n<\/td>\n

\n

Benzyl cyanide<\/p>\n<\/td>\n

\n

2-Phenylacetonenitrile<\/p>\n<\/td>\n

\n

140-29-4<\/p>\n<\/td>\n

\n

2926.90.00<\/p>\n<\/td>\n

\n

B\u1ed9\u00a0C\u00f4ng Th\u01b0\u01a1ng<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

14<\/p>\n<\/td>\n

\n

Cyclopentyl bromide<\/p>\n<\/td>\n

\n

Bromocyclopentane<\/p>\n<\/td>\n

\n

137-43-9<\/p>\n<\/td>\n

\n

2903.89.90<\/p>\n<\/td>\n

\n

B\u1ed9\u00a0C\u00f4ng Th\u01b0\u01a1ng<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

15<\/p>\n<\/td>\n

\n

Cyclopentyl chloride<\/p>\n<\/td>\n

\n

Chlorocyclopentane<\/p>\n<\/td>\n

\n

930-28-9<\/p>\n<\/td>\n

\n

2903.89.00<\/p>\n<\/td>\n

\n

B\u1ed9\u00a0C\u00f4ng Th\u01b0\u01a1ng<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

16<\/p>\n<\/td>\n

\n

Cyclopentyl magnesium bromide<\/p>\n<\/td>\n

\n

Cyclopentyl magnesium bromide<\/p>\n<\/td>\n

\n

33240-34-5<\/p>\n<\/td>\n

\n

2903.89.00<\/p>\n<\/td>\n

\n

B\u1ed9\u00a0C\u00f4ng Th\u01b0\u01a1ng<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

17<\/p>\n<\/td>\n

\n

Ephedrine*<\/p>\n<\/td>\n

\n

(1R<\/i>,2R<\/i>)-2-methy lamino-1-phenyl propan \u2013 1 \u2013 ol<\/p>\n<\/td>\n

\n

299-42-3<\/p>\n<\/td>\n

\n

2939.41.00<\/p>\n<\/td>\n

\n

B\u1ed9 Y t\u1ebf<\/p>\n<\/td>\n<\/tr>\n

\n

18<\/p>\n<\/td>\n

\n

Ergometrine*<\/p>\n<\/td>\n

\n

N<\/i>\u00a0\u2013 (2 \u2013 hydroxy \u2013 1 \u2013 methylethyl) \u2013 D (+) \u2013 lysergamide<\/p>\n<\/td>\n

\n

60-79-7<\/p>\n<\/td>\n

\n

2939.61.00<\/p>\n<\/td>\n

\n

B\u1ed9 Y t\u1ebf<\/p>\n<\/td>\n<\/tr>\n

\n

19<\/p>\n<\/td>\n

\n

Ergotamine*<\/p>\n<\/td>\n

\n

Ergotaman-3\u2019,6\u2019,18 \u2013 trione, 12-hydroxy-2-methyl -5\u2019- (phenylmethyl) -(5\u2019a<\/i>)<\/p>\n<\/td>\n

\n

113-15-5<\/p>\n<\/td>\n

\n

2939.62.00<\/p>\n<\/td>\n

\n

B\u1ed9 Y t\u1ebf<\/p>\n<\/td>\n<\/tr>\n

\n

20<\/p>\n<\/td>\n

\n

Gamma<\/i>-butyro lactone (GBL)<\/p>\n<\/td>\n

\n

Dihidrofuran-2(3H<\/i>)-one<\/p>\n<\/td>\n

\n

96-48-0<\/p>\n<\/td>\n

\n

2932.20.90<\/p>\n<\/td>\n

\n

B\u1ed9 C\u00f4ng\u00a0Th\u01b0\u01a1ng<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

21<\/p>\n<\/td>\n

\n

Hydroxylimine<\/p>\n<\/td>\n

\n

1-hydroxycyclopentyl -(o-chlorophenyl)-ketone-N-methylimine<\/p>\n<\/td>\n

\n

90717-16-1<\/p>\n<\/td>\n

\n

2925.29.00<\/p>\n<\/td>\n

\n

B\u1ed9 C\u00f4ng an<\/p>\n<\/td>\n<\/tr>\n

\n

22<\/p>\n<\/td>\n

\n

Isosafrole<\/p>\n<\/td>\n

\n

1,3 \u2013 Benzodioxole \u2013 5 \u2013 (1 \u2013 propenyl)<\/p>\n<\/td>\n

\n

120-58-1<\/p>\n<\/td>\n

\n

2932.91.00<\/p>\n<\/td>\n

\n

B\u1ed9\u00a0C\u00f4ng Th\u01b0\u01a1ng<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

23<\/p>\n<\/td>\n

\n

Lysergic acid*<\/p>\n<\/td>\n

\n

(8b) \u2013 9,10 \u2013 didehydro \u2013 6 \u2013 methylergolin \u2013 8 \u2013 carboxylic acid<\/p>\n<\/td>\n

\n

82-58-6<\/p>\n<\/td>\n

\n

2939.63.00<\/p>\n<\/td>\n

\n

B\u1ed9\u00a0C\u00f4ng Th\u01b0\u01a1ng<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

24<\/p>\n<\/td>\n

\n

Methyl alpha-phenyl acetoacetate (MAPA)<\/p>\n<\/td>\n

\n

Methyl 3-oxo-2-phenylbutanoate<\/p>\n<\/td>\n

\n

16648-44-5<\/p>\n<\/td>\n

\n

2918.30.00<\/p>\n<\/td>\n

\n

B\u1ed9 C\u00f4ng an<\/p>\n<\/td>\n<\/tr>\n

\n

25<\/p>\n<\/td>\n

\n

N-acetylanthranilic acid*<\/p>\n<\/td>\n

\n

1 \u2013 Acetylamino \u2013 2 \u2013 carboxybenzene<\/p>\n<\/td>\n

\n

89-52-1<\/p>\n<\/td>\n

\n

2924.23.00<\/p>\n<\/td>\n

\n

B\u1ed9\u00a0C\u00f4ng Th\u01b0\u01a1ng<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

26<\/p>\n<\/td>\n

\n

N-Ethylephedrine*<\/p>\n<\/td>\n

\n

1-Ethylephedrine<\/p>\n<\/td>\n

\n

7681-79-0<\/p>\n<\/td>\n

\n

2939.49.90<\/p>\n<\/td>\n

\n

B\u1ed9 Y t\u1ebf<\/p>\n<\/td>\n<\/tr>\n

\n

27<\/p>\n<\/td>\n

\n

N-Ethyl pseudoephedrine*<\/p>\n<\/td>\n

\n

Ethyl methylamino-phenyl-propane -1-ol<\/p>\n<\/td>\n

\n

258827- 65-5<\/p>\n<\/td>\n

\n

2939.49.90<\/p>\n<\/td>\n

\n

B\u1ed9 Y t\u1ebf<\/p>\n<\/td>\n<\/tr>\n

\n

28<\/p>\n<\/td>\n

\n

N-Methylephedrine*<\/p>\n<\/td>\n

\n

(1R,2S)-2-(Dimethylamino)-1-phenyl\u20131-propanol<\/p>\n<\/td>\n

\n

552-79-4<\/p>\n<\/td>\n

\n

2939.49.90<\/p>\n<\/td>\n

\n

B\u1ed9 Y t\u1ebf<\/p>\n<\/td>\n<\/tr>\n

\n

29<\/p>\n<\/td>\n

\n

N-Methyl pseudoephedrine*<\/p>\n<\/td>\n

\n

Dimethylamino-phenyl-propane-1-ol<\/p>\n<\/td>\n

\n

51018-28- 1<\/p>\n<\/td>\n

\n

2939.49.90<\/p>\n<\/td>\n

\n

B\u1ed9 Y t\u1ebf<\/p>\n<\/td>\n<\/tr>\n

\n

30<\/p>\n<\/td>\n

\n

Norephedrine (Phenylpropanolamine)<\/p>\n<\/td>\n

\n

\u03b1-(1-Aminoethyl) enzylalcohol<\/p>\n<\/td>\n

\n

14838-15-4<\/p>\n<\/td>\n

\n

2939.44.00<\/p>\n<\/td>\n

\n

B\u1ed9 C\u00f4ng an<\/p>\n<\/td>\n<\/tr>\n

\n

31<\/p>\n<\/td>\n

\n

Norfentanyl<\/p>\n<\/td>\n

\n

N-phenyl-N-4-piperidinyl-propanamide<\/p>\n<\/td>\n

\n

1609-66-1<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n

\n

B\u1ed9 C\u00f4ng an<\/p>\n<\/td>\n<\/tr>\n

\n

32<\/p>\n<\/td>\n

\n

N<\/i>-Phenethyl-4-piperidinone (NPP)<\/p>\n<\/td>\n

\n

1- (2-Phenylethyl) piperidine-4-one<\/p>\n<\/td>\n

\n

39742-60<\/p>\n<\/td>\n

\n

2933.39.90<\/p>\n<\/td>\n

\n

B\u1ed9 C\u00f4ng an<\/p>\n<\/td>\n<\/tr>\n

\n

33<\/p>\n<\/td>\n

\n

o-Chlorobenzonitrile<\/p>\n<\/td>\n

\n

2-Chlorobenzonitrile<\/p>\n<\/td>\n

\n

873-32-5<\/p>\n<\/td>\n

\n

2926.90.00<\/p>\n<\/td>\n

\n

B\u1ed9\u00a0C\u00f4ng Th\u01b0\u01a1ng<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

34<\/p>\n<\/td>\n

\n

o-Bromobenzonitrile<\/p>\n<\/td>\n

\n

2-Bromobenzonitrile<\/p>\n<\/td>\n

\n

2042-37-7<\/p>\n<\/td>\n

\n

2926.90.00<\/p>\n<\/td>\n

\n

B\u1ed9\u00a0C\u00f4ng Th\u01b0\u01a1ng<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

35<\/p>\n<\/td>\n

\n

o-Chlorophenyl cyclopentyl ketone<\/p>\n<\/td>\n

\n

2-Chlorophenyl cyclopentyl ketone<\/p>\n<\/td>\n

\n

6740-85-8<\/p>\n<\/td>\n

\n

2914.29.90<\/p>\n<\/td>\n

\n

B\u1ed9 C\u00f4ng an<\/p>\n<\/td>\n<\/tr>\n

\n

36<\/p>\n<\/td>\n

\n

Phenylacetic acid*<\/p>\n<\/td>\n

\n

Benzeneacetic acid<\/p>\n<\/td>\n

\n

103-82-2<\/p>\n<\/td>\n

\n

2916.34.00<\/p>\n<\/td>\n

\n

B\u1ed9\u00a0C\u00f4ng Th\u01b0\u01a1ng<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

37<\/p>\n<\/td>\n

\n

Piperidine*<\/p>\n<\/td>\n

\n

Cyclopentimine<\/p>\n<\/td>\n

\n

110-89-4<\/p>\n<\/td>\n

\n

2933.32.00<\/p>\n<\/td>\n

\n

B\u1ed9\u00a0C\u00f4ng Th\u01b0\u01a1ng<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

38<\/p>\n<\/td>\n

\n

Piperonal*<\/p>\n<\/td>\n

\n

1,3-Benzodioxole-5-carbaldehyde<\/p>\n<\/td>\n

\n

120-57-0<\/p>\n<\/td>\n

\n

2932.93.00<\/p>\n<\/td>\n

\n

B\u1ed9\u00a0C\u00f4ng Th\u01b0\u01a1ng<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

39<\/p>\n<\/td>\n

\n

Piperonyl methyl ketone<\/p>\n<\/td>\n

\n

3,4 \u2013 methylenedioxyphenyl-2-propanone<\/p>\n<\/td>\n

\n

4676-39-5<\/p>\n<\/td>\n

\n

2932.92.00<\/p>\n<\/td>\n

\n

B\u1ed9\u00a0C\u00f4ng Th\u01b0\u01a1ng<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

40<\/p>\n<\/td>\n

\n

Propiophenone<\/p>\n<\/td>\n

\n

1-phenyl-1-propanone<\/p>\n<\/td>\n

\n

93-55-0<\/p>\n<\/td>\n

\n

2914.39.00<\/p>\n<\/td>\n

\n

B\u1ed9\u00a0C\u00f4ng Th\u01b0\u01a1ng<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

41<\/p>\n<\/td>\n

\n

Pseudoephedrine*<\/p>\n<\/td>\n

\n

(1S, 2S) \u2013 2-methylamino -1- phenyl propane -1-ol<\/p>\n<\/td>\n

\n

90-82-4<\/p>\n<\/td>\n

\n

2939.42.00<\/p>\n<\/td>\n

\n

B\u1ed9 Y t\u1ebf<\/p>\n<\/td>\n<\/tr>\n

\n

42<\/p>\n<\/td>\n

\n

Safrole<\/p>\n<\/td>\n

\n

5-(prop-2-en-1-yl)-2H<\/i>-1,3-benzodioxole<\/p>\n<\/td>\n

\n

94-59-7<\/p>\n<\/td>\n

\n

2932.94.00<\/p>\n<\/td>\n

\n

B\u1ed9\u00a0C\u00f4ng Th\u01b0\u01a1ng<\/span><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

IVB: C\u00e1c ti\u1ec1n ch\u1ea5t l\u00e0 h\u00f3a ch\u1ea5t, dung m\u00f4i, ch\u1ea5t x\u00fac t\u00e1c d\u00f9ng trong qu\u00e1 tr\u00ecnh s\u1ea3n xu\u1ea5t ch\u1ea5t ma t\u00fay.<\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n

STT<\/b><\/p>\n<\/td>\n

\n

T\u00ean ch\u1ea5t<\/b><\/p>\n<\/td>\n

\n

T\u00ean khoa h\u1ecdc<\/b><\/p>\n<\/td>\n

\n

M\u00e3 th\u00f4ng tin CAS<\/b><\/p>\n<\/td>\n

\n

M\u00e3 s\u1ed1 h\u00e0ng h\u00f3a<\/b><\/p>\n<\/td>\n

\n

C\u01a1 quan qu<\/span>\u1ea3n l\u00fd<\/b><\/p>\n<\/td>\n<\/tr>\n

\n

1<\/p>\n<\/td>\n

\n

Acetic acid<\/p>\n<\/td>\n

\n

Ethanoic acid<\/p>\n<\/td>\n

\n

64-19-7<\/p>\n<\/td>\n

\n

2915.21.00<\/p>\n<\/td>\n

\n

B\u1ed9\u00a0C\u00f4ng Th\u01b0\u01a1ng<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

2<\/p>\n<\/td>\n

\n

Acetone<\/p>\n<\/td>\n

\n

2-propanone<\/p>\n<\/td>\n

\n

67-64-1<\/p>\n<\/td>\n

\n

2914.11.00<\/p>\n<\/td>\n

\n

B\u1ed9\u00a0C\u00f4ng Th\u01b0\u01a1ng<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

3<\/p>\n<\/td>\n

\n

Acetyl chloride<\/p>\n<\/td>\n

\n

Acetyl chloride<\/p>\n<\/td>\n

\n

75-36-5<\/p>\n<\/td>\n

\n

2915.90.10<\/p>\n<\/td>\n

\n

B\u1ed9\u00a0C\u00f4ng Th\u01b0\u01a1ng<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

4<\/p>\n<\/td>\n

\n

Ammonium formate<\/p>\n<\/td>\n

\n

Ammonium formate<\/p>\n<\/td>\n

\n

540-69-2<\/p>\n<\/td>\n

\n

2915.12.00<\/p>\n<\/td>\n

\n

B\u1ed9\u00a0C\u00f4ng Th\u01b0\u01a1ng<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

5<\/p>\n<\/td>\n

\n

Diethylamine<\/p>\n<\/td>\n

\n

N<\/i>-ethylethanamine<\/p>\n<\/td>\n

\n

109-89-7<\/p>\n<\/td>\n

\n

2921.19.00<\/p>\n<\/td>\n

\n

B\u1ed9\u00a0C\u00f4ng Th\u01b0\u01a1ng<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

6<\/p>\n<\/td>\n

\n

Ethyl ether<\/p>\n<\/td>\n

\n

1-1\u2019-oxybis[ethane]<\/p>\n<\/td>\n

\n

60-29-7<\/p>\n<\/td>\n

\n

2909.11.00<\/p>\n<\/td>\n

\n

B\u1ed9\u00a0C\u00f4ng Th\u01b0\u01a1ng<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

7<\/p>\n<\/td>\n

\n

Ethylene diacetate<\/p>\n<\/td>\n

\n

1,2-ethanediol diacetate<\/p>\n<\/td>\n

\n

111-55-7<\/p>\n<\/td>\n

\n

2915.39.90<\/p>\n<\/td>\n

\n

B\u1ed9\u00a0C\u00f4ng Th\u01b0\u01a1ng<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

8<\/p>\n<\/td>\n

\n

Formamide<\/p>\n<\/td>\n

\n

Methanamide<\/p>\n<\/td>\n

\n

75-12-7<\/p>\n<\/td>\n

\n

2924.19.90<\/p>\n<\/td>\n

\n

B\u1ed9\u00a0C\u00f4ng Th\u01b0\u01a1ng<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

9<\/p>\n<\/td>\n

\n

Formic Acid<\/p>\n<\/td>\n

\n

Methamoic Acid<\/p>\n<\/td>\n

\n

64-18-6<\/p>\n<\/td>\n

\n

2915.11.00<\/p>\n<\/td>\n

\n

B\u1ed9\u00a0C\u00f4ng Th\u01b0\u01a1ng<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

10<\/p>\n<\/td>\n

\n

Hydrochloric acid<\/p>\n<\/td>\n

\n

Hydrochloric acid<\/p>\n<\/td>\n

\n

7647-01-0<\/p>\n<\/td>\n

\n

2806.10.00<\/p>\n<\/td>\n

\n

B\u1ed9\u00a0C\u00f4ng Th\u01b0\u01a1ng<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

11<\/p>\n<\/td>\n

\n

Methyl ethyl ketone<\/p>\n<\/td>\n

\n

2-Butanone<\/p>\n<\/td>\n

\n

78-93-3<\/p>\n<\/td>\n

\n

2914.12.00<\/p>\n<\/td>\n

\n

B\u1ed9\u00a0C\u00f4ng Th\u01b0\u01a1ng<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

12<\/p>\n<\/td>\n

\n

Methylamine<\/p>\n<\/td>\n

\n

Methanamine<\/p>\n<\/td>\n

\n

74-89-5<\/p>\n<\/td>\n

\n

2921.11.00<\/p>\n<\/td>\n

\n

B\u1ed9\u00a0C\u00f4ng Th\u01b0\u01a1ng<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

13<\/p>\n<\/td>\n

\n

Nitroethane<\/p>\n<\/td>\n

\n

Nitroethane<\/p>\n<\/td>\n

\n

79-24-3<\/p>\n<\/td>\n

\n

2904.20.90<\/p>\n<\/td>\n

\n

B\u1ed9\u00a0C\u00f4ng Th\u01b0\u01a1ng<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

14<\/p>\n<\/td>\n

\n

Potassium permanganate<\/p>\n<\/td>\n

\n

Potassium permanganate<\/p>\n<\/td>\n

\n

7722-64-7<\/p>\n<\/td>\n

\n

2841.61.00<\/p>\n<\/td>\n

\n

B\u1ed9\u00a0C\u00f4ng Th\u01b0\u01a1ng<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

15<\/p>\n<\/td>\n

\n

Sulfuric acid<\/p>\n<\/td>\n

\n

Sulfuric acid<\/p>\n<\/td>\n

\n

7664-93-9<\/p>\n<\/td>\n

\n

2807.00.00<\/p>\n<\/td>\n

\n

B\u1ed9\u00a0C\u00f4ng Th\u01b0\u01a1ng<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

16<\/p>\n<\/td>\n

\n

Tartaric acid<\/p>\n<\/td>\n

\n

2,3-Dihydroxy butanedioic acid<\/p>\n<\/td>\n

\n

526-83-0<\/p>\n

87-69-4<\/p>\n

133-37-9<\/p>\n<\/td>\n

\n

2918.12.00<\/p>\n<\/td>\n

\n

B\u1ed9\u00a0C\u00f4ng Th\u01b0\u01a1ng<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

17<\/p>\n<\/td>\n

\n

Thionyl chloride<\/p>\n<\/td>\n

\n

Thionyl chloride<\/p>\n<\/td>\n

\n

7719-09-7<\/p>\n<\/td>\n

\n

2812.17.00<\/p>\n<\/td>\n

\n

B\u1ed9\u00a0C\u00f4ng Th\u01b0\u01a1ng<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

18<\/p>\n<\/td>\n

\n

Toluene<\/p>\n<\/td>\n

\n

Methyl benzene<\/p>\n<\/td>\n

\n

108-88-3<\/p>\n<\/td>\n

\n

2902.30.00<\/p>\n<\/td>\n

\n

B\u1ed9\u00a0C\u00f4ng Th\u01b0\u01a1ng<\/span><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Ghi ch\u00fa:<\/i><\/b>\u00a0B\u1ed9 N\u00f4ng nghi\u1ec7p v\u00e0 Ph\u00e1t tri\u1ec3n n\u00f4ng th\u00f4n c\u00f3 tr\u00e1ch nhi\u1ec7m qu\u1ea3n l\u00fd c\u00e1c ti\u1ec1n ch\u1ea5t d\u00f9ng l\u00e0m nguy\u00ean li\u1ec7u s\u1ea3n xu\u1ea5t thu\u1ed1c th\u00fa y theo quy \u0111\u1ecbnh t\u1ea1i Ngh\u1ecb \u0111\u1ecbnh s\u1ed1\u00a0105\/2021\/N\u0110-CP\u00a0ng\u00e0y 04 th\u00e1ng 12 n\u0103m 2021 c<\/span>\u1ee7a Ch\u00ednh ph\u1ee7 quy \u0111\u1ecbnh chi ti\u1ebft v\u00e0 h\u01b0<\/span>\u1edbng d\u1eabn thi h\u00e0nh m\u1ed9t s\u1ed1 \u0111i\u1ec1u c\u1ee7a Lu\u1eadt Ph\u00f2ng, ch\u1ed1ng ma t\u00fay.<\/p>\n

\u00bb Lu\u1eadt s\u01b0 chuy\u00ean t\u01b0 v\u1ea5n, b\u00e0o ch\u1eefa t\u1ed9i ma t\u00fay<\/a><\/p>\n

\u00bb Ma tu\u00fd n\u00fap b\u00f3ng thu\u1ed1c l\u00e1 \u0111i\u1ec7n t\u1eed<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Ngh\u1ecb \u0111\u1ecbnh s\u1ed1 57\/2022\/N\u0110-CP Quy \u0111\u1ecbnh c\u00e1c danh m\u1ee5c ch\u1ea5t ma t\u00fay v\u00e0 ti\u1ec1n ch\u1ea5t.\u00a0 CH\u00cdNH PH\u1ee6 C\u1ed8NG H\u00d2A X\u00c3 H\u1ed8I CH\u1ee6 NGH\u0128A VI\u1ec6T NAM\u0110\u1ed9c l\u1eadp \u2013 T\u1ef1 do \u2013 H\u1ea1nh ph\u00fac S\u1ed1: 57\/2022\/N\u0110-CP H\u00e0 N\u1ed9i, ng\u00e0y 25 th\u00e1ng 8 n\u0103m 2022 NGH\u1eca \u0110\u1ecaNH QUY \u0110\u1ecaNH C\u00c1C DANH M\u1ee4C CH\u1ea4T MA T\u00daY V\u00c0 TI\u1ec0N CH\u1ea4T […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[162],"tags":[],"_links":{"self":[{"href":"https:\/\/luatsubaoho.com\/phapluat\/wp-json\/wp\/v2\/posts\/35412"}],"collection":[{"href":"https:\/\/luatsubaoho.com\/phapluat\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/luatsubaoho.com\/phapluat\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/luatsubaoho.com\/phapluat\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/luatsubaoho.com\/phapluat\/wp-json\/wp\/v2\/comments?post=35412"}],"version-history":[{"count":8,"href":"https:\/\/luatsubaoho.com\/phapluat\/wp-json\/wp\/v2\/posts\/35412\/revisions"}],"predecessor-version":[{"id":41645,"href":"https:\/\/luatsubaoho.com\/phapluat\/wp-json\/wp\/v2\/posts\/35412\/revisions\/41645"}],"wp:attachment":[{"href":"https:\/\/luatsubaoho.com\/phapluat\/wp-json\/wp\/v2\/media?parent=35412"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/luatsubaoho.com\/phapluat\/wp-json\/wp\/v2\/categories?post=35412"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/luatsubaoho.com\/phapluat\/wp-json\/wp\/v2\/tags?post=35412"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}